Code	Codelist Code	Codelist Extensible (Yes/No)	Codelist Name	CDISC Submission Value	CDISC Preferred Term	CDISC Synonym(s)	CDISC Definition	NCI Preferred Term	Pre-release/ Production
C66767	C66767	No	Action Taken with Study Treatment 	ACN	ACN	Action Taken with Study Treatment	The reason that changes were made to the therapy under study. (NCI)	CDISC SDTM Action Taken with Study Treatment Terminology	Production
C49503	C66767		Action Taken with Study Treatment 	DOSE INCREASED	DOSE INCREASED		An indication that a medication schedule was modified by addition; either by changing the frequency, strength or amount. (NCI)	Dose Increased	Production
C49504	C66767		Action Taken with Study Treatment 	DOSE NOT CHANGED	DOSE NOT CHANGED		An indication that a medication schedule was maintained. (NCI)	Dose Not Changed	Production
C49505	C66767		Action Taken with Study Treatment 	DOSE REDUCED	DOSE REDUCED		An indication that a medication schedule was modified by subtraction, either by changing the frequency, strength or amount. (NCI)	Dose Reduced	Production
C49501	C66767		Action Taken with Study Treatment 	DRUG INTERRUPTED	DRUG INTERRUPTED		An indication that a medication schedule was modified by temporarily terminating a prescribed regimen of medication. (NCI)	Drug Interrupted	Production
C49502	C66767		Action Taken with Study Treatment 	DRUG WITHDRAWN	DRUG WITHDRAWN		An indication that a medication schedule was modified through termination of a prescribed regimen of medication. (NCI)	Drug Withdrawn	Production
C48660	C66767		Action Taken with Study Treatment 	NOT APPLICABLE	NOT APPLICABLE	NA	Determination of a value is not relevant in the current context. (NCI)	Not Applicable	Production
C17998	C66767		Action Taken with Study Treatment 	UNKNOWN	UNKNOWN	U; Unknown	Not known, not observed, not recorded, or refused. (NCI)	Unknown	Production
C66768	C66768	No	Outcome of Event	OUT	OUT	Outcome of Event	A condition or event that is attributed to the adverse event and is the result or conclusion of the adverse event. (NCI)	CDISC SDTM Adverse Event Outcome Terminology	Production
C48275	C66768		Outcome of Event	FATAL	FATAL	Grade 5; 5	The termination of life as a result of an adverse event. (NCI)	Death Related to Adverse Event	Production
C49494	C66768		Outcome of Event	NOT RECOVERED/NOT RESOLVED	NOT RECOVERED/NOT RESOLVED		One of the possible results of an adverse event outcome that indicates that the event has not improved or recuperated. (NCI)	Not Recovered or Not Resolved	Production
C49498	C66768		Outcome of Event	RECOVERED/RESOLVED	RECOVERED/RESOLVED		One of the possible results of an adverse event outcome that indicates that the event has improved or recuperated. (NCI)	Recovered or Resolved	Production
C49495	C66768		Outcome of Event	RECOVERED/RESOLVED WITH SEQUELAE	RECOVERED/RESOLVED WITH SEQUELAE		One of the possible results of an adverse event outcome where the subject recuperated but retained pathological conditions resulting from the prior disease or injury. (NCI)	Recovered or Resolved with Sequelae	Production
C49496	C66768		Outcome of Event	RECOVERING/RESOLVING	RECOVERING/RESOLVING		One of the possible results of an adverse event outcome that indicates that the event is improving. (NCI)	Recovering or Resolving	Production
C17998	C66768		Outcome of Event	UNKNOWN	UNKNOWN	U; Unknown	Not known, not observed, not recorded, or refused. (NCI)	Unknown	Production
C66780	C66780	Yes	Age Span	AGESPAN	AGESPAN	Age Span	Subgroups of populations based on age. (NCI)	CDISC SDTM Age GroupTerminology	Production
C27954	C66780		Age Span	ADOLESCENT (12-17 YEARS)	ADOLESCENT (12-17 YEARS)		A juvenile between the onset of puberty and maturity; in the state of development between puberty and maturity. (NCI)	Adolescent	Production
C49685	C66780		Age Span	ADULT (18-65)	ADULT (18-65)		A person from 18 years to 65 years of age. (NCI)	Adult 18-65 Years Old	Production
C49683	C66780		Age Span	CHILDREN (2-11 YEARS)	CHILDREN (2-11 YEARS)		A person from 2 years to 11 years of age. (NCI)	Children 2-11 Years Old	Production
C16268	C66780		Age Span	ELDERLY (> 65)	ELDERLY (> 65)		An age group comprised by people 65 years of age and older. (NCI) 	Elderly	Production
C49641	C66780		Age Span	IN UTERO	IN UTERO		The period of time during which the embryo or foetus is present in the uterus of the female. Also describes the location of the embryo or foetus as being in the uterus in contrast to outside the uterus (ex utero). (NCI)	In Utero	Production
C49643	C66780		Age Span	INFANT AND TODDLER (28 DAYS - 23 MONTHS)	INFANT AND TODDLER (28 DAYS - 23 MONTHS)		A person from 28 days to 23 months of age. (NCI)	Infant And Toddler	Production
C16731	C66780		Age Span	NEWBORN (0-27 DAYS)	NEWBORN (0-27 DAYS)		An infant during the first month after birth. (NCI)	Newborn	Production
C49642	C66780		Age Span	PRETERM NEWBORN INFANTS	PRETERM NEWBORN INFANTS		An infant born prior to completion of the normal gestation period. (NCI)	Preterm Newborn Infant	Production
C66781	C66781	No	Age Unit	AGEU	AGEU	Age Unit	Those units of time that are routinely used to express the age of a person. (NCI)	CDISC SDTM Age UnitTerminology	Production
C25301	C66781		Age Unit	DAYS	DAYS		The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours.  This also refers to a specific day. (NCI)	Day	Production
C25529	C66781		Age Unit	HOURS	HOURS		A unit measure of time equal to 3,600 seconds or 60 minutes. It is approximately 1/24 of a median day. (NCI)	Hour	Production
C29846	C66781		Age Unit	MONTHS	MONTHS		One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon's phases, about 30 days or 4 weeks. (NCI)	Month	Production
C29844	C66781		Age Unit	WEEKS	WEEKS		Any period of seven consecutive days. (NCI)	Week	Production
C29848	C66781		Age Unit	YEARS	YEARS		The period of time that it takes for Earth to make a complete revolution around the sun, approximately 365 days; a specific one year period. (NCI)	Year	Production
C66797	C66797	No	Category for Inclusion/Exclusion	IECAT	IECAT	Category for Inclusion/Exclusion	A collection of criteria on which subjects are evaluated and that must be met by all study subjects. (NCI)	CDISC SDTM Category of Inclusion And Or ExclusionTerminology	Production
C25370	C66797		Category for Inclusion/Exclusion	EXCLUSION	EXCLUSION		List of characteristics in a protocol, any one of which may exclude a potential subject from participation in a study. (CDISC glossary)	Exclusion	Production
C25532	C66797		Category for Inclusion/Exclusion	INCLUSION	INCLUSION		The criteria in a protocol that prospective subjects must meet to be eligible for participation in a study.  NOTE: Exclusion and inclusion criteria define the study population. See also exclusion criteria. (CDISC glossary)	Inclusion	Production
C66783	C66783	No	CDISC System Organ Class	SOC	SOC	CDISC System Organ Class	Terms at the highest level of the CDISC system organ class terminology.	CDISC SDTM System Organ Class Terminology	Production
C35814	C66783		CDISC System Organ Class	BLOOD AND LYMPHATIC SYSTEM DISORDERS	BLOOD AND LYMPHATIC SYSTEM DISORDERS		Any deviation from the normal structure or function of the blood or lymphatic system that is manifested by a characteristic set of symptoms and signs. (NCI)	Hematopoietic and Lymphoid System Disorder	Production
C3079	C66783		CDISC System Organ Class	CARDIAC DISORDERS	CARDIAC DISORDERS		Any deviation from the normal structure or function of the cardiac system that is manifested by a characteristic set of symptoms and signs. (NCI)	Heart Disorder	Production
C49399	C66783		CDISC System Organ Class	CONGENITAL, FAMILIAL AND GENETIC DISORDERS	CONGENITAL, FAMILIAL AND GENETIC DISORDERS		A class of disorders that encompasses conditions resulting from a congenital, familial hereditary trait or genetic abnormality as is manifested by a characterstic set of symptoms and signs. (NCI)	Congenital, Familial and Genetic Disorder Class	Production
C49400	C66783		CDISC System Organ Class	EAR AND LABYRINTH DISORDERS	EAR AND LABYRINTH DISORDERS		Any deviation from the normal structure or function of the ear or labyrinth that is manifested by a characteristic set of symptoms and signs. (NCI)	Ear and Labyrinth Disorder Class	Production
C3009	C66783		CDISC System Organ Class	ENDOCRINE DISORDERS	ENDOCRINE DISORDERS		Any deviation from the normal structure or function of the endocrine system that is manifested by a characteristic set of symptoms and signs. (NCI)	Endocrine Disorder	Production
C26767	C66783		CDISC System Organ Class	EYE DISORDERS	EYE DISORDERS		Any deviation from the normal structure or function of the eye that is manifested by a characteristic set of symptoms and signs. (NCI)	Eye Disorder	Production
C2990	C66783		CDISC System Organ Class	GASTROINTESTINAL DISORDERS	GASTROINTESTINAL DISORDERS		Diseases of the digestive tract (oral cavity to anus) and associated organs (salivary glands, liver, pancreas). (NCI)	Gastrointestinal Disorder	Production
C49401	C66783		CDISC System Organ Class	GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS	GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS		A class of disorders that encompasses conditions of a general kind that result from a disease, the treatment of disease or administration of treatment at a particular site and are manifested by a characteristic set of symptoms and signs. (NCI)	General Disorders and Administration Site Conditions Class	Production
C3959	C66783		CDISC System Organ Class	HEPATOBILIARY DISORDERS	HEPATOBILIARY DISORDERS		Any deviation from the normal structure or function of the liver or biliary tract that is manifested by a characteristic set of symptoms and signs. (NCI)	Liver and Biliary Tract Disorder	Production
C3507	C66783		CDISC System Organ Class	IMMUNE SYSTEM DISORDERS	IMMUNE SYSTEM DISORDERS		A disorder resulting from an abnormality in the immune system. -- 2003 (NCI)	Immune System Disorder	Production
C26726	C66783		CDISC System Organ Class	INFECTIONS AND INFESTATIONS	INFECTIONS AND INFESTATIONS		A disorder resulting from the presence and activity of a microbial, viral, or parasitic agent. It can be transmitted by direct or indirect contact. -- 2003 (NCI)	Infectious Disorder	Production
C49402	C66783		CDISC System Organ Class	INJURY, POISONING AND PROCEDURAL COMPLICATIONS	INJURY, POISONING AND PROCEDURAL COMPLICATIONS		A class of disorders that encompasses conditions resulting from an injury, poisoning or procedure. (NCI)	Injury, Poisoning and Procedural Complication Class	Production
C41198	C66783		CDISC System Organ Class	INVESTIGATIONS	INVESTIGATIONS		The act or process of a systematic and thorough examination; research, study; the process of inquiring into or following up, intended to develop facts. (NCI)	Investigation	Production
C49403	C66783		CDISC System Organ Class	METABOLISM AND NUTRITION DISORDERS	METABOLISM AND NUTRITION DISORDERS		A class of disorders that encompasses conditions occurring as a result of metabolic dysfunction or deviation from the normal nutritional requirements. (NCI)	Metabolism and Nutrition Disorder Class	Production
C27574	C66783		CDISC System Organ Class	MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS	MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS		Any deviation from the normal structure or function of the musculoskeletal or connective tissue that is manifested by a characteristic set of symptoms and signs. (NCI)	Connective and Soft Tissue Disorder	Production
C3262	C66783		CDISC System Organ Class	NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)	NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)		An abnormal tissue growth resulted from uncontrolled cell proliferation.  Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant ones exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia.  Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias. -- 2004 (NCI)	Neoplasm	Production
C26835	C66783		CDISC System Organ Class	NERVOUS SYSTEM DISORDERS	NERVOUS SYSTEM DISORDERS		Any deviation from the normal structure or function of the nervous system that is manifested by a characteristic set of symptoms and signs. (NCI)	Nervous System Disorder	Production
C49404	C66783		CDISC System Organ Class	PREGNANCY, PUERPERIUM AND PERINATAL CONDITIONS	PREGNANCY, PUERPERIUM AND PERINATAL CONDITIONS		A class of conditions associated with pregnancy, puerperium and perinatal status. (NCI)	Pregnancy, Puerperium and Perinatal Condition Class	Production
C2893	C66783		CDISC System Organ Class	PSYCHIATRIC DISORDERS	PSYCHIATRIC DISORDERS		Any deviation from the normal structure or function of the brain and a psychiatric condition, that results in an impairment of an individual's normal cognitive, emotional, or behavioral functioning, and is caused by physiological or psychosocial factors. (NCI)	Psychiatric Disorder	Production
C3430	C66783		CDISC System Organ Class	RENAL AND URINARY DISORDERS	RENAL AND URINARY DISORDERS		Disorders of any part of the urologic system. (NCI)	Urinary System Disorder	Production
C49405	C66783		CDISC System Organ Class	REPRODUCTIVE SYSTEM AND BREAST DISORDERS	REPRODUCTIVE SYSTEM AND BREAST DISORDERS		Any deviation from the normal structure or function of the reproductive system or breast that is manifested by a characteristic set of symptoms and signs. (NCI)	Reproductive System and Breast Disorder Class	Production
C27669	C66783		CDISC System Organ Class	RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS	RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS		Any deviation from the normal structure or function of the respiratory system including the thorax and mediastinum that is manifested by a characteristic set of symptoms and signs. (NCI)	Respiratory and Thoracic Disorder	Production
C3371	C66783		CDISC System Organ Class	SKIN AND SUBCUTANEOUS TISSUE DISORDERS	SKIN AND SUBCUTANEOUS TISSUE DISORDERS		Any deviation from the normal structure or function of the skin or subcutaneous tissue that is manifested by a characteristic set of symptoms and signs.(NCI)	Skin Disorder	Production
C20188	C66783		CDISC System Organ Class	SOCIAL CIRCUMSTANCES	SOCIAL CIRCUMSTANCES		A set of concepts that results from or is influenced by criteria or activities associated with the social environment of a person. (NCI)	Social Circumstances	Production
C25218	C66783		CDISC System Organ Class	SURGICAL AND MEDICAL PROCEDURES	SURGICAL AND MEDICAL PROCEDURES		A particular course of action intended to achieve a result. (NCI)	Procedure	Production
C35117	C66783		CDISC System Organ Class	VASCULAR DISORDERS	VASCULAR DISORDERS		Any deviation from the normal structure or function of the vascular system that is manifested by a characteristic set of symptoms and signs. (NCI)	Vascular Disorder	Production
C66784	C66784	No	Common Terminology Criteria for Adverse Events	TOXGR	TOXGR	Common Terminology Criteria for Adverse Events	A standard terminology developed to report adverse events occurring in cancer clinical trials.  Common terminology criteria for adverse events (CTCAE) are used in study adverse event summaries and Investigational New Drug reports to the Food and Drug Administration.  The CTCAE contain a grading scale for each adverse event term representing the severity of the event. (NCI)	CDISC SDTM CommonTerminology Criteria for Adverse Event Grade Terminology	Production
C41338	C66784		Common Terminology Criteria for Adverse Events	1	MILD	Grade 1; 1	A type of adverse event that is usually transient and may require only minimal treatment or therapeutic intervention. The event does not generally interfere with usual activities of daily living.	Mild Adverse Event	Production
C41339	C66784		Common Terminology Criteria for Adverse Events	2	MODERATE	Grade 2; 2	A type of adverse event that is usually alleviated with additional specific therapeutic intervention. The event interferes with usual activities of daily living, causing discomfort but poses no significant or permanent risk of harm to the research participant.	Moderate Adverse Event	Production
C41340	C66784		Common Terminology Criteria for Adverse Events	3	SEVERE	Grade 3; 3	A type of adverse event that requires intensive therapeutic intervention. The event interrupts usual activities of daily living, or significantly affects clinical status. The event possesses a significant risk of harm to the research participant and hospitalization may be required.	Severe Adverse Event	Production
C41337	C66784		Common Terminology Criteria for Adverse Events	4	LIFE THREATENING	Grade 4; 4	An adverse event, and/or its immediate sequelae, which is associated with an imminent risk of death or which is associated with physical or mental disabilities that affect or limit the ability of a person to perform activities of daily living (eating, ambulation, toileting, etc.) See NCI Common Terminology Criteria for Adverse Events.	Life Threatening or Disabling Adverse Event	Production
C48275	C66784		Common Terminology Criteria for Adverse Events	5	FATAL	Grade 5; 5	The termination of life as a result of an adverse event. (NCI)	Death Related to Adverse Event	Production
C66785	C66785	Yes	Control Type	TCNTRL	TCNTRL	Control Type; Type of Control	Comparator against which the study treatment is evaluated (e.g., concurrent (placebo, no treatment, dose-response, active), external (historical, published literature).	CDISC SDTM Control Type Terminology	Production
C49649	C66785		Control Type	ACTIVE	ACTIVE		A type of control, which has a demonstrated effect, administered as a comparator, to subjects in a clinical trial. [From ICH E10].	Active Control	Production
C41132	C66785		Control Type	NONE	NONE		No person or thing, nobody, not any. (NCI)	None	Production
C49648	C66785		Control Type	PLACEBO	PLACEBO		Use of an inactive compound identical in appearance to drug or treatment being tested in experimental research, which may or may not be known to the physician and/or subject, administered to distinguish between drug action and suggestive effect of the drug or treatment under study. The effects of the active drug or treatment are compared to the effects of the placebo. (NCI)	Placebo Control	Production
C66786	C66786	No	Country	COUNTRY	COUNTRY	Country 	A collective generic term that refers here to a wide variety of dependencies, areas of special sovereignty, uninhabited islands, and other entities in addition to the traditional countries or independent states. (NCI)	CDISC SDTM Country Terminology	Production
C17884	C66786		Country	ABW	ABW	ARUBA	Island in the Caribbean Sea, north of Venezuela.	Aruba	Production
C16267	C66786		Country	AFG	AFG	AFGHANISTAN	A country in Southern Asia, north and west of Pakistan, east of Iran.	Afghanistan	Production
C16292	C66786		Country	AGO	AGO	ANGOLA	A country in Southern Africa, bordering the South Atlantic Ocean, between Namibia and Democratic Republic of the Congo.	Angola	Production
C20133	C66786		Country	AIA	AIA	ANGUILLA	An island in the Caribbean Sea, east of Puerto Rico.	Anguilla	Production
C44481	C66786		Country	ALA	ALA	ALAND ISLANDS	An archipelago in the Baltic Sea at the entrance to the Gulf of Bothnia between Sweden and Finland.	Aland Islands	Production
C16271	C66786		Country	ALB	ALB	ALBANIA	A country in Southeastern Europe, bordering the Adriatic Sea and Ionian Sea, between Greece and Serbia and Montenegro.	Albania	Production
C16289	C66786		Country	AND	AND	ANDORRA	A country in Southwestern Europe, between France and Spain.	Andorra	Production
C16904	C66786		Country	ANT	ANT	NETHERLANDS ANTILLES	A country in the Caribbean, comprising two island groups in the Caribbean Sea - one includes Curacao and Bonaire north of Venezuela; the other is east of the Virgin Islands.	Netherlands Antilles	Production
C17232	C66786		Country	ARE	ARE	UNITED ARAB EMIRATES	A country in the Middle East, bordering the Gulf of Oman and the Persian Gulf, between Oman and Saudi Arabia.	United Arab Emirates	Production
C16305	C66786		Country	ARG	ARG	ARGENTINA	A country in Southern South America, bordering the South Atlantic Ocean, between Chile and Uruguay.	Argentina	Production
C16306	C66786		Country	ARM	ARM	ARMENIA	A country in Southwestern Asia, east of Turkey.	Armenia	Production
C17739	C66786		Country	ASM	ASM	AMERICAN SAMOA	A group of islands in the South Pacific Ocean, about half way between Hawaii and New Zealand.	American Samoa	Production
C18007	C66786		Country	ATA	ATA	ANTARCTICA	The continent lying mostly south of the Antarctic Circle.	Antarctica	Production
C20105	C66786		Country	ATF	ATF	FRENCH SOUTHERN TERRITORIES	Islands in the southern Indian Ocean, south of Africa, about equidistant between Africa, Antarctica, and Australia.	French Southern Territories	Production
C16303	C66786		Country	ATG	ATG	ANTIGUA AND BARBUDA	Islands between the Caribbean Sea and the North Atlantic Ocean, east-southeast of Puerto Rico.	Antigua and Barbuda	Production
C16311	C66786		Country	AUS	AUS	AUSTRALIA	The continent between the Indian Ocean and the South Pacific Ocean.	Australia	Production
C16312	C66786		Country	AUT	AUT	AUSTRIA	A country in Central Europe, north of Italy and Slovenia.	Austria	Production
C16316	C66786		Country	AZE	AZE	AZERBAIJAN	A country in Southwestern Asia, bordering the Caspian Sea, between Iran and Russia.	Azerbaijan	Production
C16371	C66786		Country	BDI	BDI	BURUNDI	A country in Central Africa, east of Democratic Republic of the Congo.	Burundi	Production
C16329	C66786		Country	BEL	BEL	BELGIUM	A country in Western Europe, bordering the North Sea, between France and the Netherlands.	Belgium	Production
C16333	C66786		Country	BEN	BEN	BENIN REPUBLIC	A country in Western Africa, bordering the North Atlantic Ocean, between Nigeria and Togo.	Benin Republic	Production
C16369	C66786		Country	BFA	BFA	BURKINA FASO	A country in Western Africa, north of Ghana.	Burkina Faso	Production
C16323	C66786		Country	BGD	BGD	BANGLADESH	A country in Southern Asia, bordering the Bay of Bengal, between Burma and India.	Bangladesh	Production
C16368	C66786		Country	BGR	BGR	BULGARIA	A country in Southeastern Europe, bordering the Black Sea, between Romania and Turkey.	Bulgaria	Production
C16322	C66786		Country	BHR	BHR	BAHRAIN	An archipelago in the Persian Gulf, east of Saudi Arabia.	Bahrain	Production
C16321	C66786		Country	BHS	BHS	BAHAMAS	A chain of islands in the North Atlantic Ocean, southeast of Florida.	Bahamas	Production
C16361	C66786		Country	BIH	BIH	BOSNIA-HERZEGOVINA	A country in Southeastern Europe, bordering the Adriatic Sea and Croatia.	Bosnia-Herzegovina	Production
C16372	C66786		Country	BLR	BLR	BELARUS	A country in Eastern Europe, east of Poland.	Belarus	Production
C16331	C66786		Country	BLZ	BLZ	BELIZE	A country in Central America, bordering the Caribbean Sea, between Guatemala and Mexico.	Belize	Production
C16334	C66786		Country	BMU	BMU	BERMUDA	No Definition	Bermuda	Production
C16359	C66786		Country	BOL	BOL	BOLIVIA	A country in Central South America, southwest of Brazil.	Bolivia	Production
C16364	C66786		Country	BRA	BRA	BRAZIL	A country in Eastern South America, bordering the Atlantic Ocean.	Brazil	Production
C16324	C66786		Country	BRB	BRB	BARBADOS	An island between the Caribbean Sea and the North Atlantic Ocean, northeast of Venezuela.	Barbados	Production
C16367	C66786		Country	BRN	BRN	BRUNEI	A country in Southeastern Asia, bordering the South China Sea and Malaysia.	Brunei Darussalam	Production
C16336	C66786		Country	BTN	BTN	BHUTAN	A country in Southern Asia, between China and India.	Bhutan	Production
C20104	C66786		Country	BVT	BVT	BOUVET ISLAND	An island in the South Atlantic Ocean, south-southwest of the Cape of Good Hope (South Africa).	Bouvet Island	Production
C16363	C66786		Country	BWA	BWA	BOTSWANA	A country in Southern Africa, north of South Africa.	Botswana	Production
C16409	C66786		Country	CAF	CAF	CENTRAL AFRICAN REPUBLIC	A country in Central Africa, north of Democratic Republic of the Congo.	Central African Republic	Production
C16380	C66786		Country	CAN	CAN	CANADA	A country in Northern North America, bordering the North Atlantic Ocean on the east, North Pacific Ocean on the west, and the Arctic Ocean on the north, north of the conterminous US.	Canada	Production
C16445	C66786		Country	CCK	CCK	COCOS (KEELING) ISLANDS	A group of islands in the Indian Ocean, south of Indonesia, about halfway from Australia to Sri Lanka.	Cocos (Keeling) Islands	Production
C17181	C66786		Country	CHE	CHE	SWITZERLAND	A country in Central Europe, east of France, north of Italy.	Switzerland	Production
C16427	C66786		Country	CHL	CHL	CHILE	A country in Southern South America, bordering the South Atlantic Ocean and South Pacific Ocean, between Argentina and Peru.	Chile	Production
C16428	C66786		Country	CHN	CHN	CHINA	A country in Eastern Asia, bordering the East China Sea, Korea Bay, Yellow Sea, and South China Sea, between North Korea and Vietnam.	China	Production
C16762	C66786		Country	CIV	CIV	COTE D'IVOIRE	A country in Western Africa, bordering the North Atlantic Ocean, between Ghana and Liberia.	Cote d'Ivoire	Production
C16379	C66786		Country	CMR	CMR	CAMEROON	A country in Western Africa, bordering the Bight of Biafra, between Equatorial Guinea and Nigeria.	Cameroon	Production
C17266	C66786		Country	COD	COD	DEMOCRATIC REPUBLIC OF THE CONGO	A country in Central Africa, northeast of Angola.	Democratic Republic of the Congo	Production
C16467	C66786		Country	COG	COG	CONGO	A country in Western Africa, bordering the South Atlantic Ocean, between Angola and Gabon.	Congo	Production
C16469	C66786		Country	COK	COK	COOK ISLANDS	A group of islands in the South Pacific Ocean, about one-half of the way from Hawaii to New Zealand.	Cook Islands	Production
C16449	C66786		Country	COL	COL	COLOMBIA	A country in Northern South America, bordering the Caribbean Sea, between Panama and Venezuela, and bordering the North Pacific Ocean, between Ecuador and Panama.	Colombia	Production
C16458	C66786		Country	COM	COM	COMOROS	A group of islands in the Mozambique Channel, about two-thirds of the way between northern Madagascar and northern Mozambique.	Comoros	Production
C16382	C66786		Country	CPV	CPV	CAPE VERDE	A group of islands in the North Atlantic Ocean, west of Senegal.	Cape Verde	Production
C16470	C66786		Country	CRI	CRI	COSTA RICA	A country in Central America, bordering both the Caribbean Sea and the North Pacific Ocean, between Nicaragua and Panama.	Costa Rica	Production
C16477	C66786		Country	CUB	CUB	CUBA	An island between the Caribbean Sea and the North Atlantic Ocean, 150 km south of Key West, Florida.	Cuba	Production
C44482	C66786		Country	CXR	CXR	CHRISTMAS ISLAND	An Australian-administered island in the eastern Indian Ocean south of Java, Indonesia.	Christmas Island	Production
C16391	C66786		Country	CYM	CYM	CAYMAN ISLANDS	An island group in the Caribbean Sea, nearly one-half of the way from Cuba to Honduras.	Cayman Islands	Production
C16480	C66786		Country	CYP	CYP	CYPRUS	An island in the Mediterranean Sea, south of Turkey.	Cyprus	Production
C17668	C66786		Country	CZE	CZE	CZECH REPUBLIC	A country in Central Europe, southeast of Germany.	Czech Republic	Production
C16636	C66786		Country	DEU	DEU	GERMANY	A country in Central Europe, bordering the Baltic Sea and the North Sea, between the Netherlands and Poland, south of Denmark.	Germany	Production
C16506	C66786		Country	DJI	DJI	DJIBOUTI	A country in Eastern Africa, bordering the Gulf of Aden and the Red Sea, between Eritrea and Somalia.	Djibouti	Production
C16519	C66786		Country	DMA	DMA	DOMINICA	An island between the Caribbean Sea and the North Atlantic Ocean, about one-half of the way from Puerto Rico to Trinidad and Tobago.	Dominica	Production
C16496	C66786		Country	DNK	DNK	DENMARK	A country in Northern Europe, bordering the Baltic Sea and the North Sea, on a peninsula north of Germany (Jutland); also includes two major islands (Sjaelland and Fyn).	Denmark	Production
C16520	C66786		Country	DOM	DOM	DOMINICAN REPUBLIC	A country comprising the eastern two-thirds of the island of Hispaniola, between the Caribbean Sea and the North Atlantic Ocean, east of Haiti.	Dominican Republic	Production
C16274	C66786		Country	DZA	DZA	ALGERIA	A country in Northern Africa, bordering the Mediterranean Sea, between Morocco and Tunisia.	Algeria	Production
C16528	C66786		Country	ECU	ECU	ECUADOR	A country in Western South America, bordering the Pacific Ocean at the Equator, between Colombia and Peru.	Ecuador	Production
C16530	C66786		Country	EGY	EGY	EGYPT	A country in Northern Africa, bordering the Mediterranean Sea, between Libya and the Gaza Strip.	Egypt	Production
C16558	C66786		Country	ERI	ERI	ERITREA	A country in Eastern Africa, bordering the Red Sea, between Djibouti and Sudan.	Eritrea	Production
C20113	C66786		Country	ESH	ESH	WESTERN SAHARA	A country in Northern Africa, bordering the North Atlantic Ocean, between Mauritania and Morocco.	Western Sahara	Production
C17152	C66786		Country	ESP	ESP	SPAIN	A country in Southwestern Europe, bordering the Bay of Biscay, Mediterranean Sea, North Atlantic Ocean, and Pyrenees Mountains, southwest of France.	Spain	Production
C16562	C66786		Country	EST	EST	ESTONIA	A country in Eastern Europe, bordering the Baltic Sea and Gulf of Finland, between Latvia and Russia.	Estonia	Production
C16563	C66786		Country	ETH	ETH	ETHIOPIA	A country in Eastern Africa, west of Somalia.	Ethiopia	Production
C16584	C66786		Country	FIN	FIN	FINLAND	A country in Northern Europe, bordering the Baltic Sea, Gulf of Bothnia, and Gulf of Finland, between Sweden and Russia.	Finland	Production
C16582	C66786		Country	FJI	FJI	FIJI	An island group in the South Pacific Ocean, about two-thirds of the way from Hawaii to New Zealand.	Fiji	Production
C17954	C66786		Country	FLK	FLK	FALKLAND ISLANDS	Islands in the South Atlantic Ocean, east of southern Argentina.	Falkland Islands	Production
C16592	C66786		Country	FRA	FRA	FRANCE	A country in Western Europe, bordering the Bay of Biscay and English Channel, between Belgium and Spain, southeast of the UK; bordering the Mediterranean Sea, between Italy and Spain.	France	Production
C16573	C66786		Country	FRO	FRO	FAROE ISLANDS	An island group between the Norwegian Sea and the North Atlantic Ocean, about one-half of the way from Iceland to Norway.	Faroe Islands	Production
C17881	C66786		Country	FSM	FSM	MICRONESIA, FEDERATED STATES OF	An island group in the North Pacific Ocean, about three-quarters of the way from Hawaii to Indonesia.	Federated States of Micronesia	Production
C16596	C66786		Country	GAB	GAB	GABON	A country in Western Africa, bordering the Atlantic Ocean at the Equator, between Republic of the Congo and Equatorial Guinea.	Gabon	Production
C17233	C66786		Country	GBR	GBR	UNITED KINGDOM	A country in Western Europe, comprising islands, including the northern one-sixth of the island of Ireland, between the North Atlantic Ocean and the North Sea, northwest of France.	United Kingdom	Production
C16634	C66786		Country	GEO	GEO	GEORGIA	A country in Southwestern Asia, bordering the Black Sea, between Turkey and Russia.	Georgia	Production
C64375	C66786		Country	GGY	GGY	GUERNSEY	The island of Guernsey and the other Channel Islands represent the last remnants of the medieval Dukedom of Normandy, which held sway in both France and England. Guernsey is a British crown dependency, but is not part of the UK.	Guernsey	Production
C26330	C66786		Country	GHA	GHA	GHANA	A country in Western Africa, bordering the Gulf of Guinea, between Cote d'Ivoire and Togo.	Ghana	Production
C16638	C66786		Country	GIB	GIB	GIBRALTAR	A dependency in Southwestern Europe, bordering the Strait of Gibraltar, on the southern coast of Spain.	Gibraltar	Production
C16655	C66786		Country	GIN	GIN	GUINEA	A country in Western Africa, bordering the North Atlantic Ocean, between Guinea-Bissau and Sierra Leone.	Guinea	Production
C16651	C66786		Country	GLP	GLP	GUADELOUPE	Islands in the eastern Caribbean Sea, southeast of Puerto Rico.	Guadeloupe	Production
C16598	C66786		Country	GMB	GMB	GAMBIA	A country in Western Africa, bordering the North Atlantic Ocean and Senegal.	Gambia	Production
C16656	C66786		Country	GNB	GNB	GUINEA-BISSAU	A country in Western Africa, bordering the North Atlantic Ocean, between Guinea and Senegal.	Guinea-Bissau	Production
C16557	C66786		Country	GNQ	GNQ	EQUATORIAL GUINEA	A country in Western Africa, bordering the Bight of Biafra, between Cameroon and Gabon; composed of a mainland portion and five inhabited islands.	Equatorial Guinea	Production
C16645	C66786		Country	GRC	GRC	GREECE	A country in Southern Europe, bordering the Aegean Sea, Ionian Sea, and the Mediterranean Sea, between Albania and Turkey.	Greece	Production
C16647	C66786		Country	GRD	GRD	GRENADA	An island between the Caribbean Sea and Atlantic Ocean, north of Trinidad and Tobago.	Grenada	Production
C16646	C66786		Country	GRL	GRL	GREENLAND	An island between the Arctic Ocean and the North Atlantic Ocean, northeast of Canada.	Greenland	Production
C16654	C66786		Country	GTM	GTM	GUATEMALA	A country in Central America, bordering the Caribbean Sea, between Honduras and Belize and bordering the North Pacific Ocean, between El Salvador and Mexico.	Guatemala	Production
C16593	C66786		Country	GUF	GUF	FRENCH GUIANA	A country in Northern South America, bordering the North Atlantic Ocean, between Brazil and Suriname.	French Guiana	Production
C16652	C66786		Country	GUM	GUM	GUAM	Island in the North Pacific Ocean, about three-quarters of the way from Hawaii to the Philippines.	Guam	Production
C16657	C66786		Country	GUY	GUY	GUYANA	A country in Northern South America, bordering the North Atlantic Ocean, between Suriname and Venezuela.	Guyana	Production
C16695	C66786		Country	HKG	HKG	HKG; HONG KONG	A special administrative region of China, bordering the South China Sea and China.	Hong Kong	Production
C20106	C66786		Country	HMD	HMD	HEARD ISLAND AND MCDONALD ISLANDS	Islands in the Indian Ocean, about two-thirds of the way from Madagascar to Antarctica.	Heard Island and McDonald Islands	Production
C16694	C66786		Country	HND	HND	HONDURAS	A country in Central America, bordering the Caribbean Sea, between Guatemala and Nicaragua and bordering the North Pacific Ocean, between El Salvador and Nicaragua.	Honduras	Production
C16474	C66786		Country	HRV	HRV	CROATIA	A country in Southeastern Europe, bordering the Adriatic Sea, between Bosnia and Herzegovina and Slovenia.	Croatia	Production
C16660	C66786		Country	HTI	HTI	HAITI	A country comprising the western one-third of the island of Hispaniola, between the Caribbean Sea and the North Atlantic Ocean, west of the Dominican Republic.	Haiti	Production
C16699	C66786		Country	HUN	HUN	HUNGARY	A country in Central Europe, northwest of Romania.	Hungary	Production
C16728	C66786		Country	IDN	IDN	INDONESIA	A country in Southeastern Asia, comprising the archipelago between the Indian Ocean and the Pacific Ocean.	Indonesia	Production
C16727	C66786		Country	IND	IND	INDIA	A country in Southern Asia, bordering the Arabian Sea and the Bay of Bengal, between Burma and Pakistan.	India	Production
C16365	C66786		Country	IOT	IOT	BRITISH INDIAN OCEAN TERRITORY	An archipelago in the Indian Ocean, about one-half the way from Africa to Indonesia.	British Indian Ocean Territory	Production
C16757	C66786		Country	IRL	IRL	IRELAND	A country in Western Europe, occupying five-sixths of the island of Ireland in the North Atlantic Ocean, west of Great Britain.	Ireland	Production
C16755	C66786		Country	IRN	IRN	IRAN	A country in the Middle East, bordering the Gulf of Oman, the Persian Gulf, and the Caspian Sea, between Iraq and Pakistan.	Iran	Production
C16756	C66786		Country	IRQ	IRQ	IRAQ	A country in the Middle East, bordering the Persian Gulf, between Iran and Kuwait.	Iraq	Production
C16704	C66786		Country	ISL	ISL	ICELAND	A country in Northern Europe, island between the Greenland Sea and the North Atlantic Ocean, northwest of the UK.	Iceland	Production
C16760	C66786		Country	ISR	ISR	ISRAEL	A country in the Middle East, bordering the Mediterranean Sea, between Egypt and Lebanon.	Israel	Production
C16761	C66786		Country	ITA	ITA	ITALY	A country in Southern Europe, occupying a peninsula extending into the central Mediterranean Sea, northeast of Tunisia.	Italy	Production
C16763	C66786		Country	JAM	JAM	JAMAICA	An island in the Caribbean Sea, south of Cuba.	Jamaica	Production
C16765	C66786		Country	JOR	JOR	JORDAN	A country in the Middle East, northwest of Saudi Arabia.	Jordan	Production
C16764	C66786		Country	JPN	JPN	JAPAN	A country in Eastern Asia, occupying an island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula.	Japan	Production
C64374	C66786		Country	JRE	JRE	JERSEY	Jersey and the other Channel Islands represent the last remnants of the medieval Dukedom of Normandy that held sway in both France and England. Jersey is a British crown dependency, but is not part of the UK.	Jersey	Production
C20107	C66786		Country	KAZ	KAZ	KAZAKHSTAN	A country in Central Asia, northwest of China.	Kazakhstan	Production
C16769	C66786		Country	KEN	KEN	KENYA	A country in Eastern Africa, bordering the Indian Ocean, between Somalia and Tanzania.	Kenya	Production
C16771	C66786		Country	KGZ	KGZ	KYRGYZSTAN	A country in Central Asia, west of China.	Kyrgyzstan	Production
C16378	C66786		Country	KHM	KHM	CAMBODIA	A country in Southeastern Asia, bordering the Gulf of Thailand, between Thailand, Vietnam, and Laos.	Cambodia	Production
C16639	C66786		Country	KIR	KIR	KIRIBATI	A group of 33 coral atolls in the Pacific Ocean, straddling the equator; the capital Tarawa is about one-half of the way from Hawaii to Australia.	Kiribati	Production
C17885	C66786		Country	KNA	KNA	SAINT KITTS AND NEVIS	Islands in the Caribbean Sea, about one-third of the way from Puerto Rico to Trinidad and Tobago.	Saint Kitts and Nevis	Production
C16774	C66786		Country	KOR	KOR	SOUTH KOREA	A country in Eastern Asia, occupying the southern half of the Korean Peninsula, bordering the Sea of Japan and the Yellow Sea.	South Korea	Production
C16775	C66786		Country	KWT	KWT	KUWAIT	A country in the Middle East, bordering the Persian Gulf, between Iraq and Saudi Arabia.	Kuwait	Production
C16780	C66786		Country	LAO	LAO	LAO PEOPLE'S DEMOCRATIC REPUBLIC	A country in Southeastern Asia, northeast of Thailand, west of Vietnam.	Lao People's Democratic Republic	Production
C16784	C66786		Country	LBN	LBN	LEBANON	A country in the Middle East, bordering the Mediterranean Sea, between Israel and Syria.	Lebanon	Production
C16791	C66786		Country	LBR	LBR	LIBERIA	A country in Western Africa, bordering the North Atlantic Ocean, between Cote d'Ivoire and Sierra Leone.	Liberia	Production
C16793	C66786		Country	LBY	LBY	LIBYAN ARAB JAMAHIRIYA	A country in Northern Africa, bordering the Mediterranean Sea, between Egypt and Tunisia.	Libyan Arab Jamahiriya	Production
C17113	C66786		Country	LCA	LCA	SAINT LUCIA	A country in the Caribbean, occupying an island between the Caribbean Sea and North Atlantic Ocean, north of Trinidad and Tobago.	Saint Lucia	Production
C16794	C66786		Country	LIE	LIE	LIECHTENSTEIN	A country in Central Europe, between Austria and Switzerland.	Liechtenstein	Production
C17163	C66786		Country	LKA	LKA	SRI LANKA	A country in Southern Asia, occupying an island in the Indian Ocean, south of India.	Sri Lanka	Production
C16787	C66786		Country	LSO	LSO	LESOTHO	A country in Southern Africa, an enclave of South Africa.	Lesotho	Production
C16799	C66786		Country	LTU	LTU	LITHUANIA	A country in Eastern Europe, bordering the Baltic Sea, between Latvia and Russia.	Lithuania	Production
C16803	C66786		Country	LUX	LUX	LUXEMBOURG	A country in Western Europe, between France, Belgium, and Germany.	Luxembourg	Production
C16783	C66786		Country	LVA	LVA	LATVIA	A country in Eastern Europe, bordering the Baltic Sea, between Estonia and Lithuania.	Latvia	Production
C16807	C66786		Country	MAC	MAC	MACAO	A country in Eastern Asia, bordering the South China Sea and China.	Macao	Production
C16878	C66786		Country	MAR	MAR	MOROCCO	A country in Northern Africa, bordering the North Atlantic Ocean and the Mediterranean Sea, between Algeria and Western Sahara.	Morocco	Production
C16874	C66786		Country	MCO	MCO	MONACO	A country in Western Europe, bordering the Mediterranean Sea on the southern coast of France, near the border with Italy.	Monaco	Production
C16871	C66786		Country	MDA	MDA	MOLDOVA, REPUBLIC OF	A country in Eastern Europe, northeast of Romania.	Moldova	Production
C16808	C66786		Country	MDG	MDG	MADAGASCAR	A country in Southern Africa, occupying an island in the Indian Ocean, east of Mozambique.	Madagascar	Production
C16815	C66786		Country	MDV	MDV	MALDIVES	A country in Southern Asia, occupying a group of atolls in the Indian Ocean, south-southwest of India.	Maldives	Production
C16850	C66786		Country	MEX	MEX	MEXICO	A country in Central America, bordering the Caribbean Sea and the Gulf of Mexico, between Belize and the US and bordering the North Pacific Ocean, between Guatemala and the US.	Mexico	Production
C16822	C66786		Country	MHL	MHL	MARSHALL ISLANDS	A group of atolls and reefs in the North Pacific Ocean, about one-half of the way from Hawaii to Australia.	Marshall Islands	Production
C17654	C66786		Country	MKD	MKD	REPUBLIC OF MACEDONIA	A country in Southeastern Europe, north of Greece.	Republic of Macedonia	Production
C16816	C66786		Country	MLI	MLI	MALI	A country in Western Africa, southwest of Algeria.	Mali	Production
C16817	C66786		Country	MLT	MLT	MALTA	A country in Southern Europe, occupying islands in the Mediterranean Sea, south of Sicily (Italy).	Malta	Production
C16370	C66786		Country	MMR	MMR	MYANMAR	A country in Southeastern Asia, bordering the Andaman Sea and the Bay of Bengal, between Bangladesh and Thailand.	Myanmar	Production
C64378	C66786		Country	MNE	MNE	MONTENEGRO	A republic in Southeastern Europe, bordering the Adriatic Sea, between Albania and Bosnia and Herzegovina. Formerly part of Serbia and Montenegro (Federation Republic of Yugoslavia).	Montenegro	Production
C16875	C66786		Country	MNG	MNG	MONGOLIA	A country in Northern Asia, between China and Russia.	Mongolia	Production
C17882	C66786		Country	MNP	MNP	NORTHERN MARIANA ISLANDS	A country in the Pacific, comprising islands in the North Pacific Ocean, about three-quarters of the way from Hawaii to the Philippines.	Northern Mariana Islands	Production
C16882	C66786		Country	MOZ	MOZ	MOZAMBIQUE	A country in Southern Africa, bordering the Mozambique Channel, between South Africa and Tanzania.	Mozambique	Production
C16826	C66786		Country	MRT	MRT	MAURITANIA	A country in Northern Africa, bordering the North Atlantic Ocean, between Senegal and Western Sahara.	Mauritania	Production
C16876	C66786		Country	MSR	MSR	MONTSERRAT	A country in the Caribbean, occupying an island in the Caribbean Sea, southeast of Puerto Rico.	Montserrat	Production
C16823	C66786		Country	MTQ	MTQ	MARTINIQUE	An island in the Caribbean Sea, north of Trinidad and Tobago.	Martinique	Production
C16827	C66786		Country	MUS	MUS	MAURITIUS	A country in Southern Africa, occupying an island in the Indian Ocean, east of Madagascar.	Mauritius	Production
C16813	C66786		Country	MWI	MWI	MALAWI	A country in Southern Africa, east of Zambia.	Malawi	Production
C16814	C66786		Country	MYS	MYS	MALAYSIA	A country in Southeastern Asia, occupying a peninsula and the northern one-third of the island of Borneo, bordering Indonesia and the South China Sea, south of Vietnam.	Malaysia	Production
C16828	C66786		Country	MYT	MYT	MAYOTTE	A country in Southern Africa, occupying an island in the Mozambique Channel, about one-half of the way from northern Madagascar to northern Mozambique.	Mayotte	Production
C16891	C66786		Country	NAM	NAM	NAMIBIA	A country in Southern Africa, bordering the South Atlantic Ocean, between Angola and South Africa.	Namibia	Production
C16913	C66786		Country	NCL	NCL	NEW CALEDONIA	A country in the Pacific, comprised of islands in the South Pacific Ocean, east of Australia.	New Caledonia	Production
C16916	C66786		Country	NER	NER	NIGER	A country in Western Africa, southeast of Algeria.	Niger	Production
C16919	C66786		Country	NFK	NFK	NORFOLK ISLAND	A country in the Pacific, occupying an island in the South Pacific Ocean, east of Australia.	Norfolk Island	Production
C16917	C66786		Country	NGA	NGA	NIGERIA	A country in Western Africa, bordering the Gulf of Guinea, between Benin and Cameroon.	Nigeria	Production
C16915	C66786		Country	NIC	NIC	NICARAGUA	A country in Central America, bordering both the Caribbean Sea and the North Pacific Ocean, between Costa Rica and Honduras.	Nicaragua	Production
C16918	C66786		Country	NIU	NIU	NIUE	A country in the Pacific, occupying an island in the South Pacific Ocean, east of Tonga.	Niue	Production
C16903	C66786		Country	NLD	NLD	NETHERLANDS	A country in Western Europe, bordering the North Sea, between Belgium and Germany.	Netherlands	Production
C16920	C66786		Country	NOR	NOR	NORWAY	A country in Northern Europe, bordering the North Sea and the North Atlantic Ocean, west of Sweden.	Norway	Production
C16901	C66786		Country	NPL	NPL	NEPAL	A country in Southern Asia, between China and India.	Nepal	Production
C16896	C66786		Country	NRU	NRU	NAURU	A country in Oceania, occupying an island in the South Pacific Ocean, south of the Marshall Islands.	Nauru	Production
C16914	C66786		Country	NZL	NZL	NEW ZEALAND	A country in the Pacific, comprised of islands in the South Pacific Ocean, southeast of Australia.	New Zealand	Production
C16933	C66786		Country	OMN	OMN	OMAN	A country in the Middle East, bordering the Arabian Sea, Gulf of Oman, and Persian Gulf, between Yemen and the United Arab Emirates.	Oman	Production
C16949	C66786		Country	PAK	PAK	PAKISTAN	A country in Southern Asia, bordering the Arabian Sea, between India on the east and Iran and Afghanistan on the west and China in the north.	Pakistan	Production
C16951	C66786		Country	PAN	PAN	PANAMA	A country in Central America, bordering both the Caribbean Sea and the North Pacific Ocean, between Colombia and Costa Rica.	Panama	Production
C16993	C66786		Country	PCN	PCN	PITCAIRN	A country in the Pacific, comprised of islands in the South Pacific Ocean, about midway between Peru and New Zealand.	Pitcairn Island	Production
C16972	C66786		Country	PER	PER	PERU	A country in Western South America, bordering the South Pacific Ocean, between Chile and Ecuador.	Peru	Production
C16978	C66786		Country	PHL	PHL	PHILIPPINES	A country in Southeastern Asia, comprised of an archipelago between the Philippine Sea and the South China Sea, east of Vietnam.	Philippines	Production
C17733	C66786		Country	PLW	PLW	PALAU	A country in the Pacific, comprising a group of islands in the North Pacific Ocean, southeast of the Philippines.	Palau	Production
C16952	C66786		Country	PNG	PNG	PAPUA NEW GUINEA	A country in Southeastern Asia, comprising a group of islands and including the eastern half of the island of New Guinea, between the Coral Sea and the South Pacific Ocean, east of Indonesia.	Papua New Guinea	Production
C17002	C66786		Country	POL	POL	POLAND	A country in Central Europe, east of Germany.	Poland	Production
C17043	C66786		Country	PRI	PRI	PUERTO RICO	An island between the Caribbean Sea and the North Atlantic Ocean, east of the Dominican Republic.	Puerto Rico	Production
C16773	C66786		Country	PRK	PRK	NORTH KOREA	A country in Eastern Asia, occupying the northern half of the Korean Peninsula, bordering the Korea Bay and the Sea of Japan, between China and South Korea.	North Korea	Production
C17006	C66786		Country	PRT	PRT	PORTUGAL	A country in Southwestern Europe, bordering the North Atlantic Ocean, west of Spain.	Portugal	Production
C16953	C66786		Country	PRY	PRY	PARAGUAY	A country in Central South America, northeast of Argentina.	Paraguay	Production
C20110	C66786		Country	PSE	PSE	PALESTINIAN TERRITORY, OCCUPIED	A collective name for the West Bank and the Gaza Strip, two territories in Palestine.	Palestinian Territory, Occupied	Production
C16594	C66786		Country	PYF	PYF	FRENCH POLYNESIA	An archipelago in the South Pacific Ocean, about one-half of the way from South America to Australia.	French Polynesia	Production
C17045	C66786		Country	QAT	QAT	QATAR	A country in the Middle East, occupying a peninsula bordering the Persian Gulf and Saudi Arabia.	Qatar	Production
C17095	C66786		Country	REU	REU	REUNION	An Southern Africa, occupying an island in the Indian Ocean, east of Madagascar.	Reunion	Production
C17108	C66786		Country	ROU	ROU	ROMANIA	A country in Southeastern Europe, bordering the Black Sea, between Bulgaria and Ukraine.	Romania	Production
C17111	C66786		Country	RUS	RUS	RUSSIAN FEDERATION	A country in Northern Asia (that part west of the Urals is sometimes included with Europe), bordering the Arctic Ocean, between Europe and the North Pacific Ocean.	Russia	Production
C17112	C66786		Country	RWA	RWA	RWANDA	A country in Central Africa, east of Democratic Republic of the Congo.	Rwanda	Production
C17117	C66786		Country	SAU	SAU	SAUDI ARABIA	A country in the Middle East, bordering the Persian Gulf and the Red Sea, north of Yemen.	Saudi Arabia	Production
C64377	C66786		Country	SCG	SCG	SERBIA	A republic in Southeastern Europe, bordering the Adriatic Sea, between Albania and Bosnia and Herzegovina. Formerly part of Serbia and Montenegro (Federation Republic of Yugoslavia).	Serbia	Production
C17170	C66786		Country	SDN	SDN	SUDAN	A country in Northern Africa, bordering the Red Sea, between Egypt and Eritrea.	Sudan	Production
C17121	C66786		Country	SEN	SEN	SENEGAL	A country in Western Africa, bordering the North Atlantic Ocean, between Guinea-Bissau and Mauritania.	Senegal	Production
C17134	C66786		Country	SGP	SGP	SINGAPORE	A country in Southeastern Asia, comprised of islands between Malaysia and Indonesia.	Singapore	Production
C20111	C66786		Country	SGS	SGS	SOUTH GEORGIA AND THE SOUTH SANDWICH ISLANDS	A group of islands in the South Atlantic Ocean, east of the tip of South America.	South Georgia and the South Sandwich Islands	Production
C17164	C66786		Country	SHN	SHN	SAINT HELENA	Islands in the South Atlantic Ocean, about midway between South America and Africa.	Saint Helena	Production
C17178	C66786		Country	SJM	SJM	SVALBARD AND JAN MAYEN	Islands between the Arctic Ocean, Barents Sea, Greenland Sea, and Norwegian Sea, northeast of Iceland and north of Norway.	Svalbard and Jan Mayen	Production
C17148	C66786		Country	SLB	SLB	SOLOMON ISLANDS	A group of islands in the South Pacific Ocean, east of Papua New Guinea.	Solomon Islands	Production
C17130	C66786		Country	SLE	SLE	SIERRA LEONE	A country in Western Africa, bordering the North Atlantic Ocean, between Guinea and Liberia.	Sierra Leone	Production
C16532	C66786		Country	SLV	SLV	EL SALVADOR	A country in Central America, bordering the North Pacific Ocean, between Guatemala and Honduras.	El Salvador	Production
C17115	C66786		Country	SMR	SMR	SAN MARINO	A country in Southern Europe, an enclave in central Italy.	San Marino	Production
C17149	C66786		Country	SOM	SOM	SOMALIA	A country in Eastern Africa, bordering the Gulf of Aden and the Indian Ocean, east of Ethiopia.	Somalia	Production
C17165	C66786		Country	SPM	SPM	SAINT PIERRE AND MIQUELON	A country in Northern North America, comprised of islands in the North Atlantic Ocean, south of Newfoundland (Canada).	Saint Pierre and Miquelon	Production
C17116	C66786		Country	STP	STP	SAO TOME AND PRINCIPE	A country in Western Africa, comprised of islands in the Gulf of Guinea, straddling the Equator, west of Gabon.	Sao Tome and Principe	Production
C17175	C66786		Country	SUR	SUR	SURINAME	A country in Northern South America, bordering the North Atlantic Ocean, between French Guiana and Guyana.	Suriname	Production
C17669	C66786		Country	SVK	SVK	SLOVAKIA	A country in Central Europe, south of Poland.	Slovakia	Production
C17138	C66786		Country	SVN	SVN	SLOVENIA	A country in Central Europe, bordering the Adriatic Sea, between Austria and Croatia.	Slovenia	Production
C17180	C66786		Country	SWE	SWE	SWEDEN	A country in Northern Europe, bordering the Baltic Sea, Gulf of Bothnia, Kattegat, and Skagerrak, between Finland and Norway.	Sweden	Production
C17179	C66786		Country	SWZ	SWZ	SWAZILAND	A country in Southern Africa, between Mozambique and South Africa.	Swaziland	Production
C17129	C66786		Country	SYC	SYC	SEYCHELLES	A country in Eastern Africa, comprised of a group of islands in the Indian Ocean, northeast of Madagascar.	Seychelles	Production
C17182	C66786		Country	SYR	SYR	SYRIAN ARAB REPUBLIC	A country in the Middle East, bordering the Mediterranean Sea, between Lebanon and Turkey.	Syria	Production
C17224	C66786		Country	TCA	TCA	TURKS AND CAICOS ISLANDS	Two island groups in the North Atlantic Ocean, southeast of The Bahamas.	Turks and Caicos Islands	Production
C16412	C66786		Country	TCD	TCD	CHAD	A country in Central Africa, south of Libya.	Chad	Production
C17202	C66786		Country	TGO	TGO	TOGO	A country in Western Africa, bordering the Bight of Benin, between Benin and Ghana.	Togo	Production
C17192	C66786		Country	THA	THA	THAILAND	A country in Southeastern Asia, bordering the Andaman Sea and the Gulf of Thailand, southeast of Burma.	Thailand	Production
C17183	C66786		Country	TJK	TJK	TAJIKISTAN	A country in Central Asia, west of China.	Tajikistan	Production
C17704	C66786		Country	TKL	TKL	TOKELAU	A group of three atolls in the South Pacific Ocean, about one-half of the way from Hawaii to New Zealand.	Tokelau	Production
C17223	C66786		Country	TKM	TKM	TURKMENISTAN	A country in Central Asia, bordering the Caspian Sea, between Iran and Kazakhstan.	Turkmenistan	Production
C17200	C66786		Country	TLS	TLS	TIMOR-LESTE	A country in Southeastern Asia, northwest of Australia in the Lesser Sunda Islands at the eastern end of the Indonesian archipelago. East Timor includes the eastern half of the island of Timor, the Oecussi (Ambeno) region on the northwest portion of the island of Timor, and the islands of Pulau Atauro and Pulau Jaco.	Timor-Leste	Production
C17205	C66786		Country	TON	TON	TONGA	An archipelago in the South Pacific Ocean, about two-thirds of the way from Hawaii to New Zealand.	Tonga	Production
C17217	C66786		Country	TTO	TTO	TRINIDAD AND TOBAGO	Islands between the Caribbean Sea and the North Atlantic Ocean, northeast of Venezuela.	Trinidad and Tobago	Production
C17221	C66786		Country	TUN	TUN	TUNISIA	A country in Northern Africa, bordering the Mediterranean Sea, between Algeria and Libya.	Tunisia	Production
C17222	C66786		Country	TUR	TUR	TURKEY	A country in southeastern Europe and southwestern Asia (that portion of Turkey west of the Bosporus is geographically part of Europe), bordering the Black Sea, between Bulgaria and Georgia, and bordering the Aegean Sea and the Mediterranean Sea, between Greece and Syria.	Turkey	Production
C17225	C66786		Country	TUV	TUV	TUVALU	An island group consisting of nine coral atolls in the South Pacific Ocean, about one-half of the way from Hawaii to Australia.	Tuvalu	Production
C17184	C66786		Country	TWN	TWN	TAIWAN	A group of islands bordering the East China Sea, Philippine Sea, South China Sea, and Taiwan Strait, north of the Philippines, off the southeastern coast of China.	Taiwan	Production
C17185	C66786		Country	TZA	TZA	TANZANIA, UNITED REPUBLIC OF	A country in Eastern Africa, bordering the Indian Ocean, between Kenya and Mozambique.	Tanzania	Production
C17228	C66786		Country	UGA	UGA	UGANDA	A country in Eastern Africa, west of Kenya.	Uganda	Production
C17229	C66786		Country	UKR	UKR	UKRAINE	A country in Eastern Europe, bordering the Black Sea, between Poland and Russia.	Ukraine	Production
C20112	C66786		Country	UMI	UMI	UNITED STATES MINOR OUTLYING ISLANDS	The U.S. Minor Outlying Islands consist of Baker Island, Howland Island, Jarvis Island, Johnston Atoll, Kingman Reef, Midway Island, Navassa Island, Palmyra Atoll, and Wake Island (Wake Atoll).	United States Minor Outlying Islands	Production
C17244	C66786		Country	URY	URY	URUGUAY	A country in Southern South America, bordering the South Atlantic Ocean, between Argentina and Brazil.	Uruguay	Production
C17234	C66786		Country	USA	USA	UNITED STATES	A country in North America, bordering both the North Atlantic Ocean and the North Pacific Ocean, between Canada and Mexico.	United States	Production
C17246	C66786		Country	UZB	UZB	UZBEKISTAN	A country in Central Asia, north of Afghanistan.	Uzbekistan	Production
C17249	C66786		Country	VAT	VAT	VATICAN CITY STATE	An enclave of Rome (Italy).	Holy See	Production
C17114	C66786		Country	VCT	VCT	SAINT VINCENT AND THE GRENADINES	A country in the Caribbean, comprised of islands in the Caribbean Sea, north of Trinidad and Tobago.	Saint Vincent and the Grenadines	Production
C17250	C66786		Country	VEN	VEN	VENEZUELA	A country in Northern South America, bordering the Caribbean Sea and the North Atlantic Ocean, between Colombia and Guyana.	Venezuela	Production
C17653	C66786		Country	VGB	VGB	VIRGIN ISLANDS,BRITISH	Islands between the Caribbean Sea and the North Atlantic Ocean, east of Puerto Rico.	British Virgin Islands	Production
C17255	C66786		Country	VIR	VIR	VIRGIN ISLANDS, U.S.	Islands between the Caribbean Sea and the North Atlantic Ocean, east of Puerto Rico.	United States Virgin Islands	Production
C17252	C66786		Country	VNM	VNM	VIETNAM	A country in Southeastern Asia, bordering the Gulf of Thailand, Gulf of Tonkin, and South China Sea, alongside China, Laos, and Cambodia.	Vietnam	Production
C17247	C66786		Country	VUT	VUT	VANUATU	A group of islands in the South Pacific Ocean, about three-quarters of the way from Hawaii to Australia.	Vanuatu	Production
C17259	C66786		Country	WLF	WLF	WALLIS AND FUTUNA	Islands in the South Pacific Ocean, about two-thirds of the way from Hawaii to New Zealand.	Wallis and Futuna Islands	Production
C17740	C66786		Country	WSM	WSM	SAMOA	A group of islands in the South Pacific Ocean, about one-half of the way from Hawaii to New Zealand.	Samoa	Production
C17264	C66786		Country	YEM	YEM	YEMEN	A country in the Middle East, bordering the Arabian Sea, Gulf of Aden, and Red Sea, between Oman and Saudi Arabia.	Yemen	Production
C17151	C66786		Country	ZAF	ZAF	SOUTH AFRICA	A country in Southern Africa, at the southern tip of the continent of Africa.	South Africa	Production
C17267	C66786		Country	ZMB	ZMB	ZAMBIA	A country in Southern Africa, east of Angola.	Zambia	Production
C17268	C66786		Country	ZWE	ZWE	ZIMBABWE	A country in Southern Africa, between South Africa and Zambia.	Zimbabwe	Production
C66787	C66787	Yes	Diagnosis Group	TDIGRP	TDIGRP	Diagnosis Group	A grouping of individuals on the basis of a shared procedure or disease, or lack thereof (e.g. healthy volunteers, type 2 diabetic subjects, subjects with renal cell cancer).  Standardized naming systems are available that define the groups within which a subject should be placed. (NCI)	CDISC SDTM Diagnosis Group Terminology	Production
C49651	C66787		Diagnosis Group	HEALTHY SUBJECTS	HEALTHY SUBJECTS		An individual who is or becomes a participant in a research study and has no significant health-related issues.  (NCI)	Healthy Subject	Production
C66788	C66788	Yes	Dictionary Name	DICTNAM	DICTNAM	Dictionary Name; Name of Dictionary	A name given to a reference source that lists words and gives their meaning. (NCI)	CDISC SDTM Dictionary Name Terminology	Production
C49471	C66788		Dictionary Name	COSTART	COSTART	Coding Symbols for a Thesaurus of Adverse Reaction Terms	A terminology developed and used by the Food and Drug Administration (FDA) for the coding, filing and retrieving of post marketing adverse reaction reports. (NCI)	Thesaurus of Adverse Reaction Term Coding Symbols	Production
C49474	C66788		Dictionary Name	ICD	ICD	International Classification of Diseases	A system of categories to which morbid entries are assigned according to established criteria. Included is the entire range of conditions in a manageable number of categories, grouped to facilitate mortality reporting. It is produced by the World Health Organization (from ICD-10, p1). The Clinical Modifications, produced by the United States Dept. of Health and Human Services, are larger extensions used for morbidity and general epidemiological purposes, primarily in the U.S. (MSH2005_2004_10_12)	International Classification of Diseases	Production
C49476	C66788		Dictionary Name	LOINC	LOINC	Logical Observation Identifiers Names and Codes	Published by the The Regenstrief Institute, the Logical Observation Identifiers Names and Codes covers clinical and clinical laboratory terminology. (NCI)	Logical Observation Identifiers Names and Codes	Production
C43820	C66788		Dictionary Name	MedDRA	MedDRA	Medical Dictionary for Regulatory Activities	MedDRA is an international medical terminology designed to support the classification, retrieval, presentation, and communication of medical information throughout the medical product regulatory cycle. MedDRA was developed under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). The MedDRA Maintenance and Support Services Organization (MSSO) holds a contract with the International Federation of Pharmaceutical Manufacturers Associations (IFPMA) to maintain and support the implementation of the terminology. (NCI)	MedDRA	Production
C53489	C66788		Dictionary Name	SNOMED	SNOMED	Systematized Nomenclature of Medicine	A multiaxial, hierarchical classification system for diseases in man developed by the College of American Pathologists. (NCI)	Systematized Nomenclature of Medicine	Production
C49468	C66788		Dictionary Name	WHOART	WHOART	World Health Organization Adverse Reaction Terms	A terminology implemented by the World Health Organization to describe adverse reactions to a prescribed medication or treatment regimen. (NCI)	World Health Organization Adverse Reaction Terminology	Production
C49475	C66788		Dictionary Name	WHODD	WHODD	World Health Organization Drug Dictionary	A reference source of drugs and drug associated information maintained by the World Health Organization. (NCI)	World Health Organization Drug Dictionary	Production
C66789	C66789	No	Not Done	ND	ND	Not Done	Indicates a task, process or examination that has either not been initiated or completed. (NCI)	CDISC SDTM Not DoneTerminology	Production
C49484	C66789		Not Done	NOT DONE	NOT DONE		Indicates a task, process or examination that has either not been initiated or completed. (NCI)	Not Done	Production
C66790	C66790	Yes	Patient Ethnic Group	ETHNIC	ETHNIC	Patient Ethnic Group	A social group characterized by a distinctive social and cultural tradition maintained from generation to generation, a common history and origin and a sense of identification with the group; members of the group have distinctive features in their way of life, shared experiences and often a common genetic heritage; these features may be reflected in their experience of health and disease. (NCI)	CDISC SDTM Patient Ethnic GroupTerminology	Production
C17459	C66790		Patient Ethnic Group	HISPANIC OR LATINO	HISPANIC OR LATINO		A person of Mexican, Puerto Rican, Cuban, Central or South American or other Spanish culture or origin, regardless of race.  (NCI)	Hispanic or Latino	Production
C41222	C66790		Patient Ethnic Group	NOT HISPANIC OR LATINO	NOT HISPANIC OR LATINO		A person not of Cuban, Mexican, Puerto Rican, South or Central American, or other Spanish culture or origin, regardless of race. An arbitrary ethnic classification. (NCI)	Not Hispanic or Latino	Production
C43234	C66790		Patient Ethnic Group	NOT REPORTED	NOT REPORTED	Not reported	Not provided or available	Not Stated	Production
C17998	C66790		Patient Ethnic Group	UNKNOWN	UNKNOWN	U; Unknown	Not known, not observed, not recorded, or refused. (NCI)	Unknown	Production
C66726	C66726	Yes	Pharmaceutical Dosage Form	FRM	FRM	Pharmaceutical Dosage Form; Dose Form	The form of the completed pharmaceutical product, e.g. tablet, capsule, injection, elixir, suppository. Dosage form can have a significant effect on the onset, duration and intensity of the pharmacological action of a drug. A pharmaceutical dosage form controls the rate at which the drug is released into the biological fluids. This release rate affects its intrinsic absorption pattern and therefore, the bioavailability of the drug.	CDISC SDTM Pharmaceutical Dosage FormTerminology	Production
C42887	C66726		Pharmaceutical Dosage Form	AEROSOL	AEROSOL		A product that is packaged under pressure and contains therapeutically active ingredients that are released upon activation of an appropriate valve system; it is intended for topical application to the skin as well as local application into the nose (nasal aerosols), mouth (lingual aerosols), or lungs (inhalation aerosols). (FDA)	Aerosol Dosage Form	Production
C42888	C66726		Pharmaceutical Dosage Form	AEROSOL, FOAM	AEROSOL, FOAM		A dosage form containing one or more active ingredients, surfactants, aqueous or non-aqueous liquids, and the propellants; if the propellant is in the internal (discontinuous) phase (i.e., of the oil-in-water type), a stable foam is discharged, and if the propellant is in the external (continuous) phase (i.e., of the water-in-oil type), a spray or a quick-breaking foam is discharged. (FDA)	Aerosol Foam Dosage Form	Production
C42960	C66726		Pharmaceutical Dosage Form	AEROSOL, METERED	AEROSOL, METERED		A pressurized dosage form consisting of metered dose valves which allow for the delivery of a uniform quantity of spray upon each activation. (NCI)	Metered Aerosol Dosage Form	Production
C42971	C66726		Pharmaceutical Dosage Form	AEROSOL, POWDER	AEROSOL, POWDER		A product that is packaged under pressure and contains therapeutically active ingredients, in the form of a powder, that are released upon activation of an appropriate valve system. (NCI)	Powder Aerosol Dosage Form	Production
C42889	C66726		Pharmaceutical Dosage Form	AEROSOL, SPRAY	AEROSOL, SPRAY		An aerosol product which utilizes a compressed gas as the propellant to provide the force necessary to expel the product as a wet spray; it is applicable to solutions of medicinal agents in aqueous solvents. (NCI)	Aerosol Spray Dosage Form	Production
C42892	C66726		Pharmaceutical Dosage Form	BAR, CHEWABLE	BAR, CHEWABLE		A solid dosage form usually in the form of a rectangle that is meant to be chewed. (NCI)	Chewable Bar Dosage Form	Production
C42890	C66726		Pharmaceutical Dosage Form	BEAD	BEAD		A solid dosage form in the shape of a small ball. (NCI)	Bead Dosage Form	Production
C43451	C66726		Pharmaceutical Dosage Form	BEAD, IMPLANT, EXTENDED RELEASE	BEAD, IMPLANT, EXTENDED RELEASE		A small sterile solid mass consisting of a highly purified drug intended for implantation in the body which would allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form.  (NCI)	Extended Release Bead Implant Dosage Form	Production
C42891	C66726		Pharmaceutical Dosage Form	BLOCK	BLOCK		Solid dosage form, usually in the shape of a square or rectangle. (NCI)	Block Dosage Form	Production
C25158	C66726		Pharmaceutical Dosage Form	CAPSULE	CAPSULE		A solid pharmaceutical dosage form that contains medicinal agent within either a hard or soft soluble container or shell, usually used for the oral administration of medicine. The shells are made of a suitable form of gelatin or other substance. (NCI)	Capsule Dosage Form	Production
C42895	C66726		Pharmaceutical Dosage Form	CAPSULE, COATED	CAPSULE, COATED		A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or "shell" made from a suitable form of gelatin; additionally, the capsule is covered in a designated coating. (NCI)	Coated Capsule Dosage Form	Production
C42896	C66726		Pharmaceutical Dosage Form	CAPSULE, COATED PELLETS	CAPSULE, COATED PELLETS		A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or "shell" made from a suitable form of gelatin; the drug itself is in the form of granules to which varying amounts of coating have been applied. (NCI)	Coated Pellets in Capsule Dosage Form	Production
C42917	C66726		Pharmaceutical Dosage Form	CAPSULE, COATED, EXTENDED RELEASE	CAPSULE, COATED, EXTENDED RELEASE		A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or "shell" made from a suitable form of gelatin; additionally, the capsule is covered in a designated coating, and which releases a drug (or drugs) in such a manner to allow at least a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (NCI)	Extended Release Coated Capsule Dosage Form	Production
C42902	C66726		Pharmaceutical Dosage Form	CAPSULE, DELAYED RELEASE	CAPSULE, DELAYED RELEASE		A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin, and which releases a drug (or drugs) at a time other than promptly after administration. Enteric-coated articles are delayed release dosage forms. (NCI)	Delayed Release Capsule Dosage Form	Production
C42904	C66726		Pharmaceutical Dosage Form	CAPSULE, DELAYED RELEASE PELLETS	CAPSULE, DELAYED RELEASE PELLETS		A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or "shell" made from a suitable form of gelatin; the drug itself is in the form of granules to which enteric coating has been applied, thus delaying release of the drug until its passage into the intestines. (NCI)	Delayed Release Pellets in Capsule Dosage Form	Production
C42916	C66726		Pharmaceutical Dosage Form	CAPSULE, EXTENDED RELEASE	CAPSULE, EXTENDED RELEASE		A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin, and which releases a drug (or drugs) in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (NCI)	Extended Release Capsule Dosage Form	Production
C42928	C66726		Pharmaceutical Dosage Form	CAPSULE, FILM COATED, EXTENDED RELEASE	CAPSULE, FILM COATED, EXTENDED RELEASE		A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or "shell" made from a suitable form of gelatin; additionally, the capsule is covered in a designated film coating, and which releases a drug (or drugs) in such a manner to allow at least a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (NCI)	Extended Release Film Coated Capsule Dosage Form	Production
C42936	C66726		Pharmaceutical Dosage Form	CAPSULE, GELATIN COATED	CAPSULE, GELATIN COATED		A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin; through a banding process, the capsule is coated with additional layers of gelatin so as to form a complete seal. (NCI)	Gelatin Coated Capsule Dosage Form	Production
C42954	C66726		Pharmaceutical Dosage Form	CAPSULE, LIQUID FILLED	CAPSULE, LIQUID FILLED		A solid dosage form in which the drug is enclosed within a soluble, gelatin shell which is plasticized by the addition of a polyol, such as sorbitol or glycerin, and is therefore of a somewhat thicker consistency than that of a hard shell capsule; typically, the active ingredients are dissolved or suspended in a liquid vehicle. (NCI)	Liquid Filled Capsule Dosage Form	Production
C45414	C66726		Pharmaceutical Dosage Form	CEMENT	CEMENT		A substance that serves to produce solid union between two surfaces. (NCI)	Cement Dosage Form	Production
C42678	C66726		Pharmaceutical Dosage Form	CIGARETTE	CIGARETTE		A narrow tube filled with material that is capable to burn with release of therapeutically-active substance(s) during the process of smoking. Cigarette is a very efficient drug-delivery inhaler system for fast-acting substances.(FDA)	Cigarette Dosage Form	Production
C60884	C66726		Pharmaceutical Dosage Form	CLOTH	CLOTH		A large piece of relatively flat, absorbent material that contains a drug. It is typically used for applying medication or for cleansing. (FDA)	Cloth Dosage Form	Production
C60891	C66726		Pharmaceutical Dosage Form	CONCENTRATE	CONCENTRATE		A liquid preparation of increased strength and reduced volume which is usually diluted prior to administration. (NCI)	Concentrate Dosage Form	Production
C42900	C66726		Pharmaceutical Dosage Form	CONE	CONE		A solid dosage form bounded by a circular base and the surface formed by line segments joining every point of the boundary of the base to a common vertex. A cone (usually containing antibiotics) is normally placed below the gingiva after a dental extraction. (NCI)	Cone Dosage Form	Production
C42919	C66726		Pharmaceutical Dosage Form	CORE, EXTENDED RELEASE	CORE, EXTENDED RELEASE		An ocular system placed in the eye from which the drug diffuses through a membrane at a constant rate over a specified period. (NCI)	Extended Release Core Dosage Form	Production
C28944	C66726		Pharmaceutical Dosage Form	CREAM	CREAM		A semisolid emulsion of either the oil-in-water or the water-in-oil type, ordinarily intended for topical use. (NCI)	Cream Dosage Form	Production
C60897	C66726		Pharmaceutical Dosage Form	CREAM, AUGMENTED	CREAM, AUGMENTED		A cream dosage form that enhances drug delivery. Augmentation does not refer to the strength of the drug in the dosage form. NOTE: CDER has decided to refrain from expanding the use of this dosage form due to difficulties in setting specific criteria that must be met to be considered augmented. (FDA)	Augmented Cream Dosage Form	Production
C42901	C66726		Pharmaceutical Dosage Form	CRYSTAL	CRYSTAL		A naturally produced angular solid of definite form in which the ultimate units from which it is built up are systematically arranged; they are usually evenly spaced on a regular space lattice.	Crystal Dosage Form	Production
C45415	C66726		Pharmaceutical Dosage Form	CULTURE	CULTURE		The propagation of microorganisms or of living tissue cells in special media conducive to their growth. (NCI)	Culture Dosage Form	Production
C47890	C66726		Pharmaceutical Dosage Form	DIAPHRAGM	DIAPHRAGM		A device usually dome-shaped, worn during copulation over the cervical mouth for prevention of conception or infection. (NCI)	Diaphragm Dosage Form	Production
C43525	C66726		Pharmaceutical Dosage Form	DISC	DISC		A circular plate-like organ or structure. (FDA)	Disc Dosage Form	Production
C42679	C66726		Pharmaceutical Dosage Form	DOUCHE	DOUCHE		A liquid preparation, intended for the irrigative cleansing of the vagina, that is prepared from powders, liquid solutions, or liquid concentrates and contains one or more chemical substances dissolved in a suitable solvent or mutually miscible solvents. (NCI)	Douche Dosage Form	Production
C42763	C66726		Pharmaceutical Dosage Form	DRESSING	DRESSING		The application of various materials for protecting a wound.(FDA)	Dressing Dosage Form	Production
C17423	C66726		Pharmaceutical Dosage Form	DRUG DELIVERY SYSTEM	DRUG DELIVERY SYSTEM		Modern technology, distributed with or as a part of a drug product that allows for the uniform release or targeting of drugs to the body. (FDA)	Drug Delivery System	Production
C42912	C66726		Pharmaceutical Dosage Form	ELIXIR	ELIXIR		A clear, pleasantly flavored, sweetened hydroalcoholic liquid containing dissolved medicinal agents; it is intended for oral use. (NCI)	Elixir Dosage Form	Production
C42913	C66726		Pharmaceutical Dosage Form	EMULSION	EMULSION		A dosage form consisting of a two-phase system comprised of at least two immiscible liquids (1), one of which is dispersed as droplets (internal or dispersed phase) within the other liquid (external or continuous phase), generally stabilized with one or more emulsifying agents. Note 1: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior. Note 2: Emulsion is used as a dosage form term unless a more specific term is applicable, e.g. cream, lotion, ointment. (NCI)	Emulsion Dosage Form	Production
C42915	C66726		Pharmaceutical Dosage Form	ENEMA	ENEMA		A rectal preparation for therapeutic, diagnostic, or nutritive purposes.  (NCI)	Enema Dosage Form	Production
C42929	C66726		Pharmaceutical Dosage Form	EXTRACT	EXTRACT		A concentrated preparation of vegetable or animal drugs obtained by removal of the active constituents of the respective drugs with a suitable menstrua, evaporation of all or nearly all of the solvent, and adjustment of the residual masses or powders to the prescribed standards. (NCI)	Extract Dosage Form	Production
C60926	C66726		Pharmaceutical Dosage Form	FIBER, EXTENDED RELEASE	FIBER, EXTENDED RELEASE		A slender and elongated solid thread-like substance that delivers drug in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (FDA)	Extended Release Fiber Dosage Form	Production
C42932	C66726		Pharmaceutical Dosage Form	FILM	FILM		A thin layer or coating. (NCI)	Film Dosage Form	Production
C42920	C66726		Pharmaceutical Dosage Form	FILM, EXTENDED RELEASE	FILM, EXTENDED RELEASE		A drug delivery system in the form of a film that releases the drug over an extended period in such a way as to maintain constant drug levels in the blood or target tissue. (NCI)	Extended Release Film Dosage Form	Production
C42984	C66726		Pharmaceutical Dosage Form	FILM, SOLUBLE	FILM, SOLUBLE		A thin layer or coating which is susceptible to being dissolved when in contact with a liquid. (NCI)	Soluble Film Dosage Form	Production
C60927	C66726		Pharmaceutical Dosage Form	FOR SOLUTION	FOR SOLUTION		A product, usually a solid, intended for solution prior to administration. (FDA)	Dosage Form For Solution	Production
C60928	C66726		Pharmaceutical Dosage Form	FOR SUSPENSION	FOR SUSPENSION		A product, usually a solid, intended for suspension prior to administration. (FDA)	Dosage Form For Suspension	Production
C60929	C66726		Pharmaceutical Dosage Form	FOR SUSPENSION, EXTENDED RELEASE	FOR SUSPENSION, EXTENDED RELEASE		A product, usually a solid, intended for suspension prior to administration; once the suspension is administered, the drug will be released at a constant rate over a specified period. (FDA)	Extended Release Dosage Form For Suspension	Production
C42933	C66726		Pharmaceutical Dosage Form	GAS	GAS		Any elastic aeriform fluid in which the molecules are separated from one another and have free paths. (NCI)	Gas Dosage Form	Production
C42934	C66726		Pharmaceutical Dosage Form	GEL	GEL		A semisolid (1) dosage form that contains a gelling agent to provide stiffness to a solution or a colloidal dispersion (2).  A gel may contain suspended particles. Note 1: A semisolid is not pourable; it does not flow or conform to its container at room temperature.  It does not flow at low shear stress and generally exhibits plastic flow behavior. Note 2: A colloidal dispersion is a system in which particles of colloidal dimension (i.e., typically between 1 nm and 1 micrometer) are distributed uniformly throughout a liquid. (NCI)	Gel Dosage Form	Production
C42906	C66726		Pharmaceutical Dosage Form	GEL, DENTIFRICE	GEL, DENTIFRICE		A combination of a dentifrice (formulation intended to clean and/or polish the teeth, and which may contain certain additional agents), and a gel. It is used with a toothbrush for the purpose of cleaning and polishing the teeth. (NCI)	Dentifrice Gel Dosage Form	Production
C60930	C66726		Pharmaceutical Dosage Form	GEL, METERED	GEL, METERED		A gel preparation, with metered dose valves, which allow for the delivery of a uniform quantity of gel upon each activation. (FDA)	Metered Gel Dosage Form	Production
C48193	C66726		Pharmaceutical Dosage Form	GENERATOR	GENERATOR		An apparatus for the formation of vapor or gas from a liquid or solid by heat or chemical action. The term GENERATOR also applies to radioactive columns from which radionuclides are provided. (NCI)	Generator Dosage Form	Production
C42937	C66726		Pharmaceutical Dosage Form	GLOBULE	GLOBULE		Also called pellets or pilules, are made of pure sucrose, lactose, or other polysaccharides. They are formed into small globular masses of various sizes, and are medicated by placing them in a vial and adding the liquid drug attenuation in the proportion not less than one percent (v/w). After shaking, the medicated globules are dried at temperatures not to exceed 40 degrees Centigrade. (NCI)	Globule Dosage Form	Production
C45416	C66726		Pharmaceutical Dosage Form	GRAFT	GRAFT		A slip of skin or of other tissue for implantation. (NCI)	Graft Dosage Form	Production
C42938	C66726		Pharmaceutical Dosage Form	GRANULE	GRANULE		A small particle or grain. (NCI)	Granule Dosage Form	Production
C42903	C66726		Pharmaceutical Dosage Form	GRANULE, DELAYED RELEASE	GRANULE, DELAYED RELEASE		A small medicinal particle or grain to which an enteric or other coating has been applied, thus delaying release of the drug until its passage into the intestines. (NCI)	Delayed Release Granule Dosage Form	Production
C42909	C66726		Pharmaceutical Dosage Form	GRANULE, EFFERVESCENT	GRANULE, EFFERVESCENT		A small particle or grain containing a medicinal agent in a dry mixture usually composed of sodium bicarbonate, citric acid, and tartaric acid which, when in contact with water, has the capability to release gas, resulting in effervescence. (NCI)	Effervescent Granule Dosage Form	Production
C42939	C66726		Pharmaceutical Dosage Form	GRANULE, FOR SOLUTION	GRANULE, FOR SOLUTION		A small medicinal particle or grain made available in its more stable dry form, to be reconstituted with solvent just before dispensing; the granules are so prepared to contain not only the medicinal agent, but the colorants, flavorants, and any other desired pharmaceutic ingredient. (NCI)	Granule For Solution Dosage Form	Production
C42940	C66726		Pharmaceutical Dosage Form	GRANULE, FOR SUSPENSION	GRANULE, FOR SUSPENSION		A small medicinal particle or grain made available in its more stable dry form, to be reconstituted with solvent just before dispensing to form a suspension; the granules are so prepared to contain not only the medicinal agent, but the colorants, flavorants, and any other desired pharmaceutic ingredient. (NCI)	Granule For Suspension Dosage Form	Production
C42921	C66726		Pharmaceutical Dosage Form	GRANULE, FOR SUSPENSION, EXTENDED RELEASE	GRANULE, FOR SUSPENSION, EXTENDED RELEASE		A small medicinal particle or grain made available in its more stable dry form, to be reconstituted with solvent just before dispensing to form a suspension; the extended release system achieves slow release of the drug over an extended period of time and maintains constant drug levels in the blood or target tissue. (NCI)	Extended Release Granule For Suspension Dosage Form	Production
C42941	C66726		Pharmaceutical Dosage Form	GUM	GUM		A mucilaginous excretion from various plants. (NCI)	Gum Dosage Form	Production
C42894	C66726		Pharmaceutical Dosage Form	GUM, CHEWING	GUM, CHEWING		A sweetened and flavored insoluble plastic material of various shapes which when chewed, releases a drug substance into the oral cavity. (NCI)	Chewing Gum Dosage Form	Production
C42978	C66726		Pharmaceutical Dosage Form	GUM, RESIN	GUM, RESIN		Natural mixture of gum and resin, usually obtained as exudations from plants. (NCI)	Resin Gum Dosage Form	Production
C42942	C66726		Pharmaceutical Dosage Form	IMPLANT	IMPLANT		A material containing drug intended to be inserted securely and deeply in a living site for growth, slow release, or formation of an organic union. (NCI)	Implant Dosage Form	Production
C42944	C66726		Pharmaceutical Dosage Form	INHALANT	INHALANT		A special class of inhalations consisting of a drug or combination of drugs, that by virtue of their high vapor pressure, can be carried by an air current into the nasal passage where they exert their effect; the container from which the inhalant generally is administered is known as an inhaler. (NCI)	Inhalant Dosage Form	Production
C60931	C66726		Pharmaceutical Dosage Form	INJECTABLE, LIPOSOMAL	INJECTABLE, LIPOSOMAL		An injection, which either consists of or forms liposomes (a lipid bilayer vesicle usually composed of phospholipids which is used to encapsulate an active drug substance). (FDA)	Liposomal Injection Dosage Form	Production
C42946	C66726		Pharmaceutical Dosage Form	INJECTION	INJECTION		A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP. (NCI)	Injectable Dosage Form	Production
C42914	C66726		Pharmaceutical Dosage Form	INJECTION, EMULSION	INJECTION, EMULSION		An emulsion consisting of a sterile, pyrogen-free preparation intended to be administered parenterally.(FDA)	Emulsion for Injection Dosage Form	Production
C42950	C66726		Pharmaceutical Dosage Form	INJECTION, LIPID COMPLEX	INJECTION, LIPID COMPLEX		[definition pending](FDA)	Injectable Lipid Complex Dosage Form	Production
C42974	C66726		Pharmaceutical Dosage Form	INJECTION, POWDER, FOR SOLUTION	INJECTION, POWDER, FOR SOLUTION		A sterile preparation intended for reconstitution to form a solution for parenteral use. (NCI)	Powder For Injectable Solution Dosage Form	Production
C42976	C66726		Pharmaceutical Dosage Form	INJECTION, POWDER, FOR SUSPENSION	INJECTION, POWDER, FOR SUSPENSION		A sterile preparation intended for reconstitution to form a suspension for parenteral use. (NCI)	Powder For Injectable Suspension Dosage Form	Production
C42977	C66726		Pharmaceutical Dosage Form	INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE	INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE		A dried preparation intended for reconstitution to form a suspension for parenteral use which has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution).(FDA)	Powder For Injectable Extended Release Suspension Dosage Form	Production
C42959	C66726		Pharmaceutical Dosage Form	INJECTION, POWDER, LYOPHILIZED, FOR LIPOSOMAL SUSPENSION	INJECTION, POWDER, LYOPHILIZED, FOR LIPOSOMAL SUSPENSION		A sterile freeze dried preparation intended for reconstitution for parenteral use which has been formulated in a manner that would allow liposomes (a lipid bilayer vesicle usually composed of phospholipids which is used to encapsulate an active drug substance, either within a lipid bilayer or in an aqueous space) to be formed upon reconstitution. (NCI)	Lyophilized Powder For Injectable Liposomal Suspension Dosage Form	Production
C42957	C66726		Pharmaceutical Dosage Form	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION		A dosage form intended for the solution prepared by lyophilization ('freeze drying'), a process which involves the removal of water from products in the frozen state at extremely low pressures; this is intended for subsequent addition of liquid to create a solution that conforms in all respects to the requirements for Injections. (NCI)	Lyophilized Powder For Injectable Solution Dosage Form	Production
C42958	C66726		Pharmaceutical Dosage Form	INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION	INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION		A liquid preparation, intended for parenteral use, that contains solids suspended in a suitable fluid medium and conforms in all respects to the requirements for Sterile Suspensions; the medicinal agents intended for the suspension are prepared by lyophilization ("freeze drying"), a process which involves the removal of water from products in the frozen state at extremely low pressures. (NCI)	Lyophilized Powder For Injectable Suspension Dosage Form	Production
C42956	C66726		Pharmaceutical Dosage Form	INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION, EXTENDED RELEASE	INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION		A sterile freeze dried preparation intended for reconstitution for parenteral use which has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution). (NCI)	Lyophilized Powder For Extended Release Injectable Suspension Dosage Form	Production
C42945	C66726		Pharmaceutical Dosage Form	INJECTION, SOLUTION	INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION, EXTENDED RELEASE		A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection. (NCI)	Injectable Solution Dosage Form	Production
C42899	C66726		Pharmaceutical Dosage Form	INJECTION, SOLUTION, CONCENTRATE	INJECTION, SOLUTION		A sterile preparation for parenteral use which, upon the addition of suitable solvents, yields a solution conforming in all respects to the requirements for Injections. (NCI)	Concentrate for Injectable Solution Dosage Form	Production
C42995	C66726		Pharmaceutical Dosage Form	INJECTION, SUSPENSION	INJECTION, SOLUTION, CONCENTRATE		A liquid preparation, suitable for injection, which consists of solid particles dispersed throughout a liquid phase in which the particles are not soluble. It can also consist of an oil phase dispersed throughout an aqueous phase, or vice-versa. (NCI)	Injectable Suspension Dosage Form	Production
C42926	C66726		Pharmaceutical Dosage Form	INJECTION, SUSPENSION, EXTENDED RELEASE	INJECTION, SUSPENSION		A sterile preparation intended for parenteral use which has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution or a prompt drug-releasing, conventional solid dosage form). (NCI)	Injectable Extended Release Suspension Dosage Form	Production
C42951	C66726		Pharmaceutical Dosage Form	INJECTION, SUSPENSION, LIPOSOMAL	INJECTION, SUSPENSION, EXTENDED RELEASE		A liquid parenteral pharmaceutical dosage form structured as a multilamellar composition of concentric phospholipid spheres that encapsulate the drug (drug delivery systems) separated by layers of water. Drug release is facilitated and controlled by in vivo erosion of the liposomes. To further increase the in vivo circulation time, liposomes in some preparations are covalently derivatized with PEG to produce PEGylated or stealth liposomes. Covalent attachment of drugs to the outer surface of liposomes can potentially serve as a delayed-release product. (NCI)	Injectable Liposomal Suspension Dosage Form	Production
C42988	C66726		Pharmaceutical Dosage Form	INJECTION, SUSPENSION, SONICATED	INJECTION, SUSPENSION, SONICATED		A liquid preparation, suitable for injection, which consists of solid particles dispersed throughout a liquid phase in which the particles are not soluble. In addition, the product is sonicated while a gas is bubbled through the suspension, and this results in the formation of microspheres by the solid particles. (NCI)	Injectable Sonicated Suspension Dosage Form	Production
C60933	C66726		Pharmaceutical Dosage Form	INSERT	INSERT		A specially formulated and shaped non-encapsulated solid preparation intended to be placed into a non-rectal orifice of the body, where drug is released, generally for localized effects. (FDA)	Insert Dosage Form	Production
C42922	C66726		Pharmaceutical Dosage Form	INSERT, EXTENDED RELEASE	INSERT, EXTENDED RELEASE		A specially formulated and shaped solid preparation (e.g., ring, tablet, or stick) intended to be placed in the vagina by special inserters, where the medication is released, generally for localized effects; the extended release preparation is designed to allow a reduction in dosing frequency. (NCI)	Extended Release Insert Dosage Form	Production
C47915	C66726		Pharmaceutical Dosage Form	INTRAUTERINE DEVICE	INTRAUTERINE DEVICE		A device inserted and left in the uterus to prevent effective conception. (NCI)	Intrauterine Device Dosage Form	Production
C42947	C66726		Pharmaceutical Dosage Form	IRRIGANT	IRRIGANT		A sterile solution intended to bathe or flush open wounds or body cavities; they're used topically, never parenterally. (NCI)	Irrigant Dosage Form	Production
C42948	C66726		Pharmaceutical Dosage Form	JELLY	JELLY		A class of gels--semisolid systems which consist of suspensions made up of either small inorganic particles or large organic molecules interpenetrated by a liquid--in which the structural coherent matrix contains a high portion of liquid, usually water. (NCI)	Jelly Dosage Form	Production
C47916	C66726		Pharmaceutical Dosage Form	KIT	KIT		A packaged collection of related material. (NCI)	Kit Dosage Form	Production
C45413	C66726		Pharmaceutical Dosage Form	LINER, DENTAL	LINER, DENTAL		A material applied to the inside of the dental cavity, for protection or insulation of the surface.(FDA)	Dental Liner Dosage Form	Production
C42949	C66726		Pharmaceutical Dosage Form	LINIMENT	LINIMENT		A solution or mixture of various substances in oil, alcoholic solutions of soap, or emulsions intended for external application. (NCI)	Liniment Dosage Form	Production
C42952	C66726		Pharmaceutical Dosage Form	LIPSTICK	LIPSTICK		A waxy solid, usually colored cosmetic, in stick form for the lips. (NCI)	Lipstick Dosage Form	Production
C42953	C66726		Pharmaceutical Dosage Form	LIQUID	LIQUID		A dosage form consisting of a pure chemical in its liquid state. This dosage form term should not be applied to solutions. Note: A liquid is pourable; it flows and conforms to its container at room temperature.  It displays Newtonian or pseudoplastic flow behavior.(FDA)	Liquid Dosage Form	Production
C60934	C66726		Pharmaceutical Dosage Form	LIQUID, EXTENDED RELEASE	LIQUID, EXTENDED RELEASE		A liquid that delivers a drug in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (FDA)	Extended Release Liquid Dosage Form	Production
C29167	C66726		Pharmaceutical Dosage Form	LOTION	LOTION		An emulsion, liquid (1) dosage form. This dosage form is generally for external application to the skin (2). Note 1: A liquid is pourable; it flows and conforms to its container at room temperature.  It displays Newtonian or pseudoplastic flow behavior. Note 2: Previously the definition of a lotion was: The term lotion has been used to categorize many topical suspensions, solutions, and emulsions intended for application to the skin. The current definition of a lotion is restricted to an emulsion. (FDA)	Lotion Dosage Form	Production
C60957	C66726		Pharmaceutical Dosage Form	LOTION. AUGMENTED	LOTION. AUGMENTED		A lotion dosage form that enhances drug delivery. Augmentation does not refer to the strength of the drug in the dosage form. NOTE: CDER has decided to refrain from expanding the use of this dosage form due to difficulties in setting specific criteria that must be met to be considered augmented. (FDA)	Augmented Lotion Dosage Form	Production
C60958	C66726		Pharmaceutical Dosage Form	LOTION/SHAMPOO	LOTION/SHAMPOO		A lotion dosage form which has a soap or detergent that is usually used to clean the hair and scalp; it is often used as a vehicle for dermatologic agents. (FDA)	Lotion Shampoo Dosage Form	Production
C42955	C66726		Pharmaceutical Dosage Form	LOZENGE	LOZENGE		A solid preparation containing one or more medicaments, usually in a flavored, sweetened base which is intended to dissolve or disintegrate slowly in the mouth. A lollipop is a lozenge on a stick.(FDA)	Lozenge Dosage Form	Production
C29269	C66726		Pharmaceutical Dosage Form	MOUTHWASH	MOUTHWASH		An aqueous solution which is most often used for its deodorant, refreshing, or antiseptic effect. (NCI)	Mouthwash Dosage Form	Production
C48624	C66726		Pharmaceutical Dosage Form	NOT APPLICABLE	NOT APPLICABLE		The use of a dosage form term is not relevant or appropriate. (NCI)	Dosage Form Not Applicable	Production
C42965	C66726		Pharmaceutical Dosage Form	OIL	OIL		An unctuous, combustible substance which is liquid, or easily liquefiable, on warming, and is soluble in ether but insoluble in water. Such substances, depending on their origin, are classified as animal, mineral, or vegetable oils. (NCI)	Oil Dosage Form	Production
C42966	C66726		Pharmaceutical Dosage Form	OINTMENT	OINTMENT		A suspension or emulsion, semisolid (1) dosage form, usually containing < 20% water and volatiles (2) and > 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes. Note 1: A semisolid is not pourable; it does not flow or conform to its container at room temperature. It does not flow at low shear stress and generally exhibits plastic flow behavior. Note 2: Percent water and volatiles are measured by a loss on drying test in which the sample is heated at 105 degrees C until constant weight is achieved. (NCI)	Ointment Dosage Form	Production
C60984	C66726		Pharmaceutical Dosage Form	OINTMENT, AUGMENTED	OINTMENT, AUGMENTED		An ointment dosage form that enhances drug delivery. Augmentation does not refer to the strength of the drug in the dosage form. NOTE: CDER has decided to refrain from expanding the use of this dosage form due to difficulties in setting specific criteria that must be met to be considered augmented. (FDA)	Augmented Ointment Dosage Form	Production
C47887	C66726		Pharmaceutical Dosage Form	PACKING	PACKING		A material, usually covered by or impregnated with a drug, that is inserted into a body cavity or between the tooth enamel and the gingival margin.(FDA)	Packing Dosage Form	Production
C42967	C66726		Pharmaceutical Dosage Form	PASTE	PASTE		A semisolid dosage form, containing a large proportion (20 - 50%) of solids finely dispersed in a fatty vehicle. This dosage form is generally for external application to the skin or mucous membranes. Note: A semisolid is not pourable; it does not flow or conform to its container at room temperature. It does not flow at low shear stress and generally exhibits plastic flow behavior. (NCI)	Paste Dosage Form	Production
C42907	C66726		Pharmaceutical Dosage Form	PASTE, DENTIFRICE	PASTE, DENTIFRICE		A paste formulation intended to clean and/or polish the teeth, and which may contain certain additional agents. (NCI)	Dentifrice Paste Dosage Form	Production
C60985	C66726		Pharmaceutical Dosage Form	PASTILLE	PASTILLE		An aromatic preparation, often with a pleasing flavor, usually intended to dissolve in the mouth. (FDA)	Pastille Dosage Form	Production
C42968	C66726		Pharmaceutical Dosage Form	PATCH	PATCH		A drug delivery system that often contains an adhesive backing that is usually applied to an external site on the body.  Its ingredients either passively diffuse from, or are actively transported from, some portion of the patch.  Depending upon the patch, the ingredients are either delivered to the outer surface of the body or into the body.  A patch is sometimes synonymous with the terms Extended Release Film and System. (NCI)	Patch Dosage Form	Production
C42923	C66726		Pharmaceutical Dosage Form	PATCH, EXTENDED RELEASE	PATCH, EXTENDED RELEASE		A drug delivery system in the form of a patch that releases the drug in such a manner that a reduction in dosing frequency compared to that drug presented as a conventional dosage form (e.g., a solution or a prompt drug-releasing, conventional solid dosage form). (NCI)	Extended Release Patch Dosage Form	Production
C42911	C66726		Pharmaceutical Dosage Form	PATCH, EXTENDED RELEASE, ELECTRICALLY CONTROLLED	PATCH, EXTENDED RELEASE, ELECTRICALLY CONTROLLED		A drug delivery system in the form of a patch which is controlled by an electric current that releases the drug in such a manner that a reduction in dosing frequency compared to that drug presented as a conventional dosage form (e.g., a solution or a prompt drug-releasing, conventional solid dosage form). (NCI)	Electrically Controlled Extended Release Patch Dosage Form	Production
C42969	C66726		Pharmaceutical Dosage Form	PELLET	PELLET		A small sterile solid mass consisting of a highly purified drug (with or without excipients) made by the formation of granules, or by compression and molding. (NCI)	Pellet Dosage Form	Production
C42943	C66726		Pharmaceutical Dosage Form	PELLET, IMPLANTABLE	PELLET, IMPLANTABLE		A small sterile solid mass consisting of a highly purified drug (with or without excipients) made by the formation of granules, or by compression and molding; they are intended for implantation in the body (usually subcutaneously) for the purpose of providing continuous release of the drug over long periods of time. (NCI)	Implantable Pellet Dosage Form	Production
C42918	C66726		Pharmaceutical Dosage Form	PELLETS, COATED, EXTENDED RELEASE	PELLETS, COATED, EXTENDED RELEASE		A solid dosage form in which the drug itself is in the form of granules to which varying amounts of coating have been applied, and which releases a drug (or drugs) in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (NCI)	Extended Release Coated Pellets Dosage Form	Production
C25394	C66726		Pharmaceutical Dosage Form	PILL	PILL		A dose of medicine in the form of a small pellet. (NCI)	Pill Dosage Form	Production
C42970	C66726		Pharmaceutical Dosage Form	PLASTER	PLASTER		Substance intended for external application made of such materials and of such consistency as to adhere to the skin and attach to a dressing; plasters are intended to afford protection and support and/or to furnish an occlusion and macerating action and to bring medication into close contact with the skin. (NCI)	Plaster Dosage Form	Production
C47913	C66726		Pharmaceutical Dosage Form	POULTICE	POULTICE		A soft, moist mass of meal, herbs, seed, etc., usually applied hot in cloth that consists of gruel-like consistency. (NCI)	Poultice Dosage Form	Production
C42972	C66726		Pharmaceutical Dosage Form	POWDER	POWDER		An intimate mixture of dry, finely divided drugs and/or chemicals that may be intended for internal or external use. (NCI)	Powder Dosage Form	Production
C42908	C66726		Pharmaceutical Dosage Form	POWDER, DENTIFRICE	POWDER, DENTIFRICE		A powder formulation intended to clean and/or polish the teeth, and which may contain certain additional agents. (NCI)	Dentifrice Powder Dosage Form	Production
C42973	C66726		Pharmaceutical Dosage Form	POWDER, FOR SOLUTION	POWDER, FOR SOLUTION		An intimate mixture of dry, finely divided drugs and/or chemicals, which, upon the addition of suitable vehicles, yields a solution. (NCI)	Powder for Solution Dosage Form	Production
C42975	C66726		Pharmaceutical Dosage Form	POWDER, FOR SUSPENSION	POWDER, FOR SUSPENSION		An intimate mixture of dry, finely divided drugs and/or chemicals, which, upon the addition of suitable vehicles, yields a suspension (a liquid preparation containing the solid particles dispersed in the liquid vehicle). (NCI)	Powder for Suspension Dosage Form	Production
C42961	C66726		Pharmaceutical Dosage Form	POWDER, METERED	POWDER, METERED		A powder dosage form that is situated inside a container that has a mechanism to deliver a specified quantity. (NCI)	Metered Powder Dosage Form	Production
C60988	C66726		Pharmaceutical Dosage Form	RING	RING		A small circular object with a vacant circular center that is usually intended to be placed in the body by special inserters, where the medication is released, generally for localized effects. (FDA)	Ring Dosage Form	Production
C42979	C66726		Pharmaceutical Dosage Form	RINSE	RINSE		A liquid used to cleanse by flushing. (NCI)	Rinse Dosage Form	Production
C42980	C66726		Pharmaceutical Dosage Form	SALVE	SALVE		A thick ointment or cerate (a fat or wax based preparation with a consistency between an ointment and a plaster). (NCI)	Salve Dosage Form	Production
C42981	C66726		Pharmaceutical Dosage Form	SHAMPOO	SHAMPOO		A liquid soap or detergent used to clean the hair and scalp and is often used as a vehicle for dermatologic agents. (NCI)	Shampoo Dosage Form	Production
C42982	C66726		Pharmaceutical Dosage Form	SHAMPOO, SUSPENSION	SHAMPOO, SUSPENSION		A liquid soap or detergent containing one or more solid, insoluble substances dispersed in a liquid vehicle that is used to clean the hair and scalp and is often used as a vehicle for dermatologic agents. (NCI)	Shampoo Suspension Dosage Form	Production
C42983	C66726		Pharmaceutical Dosage Form	SOAP	SOAP		Any compound of one or more fatty acids, or their equivalents, with an alkali; soap is detergent and is much employed in liniments, enemas, and in making pills. It is also a mild aperient, antacid and antiseptic. (NCI)	Soap Dosage Form	Production
C42986	C66726		Pharmaceutical Dosage Form	SOLUTION	SOLUTION		A clear, homogeneous liquid dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents. Note: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior. (NCI)	Solution Dosage Form	Production
C42898	C66726		Pharmaceutical Dosage Form	SOLUTION, CONCENTRATE	SOLUTION, CONCENTRATE		A liquid preparation (i.e., a substance that flows readily in its natural state) that contains a drug dissolved in a suitable solvent or mixture of mutually miscible solvents; the drug has been strengthened by the evaporation of its non-active parts. (NCI)	Concentrate for Solution Dosage Form	Production
C42987	C66726		Pharmaceutical Dosage Form	SOLUTION, FOR SLUSH	SOLUTION, FOR SLUSH		A solution for the preparation of an iced saline slush, which is administered by irrigation and used to induce regional hypothermia (in conditions such as certain open heart and kidney surgical procedures) by its direct application. (NCI)	Solution For Slush Dosage Form	Production
C60994	C66726		Pharmaceutical Dosage Form	SOLUTION, GEL FORMING / DROPS	SOLUTION, GEL FORMING / DROPS		A solution, which after usually being administered in a drop-wise fashion, forms a gel. (FDA)	Gel Forming Drops Solution Dosage Form	Production
C42935	C66726		Pharmaceutical Dosage Form	SOLUTION, GEL FORMING, EXTENDED RELEASE	SOLUTION, GEL FORMING, EXTENDED RELEASE		A solution that forms a gel when it comes in contact with ocular fluid, and which allows at least a reduction in dosing frequency	Extended Release Gel Forming Solution Dosage Form	Production
C60992	C66726		Pharmaceutical Dosage Form	SOLUTION/ DROPS	SOLUTION/ DROPS		A solution which is usually administered in a drop-wise fashion. (FDA)	Drops Solution Dosage Form	Production
C47912	C66726		Pharmaceutical Dosage Form	SPONGE	SPONGE		A porous, interlacing, absorbent material that contains a drug.  It is typically used for applying or introducing medication, or for cleansing.  A sponge usually retains its shape.(FDA)	Sponge Dosage Form	Production
C42989	C66726		Pharmaceutical Dosage Form	SPRAY	SPRAY		A liquid minutely divided as by a jet of air or steam. (NCI)	Spray Dosage Form	Production
C42962	C66726		Pharmaceutical Dosage Form	SPRAY, METERED	SPRAY, METERED		A non-pressurized dosage form consisting of valves which allow the dispensing of a specified quantity of spray upon each activation. (NCI)	Metered Spray Dosage Form	Production
C42990	C66726		Pharmaceutical Dosage Form	SPRAY, SUSPENSION	SPRAY, SUSPENSION		A liquid preparation containing solid particles dispersed in a liquid vehicle and in the form of coarse droplets or as finely divided solids to be applied locally, most usually to the nasal-pharyngeal tract, or topically to the skin. (NCI)	Spray Suspension Dosage Form	Production
C42991	C66726		Pharmaceutical Dosage Form	STICK	STICK		A dosage form prepared in a relatively long and slender often cylindrical form. (NCI)	Stick Dosage Form	Production
C47914	C66726		Pharmaceutical Dosage Form	STRIP	STRIP		A long narrow piece of material.	Strip Dosage Form	Production
C42993	C66726		Pharmaceutical Dosage Form	SUPPOSITORY	SUPPOSITORY		A solid body of various weights and shapes, adapted for introduction into the rectal, vaginal, or urethral orifice of the human body; they usually melt, soften, or dissolve at body temperature. (NCI)	Suppository Dosage Form	Production
C42924	C66726		Pharmaceutical Dosage Form	SUPPOSITORY, EXTENDED RELEASE	SUPPOSITORY, EXTENDED RELEASE		A drug delivery system in the form of a suppository that allows at least a reduction in dosing frequency. (NCI)	Extended Release Suppository Dosage Form	Production
C42994	C66726		Pharmaceutical Dosage Form	SUSPENSION	SUSPENSION		A liquid dosage form that contains solid particles dispersed in a liquid vehicle. Note: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior.(FDA)	Suspension Dosage Form	Production
C42925	C66726		Pharmaceutical Dosage Form	SUSPENSION, EXTENDED RELEASE	SUSPENSION, EXTENDED RELEASE		A liquid preparation consisting of solid particles dispersed throughout a liquid phase in which the particles are not soluble; the suspension has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution or a prompt drug-releasing, conventional solid dosage form). (NCI)	Extended Release Suspension Dosage Form	Production
C60995	C66726		Pharmaceutical Dosage Form	SUSPENSION/DROPS	SUSPENSION/DROPS		A suspension which is usually administered in a dropwise fashion. (FDA)	Drops Suspension Dosage Form	Production
C47889	C66726		Pharmaceutical Dosage Form	SUTURE	SUTURE		A strand or fiber used to hold wound edges in apposition during healing. (NCI)	Suture Dosage Form	Production
C47898	C66726		Pharmaceutical Dosage Form	SWAB	SWAB		A small piece of relatively flat absorbent material that contains a drug.  A swab may also be attached to one end of a small stick.  A swab is typically used for applying medication or for cleansing. (NCI)	Swab Dosage Form	Production
C42996	C66726		Pharmaceutical Dosage Form	SYRUP	SYRUP		An oral solution containing high concentrations of sucrose or other sugars; the term has also been used to include any other liquid dosage form prepared in a sweet and viscid vehicle, including oral suspensions.  (NCI)	Syrup Dosage Form	Production
C42998	C66726		Pharmaceutical Dosage Form	TABLET	TABLET		A solid dosage form containing medicinal substances with or without suitable diluents.  (NCI)	Tablet Dosage Form	Production
C42893	C66726		Pharmaceutical Dosage Form	TABLET, CHEWABLE	TABLET, CHEWABLE		A solid dosage form containing medicinal substances with or without suitable diluents that is intended to be chewed, producing a pleasant tasting residue in the oral cavity that is easily swallowed and does not leave a bitter or unpleasant after-taste. (NCI)	Chewable Tablet Dosage Form	Production
C42897	C66726		Pharmaceutical Dosage Form	TABLET, COATED	TABLET, COATED		A solid dosage form that contains medicinal substances with or without suitable diluents and is covered with a designated coating. (NCI)	Coated Tablet Dosage Form	Production
C60997	C66726		Pharmaceutical Dosage Form	TABLET, COATED PARTICLES	TABLET, COATED PARTICLES		A solid dosage form containing a conglomerate of medicinal particles that have each been covered with a coating. (FDA)	Tablet Coated Particles Dosage Form	Production
C42905	C66726		Pharmaceutical Dosage Form	TABLET, DELAYED RELEASE	TABLET, DELAYED RELEASE		A solid dosage form which releases a drug (or drugs) at a time other than promptly after administration. Enteric-coated articles are delayed release dosage forms. (NCI)	Delayed Release Tablet Dosage Form	Production
C42997	C66726		Pharmaceutical Dosage Form	TABLET, DELAYED RELEASE PARTICLES	TABLET, DELAYED RELEASE PARTICLES		A solid dosage form containing a conglomerate of medicinal particles that have been covered with a coating which releases a drug (or drugs) at a time other than promptly after administration. Enteric-coated articles are delayed release dosage forms.  (NCI)	Delayed Release Particles Tablet Dosage Form	Production
C42910	C66726		Pharmaceutical Dosage Form	TABLET, EFFERVESCENT	TABLET, EFFERVESCENT		A solid dosage form containing mixtures of acids (e.g., citric acid, tartaric acid) and sodium bicarbonate, which release carbon dioxide when dissolved in water; it is intended to be dissolved or dispersed in water before administration.(FDA)	Effervescent Tablet Dosage Form	Production
C42927	C66726		Pharmaceutical Dosage Form	TABLET, EXTENDED RELEASE	TABLET, EXTENDED RELEASE		A solid dosage form containing a drug which allows at least a reduction in dosing frequency as compared to that drug presented in conventional dosage form. (NCI)	Extended Release Tablet Dosage Form	Production
C42931	C66726		Pharmaceutical Dosage Form	TABLET, FILM COATED	TABLET, FILM COATED		A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer. (NCI)	Film Coated Tablet Dosage Form	Production
C42930	C66726		Pharmaceutical Dosage Form	TABLET, FILM COATED, EXTENDED RELEASE	TABLET, FILM COATED, EXTENDED RELEASE		A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer; the tablet is formulated in such manner as to make the contained medicament available over an extended period of time following ingestion. (NCI)	Film Coated Extended Release Tablet Dosage Form	Production
C61004	C66726		Pharmaceutical Dosage Form	TABLET, FOR SOLUTION	TABLET, FOR SOLUTION		A tablet that forms a solution when placed in a liquid. (FDA)	Tablet For Solution Dosage Form	Production
C61005	C66726		Pharmaceutical Dosage Form	TABLET, FOR SUSPENSION	TABLET, FOR SUSPENSION; TABLET, DISPERSIBLE		A tablet that forms a suspension when placed in a liquid (formerly referred to as a Dispersible Tablet).	Tablet For Suspension Dosage Form	Production
C42964	C66726		Pharmaceutical Dosage Form	TABLET, MULTILAYER	TABLET, MULTILAYER		A solid dosage form containing medicinal substances that have been compressed to form a multiple-layered tablet or a tablet-within-a-tablet, the inner tablet being the core and the outer portion being the shell. (NCI)	Multilayered Tablet Dosage Form	Production
C42963	C66726		Pharmaceutical Dosage Form	TABLET, MULTILAYER, EXTENDED RELEASE	TABLET, MULTILAYER, EXTENDED RELEASE		A solid dosage form containing medicinal substances that have been compressed to form a multiple-layered tablet or a tablet-within-a-tablet, the inner tablet being the core and the outer portion being the shell, which, additionally, is covered in a designated coating; the tablet is formulated in such manner as to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form. (NCI)	Multilayered Extended Release Tablet Dosage Form	Production
C42999	C66726		Pharmaceutical Dosage Form	TABLET, ORALLY DISINTEGRATING	TABLET, ORALLY DISINTEGRATING		A solid dosage form containing medicinal substances which disintegrates rapidly, usually within a matter of seconds, when placed upon the tongue.  (NCI)	Orally Disintegrating Tablet Dosage Form	Production
C61006	C66726		Pharmaceutical Dosage Form	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE		A solid dosage form containing medicinal substances which disintegrates rapidly, usually within a matter of seconds, when placed upon the tongue, but which releases a drug (or drugs) at a time other than promptly after administration. (FDA)	Tablet Orally Disintegrating Delayed Release Dosage Form	Production
C42985	C66726		Pharmaceutical Dosage Form	TABLET, SOLUBLE	TABLET, SOLUBLE		A solid dosage form that contains medicinal substances with or without suitable diluents and possesses the ability to dissolve in fluids. (NCI)	Soluble Tablet Dosage Form	Production
C42992	C66726		Pharmaceutical Dosage Form	TABLET, SUGAR COATED	TABLET, SUGAR COATED		A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a colored or an uncolored water-soluble sugar. (NCI)	Sugar Coated Tablet Dosage Form	Production
C47892	C66726		Pharmaceutical Dosage Form	TAMPON	TAMPON		A plug made of cotton, sponge, or oakum variously used in surgery to plug the nose, vagina, etc., for the control of hemorrhage or the absorption of secretions. (NCI)	Tampon Dosage Form	Production
C47897	C66726		Pharmaceutical Dosage Form	TAPE	TAPE		A narrow woven fabric, or a narrow extruded synthetic (such as plastic), usually with an adhesive on one or both sides. (NCI)	Tape Dosage Form	Production
C43000	C66726		Pharmaceutical Dosage Form	TINCTURE	TINCTURE		An alcoholic or hydroalcoholic solution prepared from vegetable materials or from chemical substances.  (NCI)	Tincture Dosage Form	Production
C43001	C66726		Pharmaceutical Dosage Form	TROCHE	TROCHE		A discoid-shaped solid containing the medicinal agent in a suitably flavored base; troches are placed in the mouth where they slowly dissolve, liberating the active ingredients.  (NCI)	Troche Dosage Form	Production
C43002	C66726		Pharmaceutical Dosage Form	UNASSIGNED	UNASSIGNED		A dosage form has yet to be assigned.  (NCI)	Unassigned Dosage Form	Production
C43003	C66726		Pharmaceutical Dosage Form	WAFER	WAFER		A thin slice of material containing a medicinal agent.  (NCI)	Wafer Dosage Form	Production
C66727	C66727	Yes	Completion/Reason for Non-Completion	NCOMPLT	NCOMPLT	Completion/Reason for Non-Completion	The reason that a subject was discontinued from a clinical trial.	CDISC SDTM Reason for Non-Completion Terminology	Production
C41331	C66727		Completion/Reason for Non-Completion	ADVERSE EVENT	ADVERSE EVENT		Any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have a causal relationship with this treatment. An adverse event (AE) can therefore be any unintended sign (including an abnormal laboratory finding), symptom,or disease temporally associated with the use of a medicinal (investigational) product, whether or not related to the medicinal (investigational) product. NOTE: For further information, see the ICH Guideline for Clinical Safety Data Management: Definitions and Standards for Expedited Reporting. “[Modified from ICH E2A]” Synonyms: side effect, adverse experience. See also serious adverse event, serious adverse experience.  (CDISC glossary)	Adverse Event	Production
C25250	C66727		Completion/Reason for Non-Completion	COMPLETED	COMPLETED		To possess every necessary or normal part or component or step; having come or been brought to a conclusion. (NCI)	Complete	Production
C28554	C66727		Completion/Reason for Non-Completion	DEATH	DEATH		The absence of life or state of being dead. (NCI)	Death	Production
C48226	C66727		Completion/Reason for Non-Completion	LACK OF EFFICACY	LACK OF EFFICACY		The lack of expected or desired effect related to a therapy. (NCI)	Lack of Efficacy	Production
C48227	C66727		Completion/Reason for Non-Completion	LOST TO FOLLOW-UP	LOST TO FOLLOW-UP		The loss or lack of continuation of follow-up after a study has officially closed.  See Follow-up. (NCI)	Lost To Follow-up	Production
C49631	C66727		Completion/Reason for Non-Completion	NON-COMPLIANCE WITH STUDY DRUG	NON-COMPLIANCE WITH STUDY DRUG		An indication that a subject has not agreed with or followed the instructions related to the study medication. (NCI)	Non-Compliance With Study Drug	Production
C17649	C66727		Completion/Reason for Non-Completion	OTHER	OTHER	Other	Different than the one(s) previously specified or mentioned. (NCI)	Other	Production
C48250	C66727		Completion/Reason for Non-Completion	PHYSICIAN DECISION	PHYSICIAN DECISION		A position, opinion or judgment reached after consideration by a physician with reference to subject. (NCI)	Physician Decision	Production
C25742	C66727		Completion/Reason for Non-Completion	PREGNANCY	PREGNANCY		Pregnancy is the state or condition of having a developing embryo or fetus in the body (uterus), after union of an ovum and spermatozoon, during the period from conception to birth. (NCI)	Pregnancy	Production
C35571	C66727		Completion/Reason for Non-Completion	PROGRESSIVE DISEASE	PROGRESSIVE DISEASE		A disease process that is increasing in scope or severity. (NCI)	Progressive Disease	Production
C48251	C66727		Completion/Reason for Non-Completion	PROTOCOL VIOLATION	PROTOCOL VIOLATION		An event or decision that stands in contrast to the guidelines set out by the protocol. (NCI)	Protocol Violation	Production
C25746	C66727		Completion/Reason for Non-Completion	RECOVERY	RECOVERY		A healing process and/or an outcome implying relative health.  The term is typically used in the context of direct and indirect effects of sickness or injury. (NCI)	Recovery	Production
C49628	C66727		Completion/Reason for Non-Completion	SCREEN FAILURE	SCREEN FAILURE		The potential subject who does not meet one or more criteria required for participation in a trial.	Trial Screen Failure	Production
C49632	C66727		Completion/Reason for Non-Completion	STUDY TERMINATED BY SPONSOR	STUDY TERMINATED BY SPONSOR		An indication that a clinical study was stopped by its sponsor.  (NCI)	Study Terminated By Sponsor	Production
C49633	C66727		Completion/Reason for Non-Completion	TECHNICAL PROBLEMS	TECHNICAL PROBLEMS		A problem with some technical aspect of a clinical study, usually related to an instrument.  (NCI)	Technical Problem	Production
C49634	C66727		Completion/Reason for Non-Completion	WITHDRAWAL BY SUBJECT	WITHDRAWAL BY SUBJECT		An indication that a study participant has removed itself from the study.  (NCI)	Withdrawal by Subject	Production
C66728	C66728	No	Relation to Reference Period	STENRF	STENRF	Relation to Reference Period	The name of a code list that contains terms that reference timepoints within and without a defined time period.	CDISC SDTM Relation to Reference Period Terminology	Production
C38008	C66728		Relation to Reference Period	AFTER	AFTER		The time period following a point or another period of time. (NCI)	Status Post	Production
C25629	C66728		Relation to Reference Period	BEFORE	BEFORE		Earlier in time or order. (NCI)	Prior	Production
C25490	C66728		Relation to Reference Period	DURING	DURING		At some point in a given period of time. (NCI)	During	Production
C49640	C66728		Relation to Reference Period	DURING/AFTER	DURING/AFTER		Within a certain period of time or after a certain point or period in time. (NCI)	During Or After	Production
C17998	C66728		Relation to Reference Period	U	UNKNOWN	U; Unknown	Not known, not observed, not recorded, or refused. (NCI)	Unknown	Production
C66729	C66729	Yes	Route of Administration	ROUTE	ROUTE	Route of Administration	The course by which a substance was administered in order to reach the site of action in the body.	CDISC SDTM Route of Administration Terminology	Production
C38192	C66729		Route of Administration	AURICULAR (OTIC)	AURICULAR (OTIC)		Administration to or by way of the ear.(FDA)	Auricular Route of Administration	Production
C38193	C66729		Route of Administration	BUCCAL	BUCCAL		Administration directed toward the cheek, generally from within the mouth.(FDA)	Buccal Route of Administration	Production
C38194	C66729		Route of Administration	CONJUNCTIVAL	CONJUNCTIVAL		Administration to the conjunctiva, the delicate membrane that lines the eyelids and covers the exposed surface of the eyeball.(FDA)	Conjunctival Route of Administration	Production
C38675	C66729		Route of Administration	CUTANEOUS	CUTANEOUS		Administration to the skin.(FDA)	Cutaneous Route of Administration	Production
C38197	C66729		Route of Administration	DENTAL	DENTAL		Administration to a tooth or teeth.(FDA)	Dental Route of Administration	Production
C38633	C66729		Route of Administration	ELECTRO-OSMOSIS	ELECTRO-OSMOSIS		Administration of through the diffusion of substance through a membrane in an electric field.(FDA)	Electro-osmosis Route of Administration	Production
C38205	C66729		Route of Administration	ENDOCERVICAL	ENDOCERVICAL		Administration within the canal of the cervix uteri. Synonymous with the term intracervical.(FDA)	Endocervical Route of Administration	Production
C38206	C66729		Route of Administration	ENDOSINUSIAL	ENDOSINUSIAL		Administration within the nasal sinuses of the head.(FDA)	Endosinusial Route of Administration	Production
C38208	C66729		Route of Administration	ENDOTRACHEAL	ENDOTRACHEAL		Administration directly into the trachea. Synonymous with the term intratracheal.(FDA)	Endotracheal Route of Administration	Production
C38209	C66729		Route of Administration	ENTERAL	ENTERAL		Administration directly into the intestines.(FDA)	Enteral Route of Administration	Production
C38210	C66729		Route of Administration	EPIDURAL	EPIDURAL		Administration upon or over the dura mater.(FDA)	Epidural Route of Administration	Production
C38211	C66729		Route of Administration	EXTRA-AMNIOTIC	EXTRA-AMNIOTIC		Administration to the outside of the membrane enveloping the fetus.(FDA)	Extraamniotic Route of Administration	Production
C38212	C66729		Route of Administration	EXTRACORPOREAL	EXTRACORPOREAL		Administration outside of the body.(FDA)	Extracorporeal Circulation Route of Administration	Production
C38200	C66729		Route of Administration	HEMODIALYSIS	HEMODIALYSIS		Administration through hemodialysate fluid.(FDA)	Administration Via Hemodialysis	Production
C38215	C66729		Route of Administration	INFILTRATION	INFILTRATION		Administration that results in substances passing into tissue spaces or into cells.(FDA)	Infiltration Route of Administration	Production
C38219	C66729		Route of Administration	INTERSTITIAL	INTERSTITIAL		Administration to or in the interstices of a tissue.(FDA)	Interstitial Route of Administration	Production
C38220	C66729		Route of Administration	INTRA-ABDOMINAL	INTRA-ABDOMINAL		Administration within the abdomen.(FDA)	Intraabdominal Route of Administration	Production
C38221	C66729		Route of Administration	INTRA-AMNIOTIC	INTRA-AMNIOTIC		Administration within the amnion.(FDA)	Intraamniotic Route of Administration	Production
C38222	C66729		Route of Administration	INTRA-ARTERIAL	INTRA-ARTERIAL		Administration within an artery or arteries.(FDA)	Intraarterial Route of Administration	Production
C38223	C66729		Route of Administration	INTRA-ARTICULAR	INTRA-ARTICULAR		Administration within a joint.(FDA)	Intraarticular Route of Administration	Production
C38224	C66729		Route of Administration	INTRABILIARY	INTRABILIARY		Administration within the bile, bile ducts or gallbladder.(FDA)	Intrabiliary Route of Administration	Production
C38225	C66729		Route of Administration	INTRABRONCHIAL	INTRABRONCHIAL		Administration within a bronchus.(FDA)	Intrabronchial Route of Administration	Production
C38226	C66729		Route of Administration	INTRABURSAL	INTRABURSAL		Administration within a bursa.(FDA)	Intrabursal Route of Administration	Production
C38227	C66729		Route of Administration	INTRACARDIAC	INTRACARDIAC		Administration within the heart.(FDA)	Intracardiac Route of Administration	Production
C38228	C66729		Route of Administration	INTRACARTILAGINOUS	INTRACARTILAGINOUS		Administration within a cartilage; endochondral.(FDA)	Intracartilaginous Route of Administration	Production
C38229	C66729		Route of Administration	INTRACAUDAL	INTRACAUDAL		Administration within the cauda equina.(FDA)	Intracaudal Route of Administration	Production
C38230	C66729		Route of Administration	INTRACAVERNOUS	INTRACAVERNOUS		Administration within a pathologic cavity, such as occurs in the lung in tuberculosis.(FDA)	Intracavernous Route of Administration	Production
C38231	C66729		Route of Administration	INTRACAVITARY	INTRACAVITARY		Administration within a non-pathologic cavity, such as that of the cervix, uterus, or penis, or such as that is formed as the result of a wound.(FDA)	Intracavitary Route of Administration	Production
C38232	C66729		Route of Administration	INTRACEREBRAL	INTRACEREBRAL		Administration within the cerebrum.(FDA)	Intracerebral Route of Administration	Production
C38233	C66729		Route of Administration	INTRACISTERNAL	INTRACISTERNAL		Administration within the cisterna magna cerebellomedularis.(FDA)	Intracisternal Route of Administration	Production
C38234	C66729		Route of Administration	INTRACORNEAL	INTRACORNEAL		Administration within the cornea (the transparent structure forming the anterior part of the fibrous tunic of the eye).(FDA)	Intracorneal Route of Administration	Production
C38217	C66729		Route of Administration	INTRACORONAL, DENTAL	INTRACORONAL, DENTAL		Administration of a drug within a portion of a tooth which is covered by enamel and which is separated from the roots by a slightly constricted region known as the neck.(FDA)	Intracoronal Dental Route of Administration	Production
C38218	C66729		Route of Administration	INTRACORONARY	INTRACORONARY		Administration within the coronary arteries.(FDA)	Intracoronary Route of Administration	Production
C38235	C66729		Route of Administration	INTRACORPORUS CAVERNOSUM	INTRACORPORUS CAVERNOSUM		Administration within the dilatable spaces of the corporus cavernosa of the penis.(FDA)	Intracorporus Cavernosum Route of Administration	Production
C38238	C66729		Route of Administration	INTRADERMAL	INTRADERMAL		Administration within the dermis.(FDA)	Intradermal Route of Administration	Production
C38239	C66729		Route of Administration	INTRADISCAL	INTRADISCAL		Administration within a disc.(FDA)	Intradiscal Route of Administration	Production
C38240	C66729		Route of Administration	INTRADUCTAL	INTRADUCTAL		Administration within the duct of a gland.(FDA)	Intraductal Route of Administration	Production
C38241	C66729		Route of Administration	INTRADUODENAL	INTRADUODENAL		Administration within the duodenum.(FDA)	Intraduodenal Route of Administration	Production
C38242	C66729		Route of Administration	INTRADURAL	INTRADURAL		Administration within or beneath the dura.(FDA)	Intradural Route of Administration	Production
C38243	C66729		Route of Administration	INTRAEPIDERMAL	INTRAEPIDERMAL		Administration within the epidermis.(FDA)	Intraepidermal Route of Administration	Production
C38245	C66729		Route of Administration	INTRAESOPHAGEAL	INTRAESOPHAGEAL		Administration within the esophagus.(FDA)	Intraesophageal Route of Administration	Production
C38246	C66729		Route of Administration	INTRAGASTRIC	INTRAGASTRIC		Administration within the stomach.(FDA)	Intragastric Route of Administration	Production
C38247	C66729		Route of Administration	INTRAGINGIVAL	INTRAGINGIVAL		Administration within the gingivae.(FDA)	Intragingival Route of Administration	Production
C38249	C66729		Route of Administration	INTRAILEAL	INTRAILEAL		Administration within the distal portion of the small intestine, from the jejunum to the cecum.(FDA)	Intraileal Route of Administration	Production
C38250	C66729		Route of Administration	INTRALESIONAL	INTRALESIONAL		Administration within or introduced directly into a localized lesion.(FDA)	Intralesional Route of Administration	Production
C38251	C66729		Route of Administration	INTRALUMINAL	INTRALUMINAL		Administration within the lumen of a tube.(FDA)	Intraluminal Route of Administration	Production
C38252	C66729		Route of Administration	INTRALYMPHATIC	INTRALYMPHATIC		Administration within the lymph.(FDA)	Intralymphatic Route of Administration	Production
C38253	C66729		Route of Administration	INTRAMEDULLARY	INTRAMEDULLARY		Administration within the marrow cavity of a bone.(FDA)	Intramedullary Route of Administration	Production
C38254	C66729		Route of Administration	INTRAMENINGEAL	INTRAMENINGEAL		Administration within the meninges (the three membranes that envelope the brain and spinal cord).(FDA)	Intrameningeal Route of Administration	Production
C28161	C66729		Route of Administration	INTRAMUSCULAR	INTRAMUSCULAR		Administration within a muscle. (FDA)	Intramuscular Route of Administration	Production
C38255	C66729		Route of Administration	INTRAOCULAR	INTRAOCULAR		Administration within the eye.(FDA)	Intraocular Route of Administration	Production
C38256	C66729		Route of Administration	INTRAOVARIAN	INTRAOVARIAN		Administration within the ovary.(FDA)	Intraovarian Route of Administration	Production
C38257	C66729		Route of Administration	INTRAPERICARDIAL	INTRAPERICARDIAL		Administration within the pericardium.(FDA)	Intrapericardial Route of Administration	Production
C38258	C66729		Route of Administration	INTRAPERITONEAL	INTRAPERITONEAL		Administration within the peritoneal cavity.(FDA)	Intraperitoneal Route of Administration	Production
C38259	C66729		Route of Administration	INTRAPLEURAL	INTRAPLEURAL		Administration within the pleura.(FDA)	Intrapleural Route of Administration	Production
C38260	C66729		Route of Administration	INTRAPROSTATIC	INTRAPROSTATIC		Administration within the prostate gland.(FDA)	Intraprostatic Route of Administration	Production
C38261	C66729		Route of Administration	INTRAPULMONARY	INTRAPULMONARY		Administration within the lungs or its bronchi.(FDA)	Intrapulmonary Route of Administration	Production
C38262	C66729		Route of Administration	INTRASINAL	INTRASINAL		Administration within the nasal or periorbital sinuses.(FDA)	Intrasinal Route of Administration	Production
C38263	C66729		Route of Administration	INTRASPINAL	INTRASPINAL		Administration within the vertebral column.(FDA)	Intraspinal Route of Administration	Production
C38264	C66729		Route of Administration	INTRASYNOVIAL	INTRASYNOVIAL		Administration within the synovial cavity of a joint.(FDA)	Intrasynovial Route of Administration	Production
C38265	C66729		Route of Administration	INTRATENDINOUS	INTRATENDINOUS		Administration within a tendon.(FDA)	Intratendinous Route of Administration	Production
C38266	C66729		Route of Administration	INTRATESTICULAR	INTRATESTICULAR		Administration within the testicle.(FDA)	Intratesticular Route of Administration	Production
C38267	C66729		Route of Administration	INTRATHECAL	INTRATHECAL		Administration within the cerebrospinal fluid at any level of the cerebrospinal axis, including injection into the cerebral ventricles.(FDA)	Intrathecal Route of Administration	Production
C38207	C66729		Route of Administration	INTRATHORACIC	INTRATHORACIC		Administration within the thorax (internal to the ribs); synonymous with the term endothoracic.(FDA)	Endothoracic Route of Administration	Production
C38268	C66729		Route of Administration	INTRATUBULAR	INTRATUBULAR		Administration within the tubules of an organ.(FDA)	Intratubular Route of Administration	Production
C38269	C66729		Route of Administration	INTRATUMOR	INTRATUMOR	Intratumor Route of Administration	Administration within a tumor.(FDA)	Intratumoral Route of Administration	Production
C38270	C66729		Route of Administration	INTRATYMPANIC	INTRATYMPANIC		Administration within the auris media.(FDA)	Intratympanic Route of Administration	Production
C38272	C66729		Route of Administration	INTRAUTERINE	INTRAUTERINE		Administration within the uterus.(FDA)	Intrauterine Route of Administration	Production
C38273	C66729		Route of Administration	INTRAVASCULAR	INTRAVASCULAR		Administration within a vessel or vessels.(FDA)	Intravascular Route of Administration	Production
C38276	C66729		Route of Administration	INTRAVENOUS	INTRAVENOUS		Administration within or into a vein or veins.(FDA)	Intravenous Route of Administration	Production
C38274	C66729		Route of Administration	INTRAVENOUS BOLUS	INTRAVENOUS BOLUS		Administration within or into a vein or veins all at once.(FDA)	Intravenous Bolus	Production
C38279	C66729		Route of Administration	INTRAVENOUS DRIP	INTRAVENOUS DRIP		Administration within or into a vein or veins over a sustained period of time.(FDA)	Intravenous Drip	Production
C38277	C66729		Route of Administration	INTRAVENTRICULAR	INTRAVENTRICULAR		Administration within a ventricle.(FDA)	Intraventricular Route of Administration	Production
C38278	C66729		Route of Administration	INTRAVESICAL	INTRAVESICAL		Administration within the bladder.(FDA)	Intravesical Route of Administration	Production
C38280	C66729		Route of Administration	INTRAVITREAL	INTRAVITREAL		Administration within the vitreous body of the eye.(FDA)	Intravitreal Route of Administration	Production
C38203	C66729		Route of Administration	IONTOPHORESIS	IONTOPHORESIS		Administration by means of an electric current where ions of soluble salts migrate into the tissues of the body.(FDA)	Iontophoresis Route of Administration	Production
C38281	C66729		Route of Administration	IRRIGATION	IRRIGATION		Administration to bathe or flush open wounds or body cavities.(FDA)	Irrigation-Route of Administration	Production
C38282	C66729		Route of Administration	LARYNGEAL	LARYNGEAL		Administration directly upon the larynx.(FDA)	Laryngeal Route of Administration	Production
C38284	C66729		Route of Administration	NASAL	NASAL		Administration to the nose; administered by way of the nose.(FDA)	Nasal Route of Administration	Production
C38285	C66729		Route of Administration	NASOGASTRIC	NASOGASTRIC		Administration through the nose and into the stomach, usually by means of a tube.(FDA)	Nasogastric Route of Administration	Production
C48623	C66729		Route of Administration	NOT APPLICABLE	NOT APPLICABLE		Routes of administration are not applicable.(FDA)	Route of Administration Not Applicable	Production
C38286	C66729		Route of Administration	OCCLUSIVE DRESSING TECHNIQUE	OCCLUSIVE DRESSING TECHNIQUE		Administration by the topical route which is then covered by a dressing which occludes the area.(FDA)	Occlusive Dressing Technique	Production
C38287	C66729		Route of Administration	OPHTHALMIC	OPHTHALMIC		Administration to the external eye.(FDA)	Ophthalmic Route of Administration	Production
C38288	C66729		Route of Administration	ORAL	ORAL		Administration to or by way of the mouth.(FDA)	Oral Route of Administration	Production
C38289	C66729		Route of Administration	OROPHARYNGEAL	OROPHARYNGEAL		Administration directly to the mouth and pharynx.(FDA)	Oropharyngeal Route of Administration	Production
C38290	C66729		Route of Administration	OTHER	OTHER		Administration is different from others on this list.(FDA)	Other Route of Administration	Production
C38291	C66729		Route of Administration	PARENTERAL	PARENTERAL		Administration by injection, infusion, or implantation.(FDA)	Parenteral Route of Administration	Production
C38676	C66729		Route of Administration	PERCUTANEOUS	PERCUTANEOUS		Administration through the skin.(FDA)	Percutaneous Route of Administration	Production
C38292	C66729		Route of Administration	PERIARTICULAR	PERIARTICULAR		Administration around a joint.(FDA)	Periarticular Route of Administration	Production
C38677	C66729		Route of Administration	PERIDURAL	PERIDURAL		Administration to the outside of the dura mater of the spinal cord.(FDA)	Peridural Route of Administration	Production
C38293	C66729		Route of Administration	PERINEURAL	PERINEURAL		Administration surrounding a nerve or nerves.(FDA)	Perineural Route of Administration	Production
C38294	C66729		Route of Administration	PERIODONTAL	PERIODONTAL		Administration around a tooth.(FDA)	Periodontal Route of Administration	Production
C38295	C66729		Route of Administration	RECTAL	RECTAL		Administration to the rectum.(FDA)	Rectal Route of Administration	Production
C38216	C66729		Route of Administration	RESPIRATORY (INHALATION)	RESPIRATORY (INHALATION)		Administration within the respiratory tract by inhaling orally or nasally for local or systemic effect.(FDA)	Inhalation Route of Administration	Production
C38296	C66729		Route of Administration	RETROBULBAR	RETROBULBAR		Administration behind the pons or behind the eyeball.(FDA)	Retrobulbar Route of Administration	Production
C38198	C66729		Route of Administration	SOFT TISSUE	SOFT TISSUE		Administration into any soft tissue.(FDA)	Soft Tissue Route Of Administration	Production
C38297	C66729		Route of Administration	SUBARACHNOID	SUBARACHNOID		Administration beneath the arachnoid.(FDA)	Subarachnoid Route of Administration	Production
C38298	C66729		Route of Administration	SUBCONJUNCTIVAL	SUBCONJUNCTIVAL		Administration beneath the conjunctiva.(FDA)	Subconjunctival Route of Administration	Production
C38299	C66729		Route of Administration	SUBCUTANEOUS	SUBCUTANEOUS		Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.(FDA)	Subcutaneous Route of Administration	Production
C38300	C66729		Route of Administration	SUBLINGUAL	SUBLINGUAL		Administration beneath the tongue.(FDA)	Sublingual Route of Administration	Production
C38301	C66729		Route of Administration	SUBMUCOSAL	SUBMUCOSAL		Administration beneath the mucous membrane.(FDA)	Submucosal Route of Administration	Production
C38304	C66729		Route of Administration	TOPICAL	TOPICAL		Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.(FDA)	Topical Route of Administration	Production
C38305	C66729		Route of Administration	TRANSDERMAL	TRANSDERMAL		Administration through the dermal layer of the skin to the systemic circulation by diffusion.(FDA)	Transdermal Route of Administration	Production
C38283	C66729		Route of Administration	TRANSMUCOSAL	TRANSMUCOSAL		Administration across the mucosa.(FDA)	Mucosal Route of Administration	Production
C38307	C66729		Route of Administration	TRANSPLACENTAL	TRANSPLACENTAL		Administration through or across the placenta.(FDA)	Transplacental Route of Administration	Production
C38308	C66729		Route of Administration	TRANSTRACHEAL	TRANSTRACHEAL		Administration through the wall of the trachea.(FDA)	Transtracheal Route of Administration	Production
C38309	C66729		Route of Administration	TRANSTYMPANIC	TRANSTYMPANIC		Administration across or through the tympanic cavity.(FDA)	Transtympanic Route of Administration	Production
C38310	C66729		Route of Administration	UNASSIGNED	UNASSIGNED		Route of administration has not yet been assigned.(FDA)	Unassigned Route of Administration	Production
C38311	C66729		Route of Administration	UNKNOWN	UNKNOWN		Route of administration is unknown.(FDA)	Unknown Route of Administration	Production
C38312	C66729		Route of Administration	URETERAL	URETERAL		Administration into the ureter.(FDA)	Ureteral Route of Administration	Production
C38271	C66729		Route of Administration	URETHRAL	URETHRAL		Administration into the urethra.(FDA)	Intraurethral Route of Administration	Production
C38313	C66729		Route of Administration	VAGINAL	VAGINAL		Administration into the vagina.(FDA)	Vaginal Route of Administration	Production
C66769	C66769	No	Severity/Intensity Scale for Adverse Events	AESEV	AESEV	Severity/Intensity Scale for Adverse Events	A scale that defines the degree or state of disease existing in a patient as a result of the occurrence of an adverse event. (NCI)	CDISC SDTM Severity Intensity Scale for Adverse Event Terminology	Production
C41338	C66769		Severity/Intensity Scale for Adverse Events	MILD	MILD	Grade 1; 1	A type of adverse event that is usually transient and may require only minimal treatment or therapeutic intervention. The event does not generally interfere with usual activities of daily living.	Mild Adverse Event	Production
C41339	C66769		Severity/Intensity Scale for Adverse Events	MODERATE	MODERATE	Grade 2; 2	A type of adverse event that is usually alleviated with additional specific therapeutic intervention. The event interferes with usual activities of daily living, causing discomfort but poses no significant or permanent risk of harm to the research participant.	Moderate Adverse Event	Production
C41340	C66769		Severity/Intensity Scale for Adverse Events	SEVERE	SEVERE	Grade 3; 3	A type of adverse event that requires intensive therapeutic intervention. The event interrupts usual activities of daily living, or significantly affects clinical status. The event possesses a significant risk of harm to the research participant and hospitalization may be required.	Severe Adverse Event	Production
C66731	C66731	No	Sex	SEX	SEX	Sex	The assemblage of physical properties or qualities by which male is distinguished from female; the physical difference between male and female; the distinguishing peculiarity of male or female. (NCI)	CDISC SDTM Sex of Individual Terminology	Production
C16576	C66731		Sex	F	F	Female	A person who belongs to the sex that normally produces ova. The term is used to indicate biological sex distinctions, or cultural gender role distinctions, or both. (NCI)	Female	Production
C20197	C66731		Sex	M	M	Male	A person who belongs to the sex that normally produces sperm.  The term is used to indicate biological sex distinctions, cultural gender role distinctions, or both. (NCI)	Male	Production
C17998	C66731		Sex	U	UNKNOWN	U; Unknown	Not known, not observed, not recorded, or refused. (NCI)	Unknown	Production
C45908	C66731		Sex	UN	UN	Undifferentiated	A person (one of unisexual specimens) who is born with genitalia and/or secondary sexual characteristics of indeterminate sex, or which combine features of both sexes. (NCI)	Intersex	Production
C66732	C66732	No	Sex of Participants	SEXPOP	SEXPOP	Sex of Participants	The specific sex, either male, female, or mixed of the subject group being studied. (NCI)	CDISC SDTM Sex of Study Group Terminology	Production
C49636	C66732		Sex of Participants	BOTH	BOTH		One and the other; relating to or being two in conjunction. (NCI)	Both	Production
C16576	C66732		Sex of Participants	F	F	Female	A person who belongs to the sex that normally produces ova. The term is used to indicate biological sex distinctions, or cultural gender role distinctions, or both. (NCI)	Female	Production
C20197	C66732		Sex of Participants	M	M	Male	A person who belongs to the sex that normally produces sperm.  The term is used to indicate biological sex distinctions, cultural gender role distinctions, or both. (NCI)	Male	Production
C66733	C66733	Yes	Size	SIZE	SIZE	Size	The physical magnitude of something. (NCI)	CDISC SDTM Size Terminology	Production
C49508	C66733		Size	LARGE	LARGE		Of considerable or relatively great size, extent, or capacity. (NCI)	Large	Production
C49507	C66733		Size	MEDIUM	MEDIUM		Mid-way between small and large in number, quantity, magnitude or extent. (NCI)	Medium	Production
C25376	C66733		Size	SMALL	SMALL		Limited in number, quantity, magnitude or extent. (NCI)	Small	Production
C66734	C66734	Yes	Domain Abbreviation	DOMAIN	DOMAIN	Domain Abbreviation	A unique, 2-character domain code used in the regulatory submission process.  The domain abbreviation is used consistently throughout the submission, i.e. in the dataset name, as the value of the domain variable within the dataset, and as a prefix for most variable names in the dataset. (CDISC Glossary)	CDISC SDTM Submission Domain Abbreviation Terminology	Production
C49563	C66734		Domain Abbreviation	AD	AD	Analysis Dataset	Datasets used for statistical analysis and reporting by the sponsor. These are submitted in addition to the data tabulation datasets.	Analysis Dataset Domain	Production
C49562	C66734		Domain Abbreviation	AE	AE	Adverse Events	Adverse events may be captured either as free text or a pre-specified list of terms.	Adverse Event Domain	Production
C49565	C66734		Domain Abbreviation	AU	AU	Autopsy	Additional data about deaths, specific to findings from autopsies.	Autopsy Domain	Production
C49566	C66734		Domain Abbreviation	BM	BM	Bone Mineral Density (BMD) Data	Findings resulting from evaluations of bone mineral density.	Bone Mineral Density Data Domain	Production
C49567	C66734		Domain Abbreviation	BR	BR	Biopsy	Findings resulting from biopsies.	Biopsy Domain	Production
C49568	C66734		Domain Abbreviation	CM	CM	Concomitant Meds	Case report form (CRF) data that captures the Concomitant and Prior Medications/Therapies used by the subject. Examples are the Concomitant Medications/Therapies given on an as needed basis and the usual Background Medications/Therapies given for a condition.	Concomitant Medication Domain	Production
C49569	C66734		Domain Abbreviation	CO	CO	Comments	The Comments dataset accommodates two sources of comments: 1) those collected alongside other data on topical case report form (CRF) pages such as Adverse Events and 2) those collected on a separate page specifically dedicated to comments.	Comment Domain	Production
C49578	C66734		Domain Abbreviation	DA	DA	Drug Accountability	Data regarding the accountability of study drug, such as information on the receipt, dispensing, return, and packaging.	Drug Accountability Domain	Production
C49570	C66734		Domain Abbreviation	DC	DC	Disease Characteristics	Data related to the characteristics of a specific disease state under study for a subject.	Disease Characteristics Domain	Production
C49572	C66734		Domain Abbreviation	DM	DM	Demographics	The Demographics domain includes a set of essential standard variables that describe each subject in a clinical study.  It is the parent domain for all other observations for human clinical subjects	Demographics Domain	Production
C49576	C66734		Domain Abbreviation	DS	DS	Disposition	A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to disposition. (NCI)	Disposition Domain	Production
C49585	C66734		Domain Abbreviation	DV	DV	Protocol Deviations	The intent of the domain is to capture protocol violations and deviations during the course of the study and will store only those criteria violation by or deviated from by the subject and not a response to each violation or deviation.	Protocol Deviations Domain	Production
C49625	C66734		Domain Abbreviation	EE	EE	Electroencephalogram	Findings resulting from electroencephalogram (EEG) tests.	Electroencephalogram Domain	Production
C49626	C66734		Domain Abbreviation	EG	EG	Electrocardiogram	Findings related to the collection of ECG data, including position of the subject, method of evaluation, all cycle measurements and all findings from the ECG including an overall interpretation if collected or derived.	Electrocardiogram Domain	Production
C49587	C66734		Domain Abbreviation	EX	EX	Exposure	The Exposure domain model records the details of a subject's exposure to protocol-specified study treatment. Study treatment may be any intervention that is prospectively defined as a test material within a study, and is typically but not always supplied to the subject.	Exposure Domain	Production
C49588	C66734		Domain Abbreviation	FH	FH	Family History	A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to family history. (NCI)	Family History Domain	Production
C49589	C66734		Domain Abbreviation	HU	HU	Healthcare Resource Utilization	Healthcare resource utilization data such as subject visits to physicians, hospitalizations, and nursing home stays.	Healthcare Resource Utilization Domain	Production
C61536	C66734		Domain Abbreviation	IE	IE	Inclusion/Exclusion	The intent of the domain model is to only collect those criteria that cause the subject to be in violation of the inclusion/exclusion criteria not a response to each criterion.	Inclusion Exclusion Domain	Production
C49592	C66734		Domain Abbreviation	LB	LB	Laboratory Data	Laboratory test findings including, but is not limited to hematology, clinical chemistry and urinalysis data. This domain does not include microbiology or pharmacokinetic data, which are stored in separate domains.	Laboratory Data Domain	Production
C49602	C66734		Domain Abbreviation	MB	MB	Microbiology	Microbiology specimen findings, including gram stain results, and organisms found.	Microbiology Specimen Domain	Production
C49603	C66734		Domain Abbreviation	MH	MH	Medical History	The medical history dataset includes the subject's prior history at the start of the trial. Examples of subject medical history information could include general medical history, gynecological history, and primary diagnosis.	Medical History Domain	Production
C49604	C66734		Domain Abbreviation	ML	ML	Meal Data	Information regarding the subject's meal consumption, such as fluid intake, amounts, form (solid or liquid state), frequency, etc., typically used for pharmacokinetic analysis.	Meal Data Domain	Production
C61531	C66734		Domain Abbreviation	MS	MS	Microbiology Susceptibility	This includes microbiology susceptibility test results, plus results of any other organism-related tests.	Microbiology Susceptibility Domain	Production
C49605	C66734		Domain Abbreviation	OM	OM	Organ Measurements	Findings from organ measurement evaluations.	Organ Measurement Domain	Production
C49606	C66734		Domain Abbreviation	PC	PC	Pharmacokinetic Concentration	Concentrations of drugs/metabolites in fluids or tissues as a function of time.	Pharmacokinetic Concentration Domain	Production
C49608	C66734		Domain Abbreviation	PE	PE	Physical Exam	Findings collected during a physical examination of the subject. It has findings that are discovered that are related to body systems. Does not include vital signs measurements, which are stored in the vital signs domain.	Physical Exam Domain	Production
C61529	C66734		Domain Abbreviation	PG	PG	Pharmacogenomics	Pharmacogenomics findings that initially focus on genotype and gene expression data.	Pharmacogenomics Domain	Production
C49607	C66734		Domain Abbreviation	PP	PP	Pharmacokinetic Parameters	Pharmacokinetic parameters derived from pharmacokinetic concentration-time (PC) data.	Pharmacokinetic Parameters Domain	Production
C49609	C66734		Domain Abbreviation	QS	QS	Questionnaires	Questionnaire data may include, but are not limited to the following: subject reported outcomes, validated or non-validated questionnaires, and validated or non-validated diaries (i.e. data with a common topicality).	Questionnaire Domain	Production
C49610	C66734		Domain Abbreviation	SC	SC	Subject Characteristics	The subject characteristics domain is for data not collected in other domains that is subject-related. Examples: subject initials, other race details, eye color, childbearing status, etc.	Subject Characteristics Domain	Production
C49616	C66734		Domain Abbreviation	SE	SE	Subject Element	The subject element table describes the actual order of elements followed by the subject, together with the start date/time and end date/time for each element.	Subject Element Domain	Production
C49611	C66734		Domain Abbreviation	SG	SG	Surgery	Surgical information.	Surgery Domain	Production
C49612	C66734		Domain Abbreviation	SK	SK	Skin Test	Findings from diagnostic skin tests.	Skin Test Domain	Production
C49613	C66734		Domain Abbreviation	SL	SL	Sleep Polysomnography Data	Findings from diagnostic sleep tests (polysomnography).	Sleep Polysomnography Domain	Production
C49614	C66734		Domain Abbreviation	ST	ST	Stress (Exercise) Test Data	Findings from exercise stress tests.	Stress Exercise Test Data Domain	Production
C49615	C66734		Domain Abbreviation	SU	SU	Substance Use	The intent of the domain is to capture substance use information that may be used to assess the efficacy and/or safety of therapies that look to mitigate the effects of chronic substance use.	Substance Use Domain	Production
C49617	C66734		Domain Abbreviation	SV	SV	Subject Visits	The subject visits table describes the actual start and end data/time for each visit of each individual subject.	Subject Visits Domain	Production
C49618	C66734		Domain Abbreviation	TA	TA	Trial Arms	The trial arms table describes each planned arm in the trial. An arm is described as an ordered sequence of elements.	Trial Arms Domain	Production
C49619	C66734		Domain Abbreviation	TE	TE	TE; Trial Elements	The trial elements table describes the element code that is unique for each element, the element description, and the rules for starting and ending an element.	Trial Elements Domain	Production
C49620	C66734		Domain Abbreviation	TI	TI	Trial Inclusion/Exclusion Criteria	The trial summary information domain is not subject oriented. It contains one record for each of the inclusion and exclusion criteria for the trial.	Trial Inclusion and Exclusion Criteria Domain	Production
C53483	C66734		Domain Abbreviation	TS	TS	Trial Summary	The trial summary information domain is not subject oriented. It contains one record for each trial summary characteristic.	Trial Summary Domain	Production
C49621	C66734		Domain Abbreviation	TV	TV	Trial Visits	The trial visits table describes the planned order and number of visits in the study within each arm.	Trial Visits Domain	Production
C49622	C66734		Domain Abbreviation	VS	VS	Vital Signs	Measurements including but not limited to blood pressure, temperature, respiration, body surface area, BMI, height and weight.	Vital Signs Domain	Production
C66735	C66735	Yes	Trial Blinding Schema	TBLIND	TBLIND	Trial Blinding Schema	The name of a code list that contains terms to define the type of blinding for the trial. (NCI)	CDISC SDTM Trial Blinding Schema Terminology	Production
C15228	C66735		Trial Blinding Schema	DOUBLE BLIND	DOUBLE BLIND		A study in which neither the subject nor the investigator nor the research team interacting with the subject or data during the trial knows what treatment a subject is receiving. (CDISC glossary)	Double Blind Study	Production
C49659	C66735		Trial Blinding Schema	OPEN LABEL	OPEN LABEL		A trial in which subjects and investigators know which product each subject is receiving; opposite of a blinded or double-blind study. (CDISC glossary)	Open Label Study	Production
C28233	C66735		Trial Blinding Schema	SINGLE BLIND	SINGLE BLIND		A study in which one party, either the investigator or the subject, does not know which medication or placebo is administered to the subject; also called singlemasked study. (CDISC glossary)	Single Blind Study	Production
C66736	C66736	Yes	Trial Indication Type	TINDTP	TINDTP	Trial Indication Type	The name of a code list that contains terms to define the type of trial, e.g. cure or prevention. (NCI)	CDISC SDTM Trial Indication Type Terminology	Production
C49654	C66736		Trial Indication Type	CURE	CURE		A type of study protocol designed to evaluate intervention(s) aimed to cure a disease or condition.  (NCI)	Cure Study	Production
C49653	C66736		Trial Indication Type	DIAGNOSIS	DIAGNOSIS		A type of study protocol designed to evaluate intervention(s) aimed at identifying a disease or condition.  (NCI)	Diagnosis Study	Production
C49655	C66736		Trial Indication Type	MITIGATION	MITIGATION		A type of study designed to identify actions necessary to eliminate or reduce the risk to human life or well-being as a result of a particular medication or treatment regimen.  (NCI)	Adverse Effect Mitigation Study	Production
C49657	C66736		Trial Indication Type	PREVENTION	PREVENTION		A type of study designed to identify actions necessary to permanently eliminate or reduce the long-term risk to human life as a result of a particular medication or treatment regimen.	Prevention Study	Production
C49656	C66736		Trial Indication Type	TREATMENT	TREATMENT		A type of study protocol designed to evaluate intervention(s) for treatment of disease, syndrome or condition.	Treatment Study	Production
C66737	C66737	Yes	Trial Phase	TPHASE	TPHASE	Trial Phase	Clinical trials are broken into three or four phases: Phase I tests a new drug or treatment for safety in a small group; Phase II expands the study to a larger group of people; Phase III expands the study to an even larger group of people to measure whether the treatment actually benefits patients, and whether its benefits exceed its risks; and Phase IV takes place after the drug or treatment has been licensed and marketed. (NCI)	CDISC SDTM Trial Phase Terminology	Production
C15600	C66737		Trial Phase	Phase I Trial	Phase I Trial	Trial Phase 1; 1	The initial introduction of an investigational new drug into humans. Phase 1 studies are typically closely monitored and may be conducted in patients or normal volunteer subjects. NOTE: These studies are designed to determine the metabolism and pharmacologic actions of the drug in humans, the side effects associated with increasing doses, and, if possible, to gain early evidence on effectiveness. During Phase 1, sufficient information about the drug’s pharmacokinetics and pharmacological effects should be obtained to permit the design of well-controlled, scientifically valid, Phase 2 studies. The total number of subjects and patients included in Phase I studies varies with the drug, but is generally in the range of 20 to 80. Phase 1 studies also include studies of drug metabolism, structure-activity relationships, and mechanism of action in humans, as well as studies in which investigational drugs are used as research tools to explore biological phenomena or disease processes.  [After FDA CDER Handbook, ICH E8] (CDISC glossary)	Phase I Trial	Production
C15693	C66737		Trial Phase	Phase I/II Trial	Phase I/II Trial	Trial Phase 1-2; 1-2	A class of clinical study that combines elements characteristic of traditional Phase I and Phase II trials. See also Phase I, Phase II.	Phase I/II Trial	Production
C15601	C66737		Trial Phase	Phase II Trial	Phase II Trial	Trial Phase 2; 2	Phase 2. Controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in patients with the disease or condition under study and to determine the common short-term side effects and risks associated with the drug. NOTE: Phase 2 studies are typically well controlled, closely monitored, and conducted in a relatively small number of patients, usually involving no more than several hundred subjects. [After FDA CDER Handbook, ICH E8]  (CDISC glossary)	Phase II Trial	Production
C15694	C66737		Trial Phase	Phase II/III Trial	Phase II/III Trial	Trial Phase 2-3; 2-3	A class of clinical study that combines elements characteristic of traditional Phase II and Phase III trials.	Phase II/III Trial	Production
C49686	C66737		Trial Phase	Phase IIa Trial	Phase IIa Trial	Trial Phase 2A; 2A	A clinical research protocol generally refered to as a pilot or feasibility trial that aims to prove the concept of the new intervention in question. (NCI)	Phase IIa Trial	Production
C49688	C66737		Trial Phase	Phase IIb Trial	Phase IIb Trial	Trial Phase 2B; 2B	A clinical research protocol generally refered to as a well-controlled and pivotal trial that aims to prove the mechanism of action of the new intervention in question. A pivotal study will generally be well-controlled, randomized, of adequate size, and whenever possible, double-blind. (NCI)	Phase IIb Trial	Production
C15602	C66737		Trial Phase	Phase III Trial	Phase III Trial	Trial Phase 3; 3	Phase 3. Studies are expanded controlled and uncontrolled trials. They are performed after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather the additional information about effectiveness and safety that is needed to confirm efficacy and evaluate the overall benefit–risk relationship of the drug and to provide an adequate basis for physician labeling. NOTE: Phase 3 studies usually include from several hundred to several thousand subjects. [After FDA CDER Handbook, ICH E8]  (CDISC glossary)	Phase III Trial	Production
C49687	C66737		Trial Phase	Phase IIIaTrial	Phase IIIaTrial	Trial Phase 3A; 3A	A classification typically assigned retrospectively to a Phase III trial upon determination by regulatory authorities of a need for a Phase III B trial.	Phase IIIa Trial	Production
C49689	C66737		Trial Phase	Phase IIIb Trial	Phase IIIb Trial	Trial Phase 3B; 3B	A subcategory of Phase III trials done near the time of approval to elicit additional findings. NOTE: Dossier review may continue while associated Phase IIIB trials are conducted. These trials may be required as a condition of regulatory authority approval.	Phase IIIb Trial	Production
C15603	C66737		Trial Phase	Phase IV Trial	Phase IV Trial	Trial Phase 4; 4	Phase 4. Postmarketing (Phase 4) studies to delineate additional information about the drug’s risks, benefits, and optimal use that may be requested by regulatory authorities in conjunction with marketing approval. NOTE: These studies could include, but would not be limited to, studying different doses or schedules of administration than were used in Phase 2 studies, use of the drug in other patient populations or other stages of the disease, or use of the drug over a longer period of time. [After FDA CDER Handbook, ICH E8]  (CDISC glossary)	Phase IV Trial	Production
C47865	C66737		Trial Phase	Phase V Trial	Phase V Trial	Trial Phase 5; 5	Postmarketing surveillance is sometimes referred to as Phase V.	Phase V Trial	Production
C48660	C66737		Trial Phase	NA	NOT APPLICABLE	NA	Determination of a value is not relevant in the current context. (NCI)	Not Applicable	Production
C66738	C66738	Yes	Trial Summary Parameter Test Code	TSPARMCD	TSPARMCD	Trial Summary Parameter Test Code	Individual characteristics of a clinical trial, e.g. description of trial design, trial blinding schema, and primary objective of trial. (NCI)	CDISC SDTM Trial Summary Parameter Terminology by Code	Production
C49703	C66738		Trial Summary Parameter Test Code	ADDON	ADDON	Added on to Existing Treatments	The addition of a therapeutic product to the existing regimen in a clinical trial, where both entities remain as discrete products.	Test Product Added to Existing Treatment	Production
C49700	C66738		Trial Summary Parameter Test Code	AEDICT	AEDICT	Adverse Event Dictionary	A reference source that provides meanings of words related to adverse events. (NCI)	Adverse Event Dictionary	Production
C49694	C66738		Trial Summary Parameter Test Code	AGEMAX	AGEMAX	Planned Maximum Age of Subjects	The anticipated maximum age of the subjects to be entered in a clinical trial. (NCI)	Planned Maximum Age of Subjects	Production
C49693	C66738		Trial Summary Parameter Test Code	AGEMIN	AGEMIN	Planned Minimum Age of Subjects	The anticipated minimum age of the subjects to be entered in a clinical trial. (NCI)	Planned Minimum Age of Subjects	Production
C20587	C66738		Trial Summary Parameter Test Code	AGESPAN	AGESPAN	Age Span	Subgroups of populations based on age. (NCI)	Age Group	Production
C50400	C66738		Trial Summary Parameter Test Code	AGEU	AGEU	Age Unit	Those units of time that are routinely used to express the age of a person. (NCI)	Age Unit	Production
C25488	C66738		Trial Summary Parameter Test Code	DOSE	DOSE	Dose per Administration	The amount of drug administered to a patient or test subject at one time or the total quantity administered. [AMA Manual of Style] (CDISC Glossary)	Dose	Production
C49701	C66738		Trial Summary Parameter Test Code	DRUGDICT	DRUGDICT	Drug Dictionary	A reference source that provides meanings of words related to drugs. (NCI)	Drug Dictionary	Production
C49697	C66738		Trial Summary Parameter Test Code	LENGTH	LENGTH	Trial Length	The anticipated length of a clinical trial measured as a unit of time. (NCI)	Trial Length	Production
C49702	C66738		Trial Summary Parameter Test Code	MHDICT	MHDICT	Medical History Dictionary	A reference source that provides meanings of words related to medical history. (NCI)	Medical History Dictionary	Production
C49692	C66738		Trial Summary Parameter Test Code	PLANSUB	PLANSUB	Planned Number of Subjects	The number of subjects entered in a clinical trial. (NCI)	Planned Subject Number	Production
C25196	C66738		Trial Summary Parameter Test Code	RANDOM	RANDOM	Trial is Randomized	The process of assigning trial subjects to treatment or control groups using an element of chance to determine the assignments in order to reduce bias. NOTE: Unequal randomization is used to allocate subjects into groups at a differential rate; for example, three subjects may be assigned to a treatment group for every one assigned to the control group. [ICH E6 1.48] See also balanced study. (CDISC glossary)	Randomization	Production
C38114	C66738		Trial Summary Parameter Test Code	ROUTE	ROUTE	Route of Administration	The course by which a substance was administered in order to reach the site of action in the body.	Route of Administration	Production
C49696	C66738		Trial Summary Parameter Test Code	SEXPOP	SEXPOP	Sex of Participants	The specific sex, either male, female, or mixed of the subject group being studied. (NCI)	Sex of Study Group	Production
C49698	C66738		Trial Summary Parameter Test Code	STOPRULE	STOPRULE	Study Stop Rules	The rule, regulation and/or condition that determines the point in time when a clinical trial will be terminated. (NCI)	Study Stop Rules	Production
C49658	C66738		Trial Summary Parameter Test Code	TBLIND	TBLIND	Trial Blinding Schema	The name of a code list that contains terms to define the type of blinding for the trial. (NCI)	Trial Blinding Schema	Production
C49647	C66738		Trial Summary Parameter Test Code	TCNTRL	TCNTRL	Control Type	Comparator against which the study treatment is evaluated (e.g., concurrent (placebo, no treatment, dose-response, active), external (historical, published literature).	Control Type	Production
C49650	C66738		Trial Summary Parameter Test Code	TDIGRP	TDIGRP	Diagnosis Group	A grouping of individuals on the basis of a shared procedure or disease, or lack thereof (e.g. healthy volunteers, type 2 diabetic subjects, subjects with renal cell cancer).  Standardized naming systems are available that define the groups within which a subject should be placed. (NCI)	Diagnosis Group	Production
C49652	C66738		Trial Summary Parameter Test Code	TINDTP	TINDTP	Trial Indication Type	The name of a code list that contains terms to define the type of trial, e.g. cure or prevention.  (NCI)	Trial Indication Type	Production
C49802	C66738		Trial Summary Parameter Test Code	TITLE	TITLE	Trial Title	The name of a clinical trial. (NCI)	Trial Title	Production
C48281	C66738		Trial Summary Parameter Test Code	TPHASE	TPHASE	Trial Phase Classification	Clinical trials are broken into three or four phases: Phase I tests a new drug or treatment for safety in a small group; Phase II expands the study to a larger group of people; Phase III expands the study to an even larger group of people to measure whether the treatment actually benefits patients, and whether its benefits exceed its risks; and Phase IV takes place after the drug or treatment has been licensed and marketed. (NCI)	Trial Phase	Production
C49660	C66738		Trial Summary Parameter Test Code	TTYPE	TTYPE	Trial Type	The type of clinical trial performed e.g. efficacy, safety. (NCI)	Trial Type	Production
C67152	C67152	Yes	Trial Summary Parameter Test Name	TSPARM	TSPARM	Trial Summary Parameter Test Name	Individual characteristics of a clinical trial, e.g. description of trial design, trial blinding schema, and primary objective of trial. (NCI)	CDISC SDTM Trial Summary Parameter Terminology by Name	Production
C49703	C67152		Trial Summary Parameter Test Name	Added on to Existing Treatments	ADDON	Added on to Existing Treatments	The addition of a therapeutic product to the existing regimen in a clinical trial, where both entities remain as discrete products.	Test Product Added to Existing Treatment	Production
C49700	C67152		Trial Summary Parameter Test Name	Adverse Event Dictionary	AEDICT	Adverse Event Dictionary	A reference source that provides meanings of words related to adverse events. (NCI)	Adverse Event Dictionary	Production
C49694	C67152		Trial Summary Parameter Test Name	Planned Maximum Age of Subjects	AGEMAX	Planned Maximum Age of Subjects	The anticipated maximum age of the subjects to be entered in a clinical trial. (NCI)	Planned Maximum Age of Subjects	Production
C49693	C67152		Trial Summary Parameter Test Name	Planned Minimum Age of Subjects	AGEMIN	Planned Minimum Age of Subjects	The anticipated minimum age of the subjects to be entered in a clinical trial. (NCI)	Planned Minimum Age of Subjects	Production
C20587	C67152		Trial Summary Parameter Test Name	Age Group	AGESPAN	Age Group	Subgroups of populations based on age. (NCI)	Age Group	Production
C50400	C67152		Trial Summary Parameter Test Name	Age Unit	AGEU	Age Unit	Those units of time that are routinely used to express the age of a person. (NCI)	Age Unit	Production
C25488	C67152		Trial Summary Parameter Test Name	Dose per Administration	DOSE	Dose per Administration	The amount of drug administered to a patient or test subject at one time or the total quantity administered. [AMA Manual of Style] (CDISC Glossary)	Dose	Production
C49701	C67152		Trial Summary Parameter Test Name	Drug Dictionary	DRUGDICT	Drug Dictionary	A reference source that provides meanings of words related to drugs. (NCI)	Drug Dictionary	Production
C49697	C67152		Trial Summary Parameter Test Name	Trial Length	LENGTH	Trial Length	The anticipated length of a clinical trial measured as a unit of time. (NCI)	Trial Length	Production
C49702	C67152		Trial Summary Parameter Test Name	Medical History Dictionary	MHDICT	Medical History Dictionary	A reference source that provides meanings of words related to medical history. (NCI)	Medical History Dictionary	Production
C49692	C67152		Trial Summary Parameter Test Name	Planned Number of Subjects	PLANSUB	Planned Number of Subjects	The number of subjects entered in a clinical trial. (NCI)	Planned Subject Number	Production
C25196	C67152		Trial Summary Parameter Test Name	Trial is Randomized	RANDOM	Trial is Randomized	The process of assigning trial subjects to treatment or control groups using an element of chance to determine the assignments in order to reduce bias. NOTE: Unequal randomization is used to allocate subjects into groups at a differential rate; for example, three subjects may be assigned to a treatment group for every one assigned to the control group. [ICH E6 1.48] See also balanced study. (CDISC glossary)	Randomization	Production
C38114	C67152		Trial Summary Parameter Test Name	Route of Administration	ROUTE	Route of Administration	The course by which a substance was administered in order to reach the site of action in the body.	Route of Administration	Production
C49696	C67152		Trial Summary Parameter Test Name	Sex of Participants	SEXPOP	Sex of Participants	The specific sex, either male, female, or mixed of the subject group being studied. (NCI)	Sex of Study Group	Production
C49698	C67152		Trial Summary Parameter Test Name	Study Stop Rules	STOPRULE	Study Stop Rules	The rule, regulation and/or condition that determines the point in time when a clinical trial will be terminated. (NCI)	Study Stop Rules	Production
C49658	C67152		Trial Summary Parameter Test Name	Trial Blinding Schema	TBLIND	Trial Blinding Schema	The name of a code list that contains terms to define the type of blinding for the trial. (NCI)	Trial Blinding Schema	Production
C49647	C67152		Trial Summary Parameter Test Name	Control Type	TCNTRL	Control Type	Comparator against which the study treatment is evaluated (e.g., concurrent (placebo, no treatment, dose-response, active), external (historical, published literature).	Control Type	Production
C49650	C67152		Trial Summary Parameter Test Name	Diagnosis Group	TDIGRP	Diagnosis Group	A grouping of individuals on the basis of a shared procedure or disease, or lack thereof (e.g. healthy volunteers, type 2 diabetic subjects, subjects with renal cell cancer).  Standardized naming systems are available that define the groups within which a subject should be placed. (NCI)	Diagnosis Group	Production
C49652	C67152		Trial Summary Parameter Test Name	Trial Indication Type	TINDTP	Trial Indication Type	The name of a code list that contains terms to define the type of trial, e.g. cure or prevention.  (NCI)	Trial Indication Type	Production
C49802	C67152		Trial Summary Parameter Test Name	Trial Title	TITLE	Trial Title	The name of a clinical trial. (NCI)	Trial Title	Production
C48281	C67152		Trial Summary Parameter Test Name	Trial Phase Classification	TPHASE	Trial Phase Classification	Clinical trials are broken into three or four phases: Phase I tests a new drug or treatment for safety in a small group; Phase II expands the study to a larger group of people; Phase III expands the study to an even larger group of people to measure whether the treatment actually benefits patients, and whether its benefits exceed its risks; and Phase IV takes place after the drug or treatment has been licensed and marketed. (NCI)	Trial Phase	Production
C49660	C67152		Trial Summary Parameter Test Name	Trial Type	TTYPE	Trial Type	The type of clinical trial performed e.g. efficacy, safety. (NCI)	Trial Type	Production
C66739	C66739	Yes	Trial Type	TTYPE	TTYPE	Trial Type	The type of clinical trial performed e.g. efficacy, safety. (NCI)	CDISC SDTM Trial Type Terminology	Production
C49664	C66739		Trial Type	BIO-AVAILABILITY	BIO-AVAILABILITY		A study of the degree to which or rate at which a drug or other substance is absorbed or becomes available at the site of physiological activity after administration. (NCI)	Bioavailability Study	Production
C49665	C66739		Trial Type	BIO-EQUIVALENCE	BIO-EQUIVALENCE		A study most often used to compare the efficacy of different formulations to treat a given disease.  It is the testing of an old versus a new formulation in healthy volunteers or subjects with the disease under study and usually in one dose. (NCI)	Therapeutic Equivalency Study	Production
C49666	C66739		Trial Type	EFFICACY	EFFICACY		A study of the relative therapeutic efficacy of treatment of a disease. Usually this is a Phase II or III study. (NCI)	Efficacy Study	Production
C49662	C66739		Trial Type	PHARMACODYNAMIC	PHARMACODYNAMIC		A study of the biochemical and physiological effect of a drug and the mechanism of drug action and the relationship between drug concentration and effect. (NCI)	Pharmacodynamic Study	Production
C39493	C66739		Trial Type	PHARMACOECONOMIC	PHARMACOECONOMIC		A study that assesses the value associated with a given drug in therapeutic and economic terms. This type of study is multidisciplinary in nature and takes into consideration the social and economic costs (resource utilization costs including direct, indirect, and intangible costs) of drug therapy in addition to its direct therapeutic benefits. Analyses relate the difference in therapeutic benefits to the difference in costs between treatment alternatives. (NCI)	Pharmacoeconomic Study	Production
C49661	C66739		Trial Type	PHARMACOGENOMIC	PHARMACOGENOMIC		A study of identification and analysis of genomic variations that affect the efficacy of a drug. Pharmacogenomic studies can potentially be predictive of an individual's drug-response or adverse reactions or susceptibility to iatrogenic disorders, and may also reveal new targets that can help in the design of new drugs. (NCI)	Pharmacogenomic Study	Production
C49663	C66739		Trial Type	PHARMACOKINETIC	PHARMACOKINETIC		A study of the process by which a drug is absorbed, distributed, metabolized, and eliminated by the body. (NCI)	Pharmacokinetic Study	Production
C49667	C66739		Trial Type	SAFETY	SAFETY		A study of the relative safety of treatment of a disease. Usually this is a Phase I or II trial. (NCI)	Safety Study	Production
C66770	C66770	Yes	Units for Vital Signs Results	VSRESU	VSRESU	Units for Vital Signs Results	The unit used to record and describe the result of a test investigating a vital sign. (NCI)	CDISC SDTM Unit for Vital Sign Result Terminology	Production
C25613	C66770		Units for Vital Signs Results	%	%	Percentage	A fraction or ratio with 100 understood as the denominator. (NCI)	Percentage	Production
C49673	C66770		Units for Vital Signs Results	BEATS/MIN	BEATS/MIN	Beats per Minute	The number of heartbeats measured per minute time. (NCI)	Beats per Minute	Production
C49674	C66770		Units for Vital Signs Results	BREATHS/MIN	BREATHS/MIN	Breaths per Minute	The number of breaths (inhalation and exhalation) taken per minute time. (NCI)	Breaths per Minute	Production
C42559	C66770		Units for Vital Signs Results	C	C	Degree Celsius	A unit of temperature of the temperature scale designed so that the freezing point of water is 0 degrees and the boiling point is 100 degrees at standard atmospheric pressure. The current official definition of the Celsius sets 0.01 C to be at the triple point of water and a degree to be 1/273.16 of the difference in temperature between the triple point of water and absolute zero. One degree Celsius represents the same temperature difference as one Kelvin. (NCI)	Degree Celsius	Production
C49668	C66770		Units for Vital Signs Results	cm	cm	Centimeter	A basic unit of length in the former CGS version of metric system, equal to one hundredth of a meter or approximately 0.393 700 787 inch. (NCI)	Centimeter	Production
C44277	C66770		Units for Vital Signs Results	F	F	Degree Fahrenheit	The Fahrenheit temperature scale is named after the German physicist Gabriel Fahrenheit (1686-1736), who proposed it in 1724.  In this scale, the freezing point of water is 32 degrees Fahrenheit and the boiling point is 212 degrees, placing the boiling and melting points of water 180 degrees apart. In this scale a degree Fahrenheit is 5/9ths of a kelvin (or of a degree Celsius), and minus 40 degrees Fahrenheit is equal to minus 40 degrees Celsius. (NCI)	Degree Fahrenheit	Production
C48155	C66770		Units for Vital Signs Results	g	g	Gram	A metric unit of mass equal to one one thousandth of a kilogram. (NCI)	Gram	Production
C48500	C66770		Units for Vital Signs Results	IN	IN	Inch	A traditional unit of length equal to 2.54 centimeters. (NCI)	Inch	Production
C28252	C66770		Units for Vital Signs Results	kg	kg	Kilogram	The basic SI unit of mass.  It is defined as the mass of an international prototype in the form of a platinum-iridium cylinder kept at Sevres in France. It is the only basic unit still defined in terms of a material object, and also the only one with a prefix [kilo] already in place. A kilogram is equal to 1,000 grams and 2.204 622 6 pounds. (NCI)	Kilogram	Production
C49671	C66770		Units for Vital Signs Results	kg/m2	kg/m2	Kilogram Per Square Meter	The SI derived unit of spread rate of a substance by mass, used also as a measure of area density. (NCI)	Kilogram Per Square Meter	Production
C48531	C66770		Units for Vital Signs Results	LB	LB	Pound	A traditional unit of mass. By international agreement, one avoirdupois pound is equal to exactly 0.453 592 37 kilogram, 16 ounces, or 1.215 28 troy pounds. (NCI)	Pound	Production
C42569	C66770		Units for Vital Signs Results	m2	m2	Square Meter	The SI unit of area measurement equal to a square whose sides are one meter long. Square meter is equal to 10,000 square centimeters; 0.01 ares; 1.196 square yards; 10.76 square feet; 1550 square inches. (NCI)	Square Meter	Production
C49670	C66770		Units for Vital Signs Results	mmHg	mmHg	Millimeter of Mercury	A unit of pressure equal to 0.001316 atmosphere and equal to the pressure indicated by one millimeter rise of mercury in a barometer at the Earth's surface. (NCI)	Millimeter of Mercury	Production
C42554	C66770		Units for Vital Signs Results	ohm	ohm	ohm	A unit of electrical resistance equal to the resistance between two points on a conductor when a potential difference of one volt between them produces a current of one ampere. Ohm is also used to measure impedance and reactance for complex resistance. A measurement in ohms is the reciprocal of a measurement in siemens. (NCI)	Ohm	Production
C66741	C66741	Yes	Vital Signs Test Code	VSTESTCD	VSTESTCD	Vital Signs Test Code	The name given to the test that analyzes a particular set of vital signs including temperature, respiratory rate, heart beat (pulse), and blood pressure. (NCI)	CDISC SDTM Vital Sign Terminology by Code	Production
C16358	C66741		Vital Signs Test Code	BMI	BMI	Body Mass Index	A general indicator of the body fat an individual is carrying based upon the ratio of weight to height. (NCI)	Body Mass Index	Production
C12472	C66741		Vital Signs Test Code	BODYFAT	BODYFAT	Adipose Tissue	A specialized form of connective tissue consisting primarily of adipocytes (fat cells), surrounded by a meshwork of collagen fibers.	Adipose Tissue	Production
C25157	C66741		Vital Signs Test Code	BSA	BSA	Body Surface Area	A measure of the 2-dimensional extent of the body surface (i.e., the skin).  Body surface area (BSA) can be calculated by mathematical formula or from a chart that relates height to weight.  BSA is often an important factor in dosing. (NCI)	Body Surface Area	Production
C25299	C66741		Vital Signs Test Code	DIABP	DIABP	Diastolic Blood Pressure	The blood pressure after the contraction of the heart while the chambers of the heart refill with blood. (NCI)	Diastolic Blood Pressure	Production
C49680	C66741		Vital Signs Test Code	FRMSIZE	FRMSIZE	Body Frame Size	The categorization of a person's body frame into small, medium and large based on the measurement of wrist circumference or the breadth of the elbow. (NCI)	Body Frame Size	Production
C25347	C66741		Vital Signs Test Code	HEIGHT	HEIGHT	Height	The vertical measurement or distance from the base to the top of an object; the vertical dimension of extension. (NCI)	Height	Production
C49677	C66741		Vital Signs Test Code	HR	HR	Heart Rate	The number of heartbeats per unit of time, usually expressed as beats per minute. (NCI)	Heart Rate	Production
C49679	C66741		Vital Signs Test Code	MAP	MAP	Mean Arterial Pressure	The mean pressure of the blood within the arterial circulation. The arterial pressure may be directly measured by insertion of an intra-arterial catheter connected to a transducer. The mean arterial pressure (MAP) can be calculated by subsequent analysis of the waveform. MAP can be approximated without an invasive procedure using the following formula: diastolic pressure plus 1/3 of the pulse pressure, where pulse pressure is systolic pressure - diastolic pressure. (NCI)	Mean Arterial Pressure	Production
C49676	C66741		Vital Signs Test Code	PULSE	PULSE	Pulse Rate	The rate of the pulse as observed in an artery, expressed as beats per minute. It can be measured at several anatomical sites, including the wrist, neck, temple, groin, behind the knees, or on top of the foot. (NCI)	Pulse Rate	Production
C49678	C66741		Vital Signs Test Code	RESP	RESP	Respiratory Rate	The rate of breathing (inhalation and exhalation) measured within in a unit time, usually expressed as breaths per minute. (NCI)	Respiratory Rate	Production
C25298	C66741		Vital Signs Test Code	SYSBP	SYSBP	Systolic Blood 	The blood pressure during the contraction of the left ventricle of the heart.	Systolic Blood Pressure	Production
C25206	C66741		Vital Signs Test Code	TEMP	TEMP	Temperature	The property of a body or region of space that determines whether or not there will be a net flow of heat into it or out of it from a neighboring body or region and in which direction (if any) the heat will flow, perceptible by living organism as a somatic sensation of cold or heat. It is a measure of the average translational kinetic energy associated with the disordered microscopic motion of atoms and molecules. Temperature is measured in one of the three standard temperature scales: Celsius, Kelvin, and Fahrenheit. (NCI)	Temperature	Production
C25208	C66741		Vital Signs Test Code	WEIGHT	WEIGHT	Weight	The vertical force exerted by a mass as a result of gravity. (NCI)	Weight	Production
C67153	C67153	Yes	Vital Signs Test Name 	VSTEST	VSTEST	Vital Signs Test Name	The name given to the test that analyzes a particular set of vital signs including temperature, respiratory rate, heart beat (pulse), and blood pressure. (NCI)	CDISC SDTM Vital Sign Terminology  by Name	Production
C16358	C67153		Vital SignsTest Name 	Body Mass Index	BMI	Body Mass Index	A general indicator of the body fat an individual is carrying based upon the ratio of weight to height. (NCI)	Body Mass Index	Production
C12472	C67153		Vital SignsTest Name 	Adipose Tissue	BODYFAT	Adipose Tissue	A specialized form of connective tissue consisting primarily of adipocytes (fat cells), surrounded by a meshwork of collagen fibers.	Adipose Tissue	Production
C25157	C67153		Vital SignsTest Name 	Body Surface Area	BSA	Body Surface Area	A measure of the 2-dimensional extent of the body surface (i.e., the skin).  Body surface area (BSA) can be calculated by mathematical formula or from a chart that relates height to weight.  BSA is often an important factor in dosing. (NCI)	Body Surface Area	Production
C25299	C67153		Vital SignsTest Name 	Diastolic Blood Pressure	DIABP	Diastolic Blood Pressure	The blood pressure after the contraction of the heart while the chambers of the heart refill with blood. (NCI)	Diastolic Blood Pressure	Production
C49680	C67153		Vital SignsTest Name 	Body Frame Size	FRMSIZE	Body Frame Size	The categorization of a person's body frame into small, medium and large based on the measurement of wrist circumference or the breadth of the elbow. (NCI)	Body Frame Size	Production
C25347	C67153		Vital SignsTest Name 	Height	HEIGHT	Height	The vertical measurement or distance from the base to the top of an object; the vertical dimension of extension. (NCI)	Height	Production
C49677	C67153		Vital SignsTest Name 	Heart Rate	HR	Heart Rate	The number of heartbeats per unit of time, usually expressed as beats per minute. (NCI)	Heart Rate	Production
C49679	C67153		Vital SignsTest Name 	Mean Arterial Pressure	MAP	Mean Arterial Pressure	The mean pressure of the blood within the arterial circulation. The arterial pressure may be directly measured by insertion of an intra-arterial catheter connected to a transducer. The mean arterial pressure (MAP) can be calculated by subsequent analysis of the waveform. MAP can be approximated without an invasive procedure using the following formula: diastolic pressure plus 1/3 of the pulse pressure, where pulse pressure is systolic pressure - diastolic pressure. (NCI)	Mean Arterial Pressure	Production
C49676	C67153		Vital SignsTest Name 	Pulse Rate	PULSE	Pulse Rate	The rate of the pulse as observed in an artery, expressed as beats per minute. It can be measured at several anatomical sites, including the wrist, neck, temple, groin, behind the knees, or on top of the foot. (NCI)	Pulse Rate	Production
C49678	C67153		Vital SignsTest Name 	Respiratory Rate	RESP	Respiratory Rate	The rate of breathing (inhalation and exhalation) measured within in a unit time, usually expressed as breaths per minute. (NCI)	Respiratory Rate	Production
C25298	C67153		Vital SignsTest Name 	Systolic Blood Pressure	SYSBP	Systolic Blood Pressure	The blood pressure during the contraction of the left ventricle of the heart.	Systolic Blood Pressure	Production
C25206	C67153		Vital SignsTest Name 	Temperature	TEMP	Temperature	The property of a body or region of space that determines whether or not there will be a net flow of heat into it or out of it from a neighboring body or region and in which direction (if any) the heat will flow, perceptible by living organism as a somatic sensation of cold or heat. It is a measure of the average translational kinetic energy associated with the disordered microscopic motion of atoms and molecules. Temperature is measured in one of the three standard temperature scales: Celsius, Kelvin, and Fahrenheit. (NCI)	Temperature	Production
C25208	C67153		Vital SignsTest Name 	Weight	WEIGHT	Weight	The vertical force exerted by a mass as a result of gravity. (NCI)	Weight	Production
C66742	C66742	No	No Yes Response	NY	NY	No Yes Response	A term that is used to indicate a question with permissible values of yes/no/unknown/not applicable.	CDISC SDTM Yes No Unknown or Not Applicable Response Terminology	Production
C49487	C66742		No Yes Response	N	N	No	The non-affirmative response to a question. (NCI)	No	Production
C48660	C66742		No Yes Response	NA	NOT APPLICABLE	NA	Determination of a value is not relevant in the current context. (NCI)	Not Applicable	Production
C17998	C66742		No Yes Response	U	UNKNOWN	U; Unknown	Not known, not observed, not recorded, or refused. (NCI)	Unknown	Production
C49488	C66742		No Yes Response	Y	Y	Yes	The affirmative response to a question. (NCI)	Yes	Production
C65047	C65047	Yes	Laboratory Test Code	LBTESTCD	LBTESTCD	Laboratory Test Code 	Terminology used for Laboratory Tests of the CDISC Standard Data Tabulation Model.	CDISC SDTM Laboratory Test Terminology by Code	Production
C35266	C65047		Laboratory Test Code	ANISO	ANISO	Anisocytosis	A measurement of the inequality in the size of the red blood cells in a whole blood specimen.	Anisocytosis	Production
C35267	C65047		Laboratory Test Code	POIKILO	POIKILO	Poikilocytes	A measurement of the odd-shaped erythrocytes in a whole blood specimen.	Poikilocytosis	Production
C38037	C65047		Laboratory Test Code	BILI	BILI	Bilirubin	A measurement of the total bilirubin in a biological specimen.	Total Bilirubin	Production
C38462	C65047		Laboratory Test Code	APTT	APTT	Activated Partial Thromboplastin Time	A measurement of the length of time that it takes for clotting to occur when reagents are added to a plasma specimen. The test is partial due to the absence of tissue factor (Factor III) from the reaction mixture.	Partial Thromboplastin Time	Production
C41376	C65047		Laboratory Test Code	GLUC	GLUC	Glucose	A measurement of the glucose in a biological specimen.	Plasma Glucose Measurement	Production
C45997	C65047		Laboratory Test Code	PH	PH	pH	A measure of the acidity or alkalinity of a fluid on a scale of 0 to 14.	pH	Production
C51946	C65047		Laboratory Test Code	RBC	RBC	Erythrocytes	A count of the total erythrocytes per unit of a biological specimen.	Erythrocyte Count	Production
C51947	C65047		Laboratory Test Code	RETI	RETI	Reticulocytes	A count of the reticulocytes per unit of a biological specimen.	Reticulocyte Count	Production
C51948	C65047		Laboratory Test Code	WBC	WBC	Leukocytes	A count of the leukocytes per unit of a biological specimen.	Leukocyte Count	Production
C51949	C65047		Laboratory Test Code	LYM	LYM	Lymphocytes	A count of the lymphocytes per unit of a biological specimen.	Lymphocyte Count	Production
C51951	C65047		Laboratory Test Code	PLAT	PLAT	Platelet	A count of the platelets per unit of a biological specimen.	Platelet Count	Production
C61019	C65047		Laboratory Test Code	BUN	BUN	Blood Urea Nitrogen	A measurement of the urea nitrogen in a blood specimen.	Blood Urea Nitrogen Measurement	Production
C61032	C65047		Laboratory Test Code	CHOL	CHOL	Cholesterol	A measurement of the cholesterol in a biological specimen.	Serum Total Cholesterol Measurement	Production
C61041	C65047		Laboratory Test Code	HDL	HDL	HDL Cholesterol	A measurement of the high density lipoprotein cholesterol in a biological specimen.	Serum HDL Cholesterol Measurement	Production
C61042	C65047		Laboratory Test Code	LDL	LDL	LDL Cholesterol	A measurement of the low density lipoprotein cholesterol in a biological specimen.	Serum LDL Cholesterol Measurement	Production
C62656	C65047		Laboratory Test Code	PT	PT	Prothrombin Time	A blood clotting measurement that evaluates the extrinsic pathway of coagulation and is expressed in units of time or percent activity.	Prothrombin Time	Production
C63321	C65047		Laboratory Test Code	NEUT	NEUT	Neutrophils	A count of the neutrophils per unit of a biological specimen.	Absolute Neutrophil Count	Production
C64431	C65047		Laboratory Test Code	ALB	ALB	Albumin	A measurement of the albumin protein in a biological specimen.	Albumin Measurement	Production
C64432	C65047		Laboratory Test Code	ALP	ALP	Alkaline Phosphatase	A measurement of the alkaline phosphatase in a biological specimen.	Alkaline Phosphatase Measurement	Production
C64433	C65047		Laboratory Test Code	ALT	ALT	Alanine Aminotransferase	A measurement of the alanine aminotransferase in a biological specimen.	Alanine Aminotransferase Measurement	Production
C64434	C65047		Laboratory Test Code	AMYLASE	AMYLASE	Amylase	A measurement of the pancreatic enzyme amylase in a biological specimen.	Amylase Measurement	Production
C64467	C65047		Laboratory Test Code	AST	AST	Aspartate Aminotransferase	A measurement of the aspartate aminotransferase in a biological specimen.	Aspartate Aminotransferase Measurement	Production
C64469	C65047		Laboratory Test Code	BACT	BACT	Bacteria	A measurement of the bacteria in a biological specimen.	Bacterial Count	Production
C64470	C65047		Laboratory Test Code	BASO	BASO	Basophils	A count of the basophils per unit of a biological specimen.	Total Basophil Count	Production
C64471	C65047		Laboratory Test Code	BASOLE	BASOLE	Basophils/Leukocytes	A relative measure (ratio or percentage) of the basophils to leukocytes in a biological specimen.	Basophil To Leukocyte Ratio	Production
C64481	C65047		Laboratory Test Code	BILDIR	BILDIR	Direct Bilirubin	A measurement of the conjugated or water-soluble bilirubin in a biological specimen.	Direct Bilirubin Measurement	Production
C64483	C65047		Laboratory Test Code	BILIND	BILIND	Indirect Bilirubin	A measurement of the unconjugated or non-water-soluble bilirubin in a biological specimen.	Indirect Bilirubin Measurement	Production
C64487	C65047		Laboratory Test Code	BLASTLE	BLASTLE	Blasts/Leukocytes	A relative measure (ratio or percentage) of the blasts to leukocytes in a biological specimen.	Blast To Leukocyte Ratio	Production
C64488	C65047		Laboratory Test Code	CA	CA	Calcium	A measurement of the calcium in a biological specimen.	Calcium Measurement	Production
C64489	C65047		Laboratory Test Code	CK	CK	Creatine Kinase	A measurement of the total creatine kinase in a biological specimen.	Creatine Kinase Measurement	Production
C64490	C65047		Laboratory Test Code	CKBB	CKBB	Creatine Kinase BB	A measurement of the homozygous B-type creatine kinase in a biological specimen.	Creatine Kinase BB Measurement	Production
C64491	C65047		Laboratory Test Code	CKMB	CKMB	Creatine Kinase MB	A measurement of the heterozygous MB-type creatine kinase in a biological specimen.	Creatine Kinase MB Measurement	Production
C64494	C65047		Laboratory Test Code	CKMM	CKMM	Creatine Kinase MM	A measurement of the homozygous M-type creatine kinase in a biological specimen.	Creatine Kinase MM Measurement	Production
C64495	C65047		Laboratory Test Code	CL	CL	Chloride	A measurement of the chloride in a biological specimen.	Chloride Measurement	Production
C64545	C65047		Laboratory Test Code	CO2	CO2	Carbon Dioxide	A measurement of the carbon dioxide gas in a biological specimen.	Carbon Dioxide Measurement	Production
C64546	C65047		Laboratory Test Code	COLOR	COLOR	Color	A measurement of the color of a biological specimen.	Color Assessment	Production
C64547	C65047		Laboratory Test Code	CREAT	CREAT	Creatinine	A measurement of the creatinine in a biological specimen.	Creatinine Measurement	Production
C64548	C65047		Laboratory Test Code	CRP	CRP	C Reactive Protein	A measurement of the C reactive protein in a biological specimen.	C-Reactive Protein Measurement	Production
C64549	C65047		Laboratory Test Code	ELLIPCY	ELLIPCY	Elliptocytes	A count of the elliptocytes per unit of a biological specimen.	Elliptocyte Count	Production
C64550	C65047		Laboratory Test Code	EOS	EOS	Eosinophils	A count of the eosinophils per unit of a biological specimen.	Eosinophil Count	Production
C64604	C65047		Laboratory Test Code	EOSLE	EOSLE	Eosinophils/Leukocytes	A relative measure (ratio or percentage) of the eosinophils to leukocytes in a biological specimen.	Eosinophil To Leukocyte Ratio	Production
C64605	C65047		Laboratory Test Code	EPIC	EPIC	Epithelial Cells	A measurement of the epithelial cells in a biological specimen.	Epithelial Cell Count	Production
C64606	C65047		Laboratory Test Code	FIBRINO	FIBRINO	Fibrinogen	A measurement of the fibrinogen in a biological specimen.	Fibrinogen Measurement	Production
C64796	C65047		Laboratory Test Code	HCT	HCT	Hematocrit	The percentage of a whole blood specimen that is composed of red blood cells (erythrocytes).	Hematocrit	Production
C64797	C65047		Laboratory Test Code	MCH	MCH	Ery. Mean Corpuscular Hemoglobin	A quantitative measurement of the mean amount of hemoglobin per erythrocyte in a biological specimen.	Erythrocyte Mean Corpuscular Hemoglobin	Production
C64798	C65047		Laboratory Test Code	MCHC	MCHC	Ery. Mean Corpuscular HB Concentration	A quantitative measurement of the mean amount of hemoglobin per erythrocytes in a specified volume of a biological specimen.	Erythrocyte Mean Corpuscular Hemoglobin Concentration	Production
C64799	C65047		Laboratory Test Code	MCV	MCV	Ery. Mean Corpuscular Volume	A quantitative measurement of the mean volume of erythrocytes in a biological specimen.	Erythrocyte Mean Corpuscular Volume	Production
C64800	C65047		Laboratory Test Code	RDW	RDW	Erythrocytes Distribution Width	A value derived from mean corpuscular volume and the standard deviation of the red blood cell volume in a whole blood specimen.	Erythrocyte Distribution Width Measurement	Production
C64801	C65047		Laboratory Test Code	TEARDCY	TEARDCY	Dacryocytes	A count of dacryocytes in unit of a biological specimen.	Dacryocyte Analysis	Production
C64802	C65047		Laboratory Test Code	HYPO	HYPO	Hypochromia	An observation which indicates that the hemoglobin concentration in a red blood cell specimen has fallen below a specified level.	Hypochromia	Production
C64803	C65047		Laboratory Test Code	POLYCHR	POLYCHR	Polychromasia	A measurement of the blue-staining characteristic of newly generated erythrocytes.	Polychromasia	Production
C64805	C65047		Laboratory Test Code	INR	INR	Prothrombin Intl. Normalized Ratio	A ratio that represents the prothrombin time for a plasma specimen, divided by the result for a control plasma specimen, further standardized for the International Sensitivity Index of the tissue factor (thromboplastin) used in the test.	International Normalized Ratio of Prothrombin Time	Production
C64806	C65047		Laboratory Test Code	VLDL	VLDL	VLDL Cholesterol	A measurement of the very low density lipoprotein cholesterol in a biological specimen.	Serum VLDL Cholesterol Measurement	Production
C64807	C65047		Laboratory Test Code	LIPASE	LIPASE	Triacylglycerol Lipase	A measurement of the pancreatic lipase in a biological specimen.	Triacylglycerol Lipase Measurement	Production
C64809	C65047		Laboratory Test Code	SODIUM	SODIUM	Sodium	A measurement of the sodium in a biological specimen.	Sodium Measurement	Production
C64810	C65047		Laboratory Test Code	NITRITE	NITRITE	Nitrite	A measurement of the nitrite in a urine specimen.	Nitrite Measurement	Production
C64812	C65047		Laboratory Test Code	TRIG	TRIG	Triglycerides	A measurement of the triglycerides in a biological specimen.	Triglyceride Measurement	Production
C64813	C65047		Laboratory Test Code	TSH	TSH	Thyrotropin	A measurement of the thyrotropin in a biological specimen.	Thyrotropin Measurement	Production
C64814	C65047		Laboratory Test Code	URATE	URATE	Urate	A measurement of the urate in a biological specimen.	Urate Measurement	Production
C64815	C65047		Laboratory Test Code	UREA	UREA	Urea	A measurement of the urea in a biological specimen.	Urea Measurement	Production
C64816	C65047		Laboratory Test Code	UROBIL	UROBIL	Urobilinogen	A measurement of the urobilinogen in a biological specimen.	Urobilinogen Measurement	Production
C64817	C65047		Laboratory Test Code	VITB12	VITB12	Vitamin B12	A measurement of the Vitamin B12 in a serum specimen.	Vitamin B12 Measurement	Production
C64818	C65047		Laboratory Test Code	LYMAT	LYMAT	Lymphocytes Atypical	A count of the atypical lymphocytes per unit of a biological specimen.	Atypical Lymphocyte Count	Production
C64819	C65047		Laboratory Test Code	LYMATLE	LYMATLE	Lymphocytes Atypical/Leukocytes	A relative measure (ratio or percentage) of the atypical lymphocytes to leukocytes in a biological specimen.	Atypical Lymphocyte To Leukocyte Ratio	Production
C64820	C65047		Laboratory Test Code	LYMLE	LYMLE	Lymphocytes/Leukocytes	A relative measure (ratio or percentage) of the lymphocytes to leukocytes in a biological specimen.	Lymphocyte To Leukocyte Ratio	Production
C64821	C65047		Laboratory Test Code	MACROCY	MACROCY	Macrocytes	A count of the macrocytes per unit of a biological specimen.	Macrocyte Count	Production
C64822	C65047		Laboratory Test Code	MICROCY	MICROCY	Microcytes	A count of the microcytes per unit of a biological specimen.	Microcyte Count	Production
C64823	C65047		Laboratory Test Code	MONO	MONO	Monocytes	A count of the monocytes per unit of a biological specimen.	Monocyte Count	Production
C64824	C65047		Laboratory Test Code	MONOLE	MONOLE	Monocytes/Leukocytes	A relative measure (ratio or percentage) of the monocytes to leukocytes in a biological specimen.	Monocyte To Leukocyte Ratio	Production
C64825	C65047		Laboratory Test Code	MYBLALE	MYBLALE	Myeloblasts/Leukocytes	A relative measure (ratio or percentage) of the myeloblasts to leukocytes in a biological specimen.	Myeloblast To Leukocyte Ratio	Production
C64826	C65047		Laboratory Test Code	MYCYLE	MYCYLE	Myelocytes/Leukocytes	A relative measure (ratio or percentage) of the myelocytes to leukocytes in a biological specimen.	Myelocyte To Leukocyte Ratio	Production
C64827	C65047		Laboratory Test Code	NEUTLE	NEUTLE	Neutrophils/Leukocytes	The determination of the ratio of neutrophils compared to leukocytes in a blood sample. The measurement may be expressed as a ratio or percentage.	Neutrophil To Leukocyte Ratio	Production
C64828	C65047		Laboratory Test Code	RETIRBC	RETIRBC	Reticulocytes/Erythrocytes	A relative measure (ratio or percentage) of reticulocytes to erythrocytes in a biological specimen.	Reticulocyte To Erythrocyte Ratio	Production
C64829	C65047		Laboratory Test Code	PRLYMLE	PRLYMLE	Prolymphocytes/Leukocytes	A relative measure (ratio or percentage) of prolymphocytes to leukocytes in a biological specimen.	Prolymphocyte To Leukocyte Ratio	Production
C64830	C65047		Laboratory Test Code	NEUTB	NEUTB	Neutrophils Band Form	A count of the banded neutrophils per unit of a biological specimen.	Neutrophil Band Form Count	Production
C64831	C65047		Laboratory Test Code	NEUTBLE	NEUTBLE	Neutrophils Band Form/Leukocytes	A relative measure (ratio or percentage) of the banded neutrophils to leukocytes in a biological specimen.	Neutrophil Band Form To Leukocyte Ratio	Production
C64832	C65047		Laboratory Test Code	SPGRAV	SPGRAV	Specific Gravity	A ratio of the density of a fluid to the density of water.	Specific Gravity	Production
C64840	C65047		Laboratory Test Code	MG	MG	Magnesium	A measurement of the magnesium in a biological specimen.	Magnesium Measurement	Production
C64847	C65047		Laboratory Test Code	GGT	GGT	Gamma Glutamyl Transferase	A measurement of the gamma glutamyl transpeptidase in a biological specimen.	Gamma Glutamyl Transpeptidase Measurement	Production
C64848	C65047		Laboratory Test Code	HGB	HGB	Hemoglobin	A measurement of the hemoglobin in a biological specimen.	Hemoglobin Measurement	Production
C64849	C65047		Laboratory Test Code	HBA1C	HBA1C	Hemoglobin A1C	A measurement of the glycosylated hemoglobin in a biological specimen.	Glycosylated Hemoglobin Measurement	Production
C64850	C65047		Laboratory Test Code	HBSAG	HBSAG	Hepatitis B Virus Surface Antigen	A measurement of the surface antigen reaction of a biological specimen to the Hepatitis B virus.	Hepatitis B Virus Surface Antigen Measurement	Production
C64851	C65047		Laboratory Test Code	HCG	HCG	Choriogonadotropin Beta	A measurement of the Choriogonadotropin Beta in a biological specimen.	Choriogonadotropin Beta Measurement	Production
C64853	C65047		Laboratory Test Code	K	K	Potassium	A measurement of the potassium in a biological specimen.	Potassium Measurement	Production
C64854	C65047		Laboratory Test Code	KETONES	KETONES	Ketones	A measurement of the ketones in a biological specimen.	Ketone Measurement	Production
C64855	C65047		Laboratory Test Code	LDH	LDH	Lactate Dehydrogenase	A measurement of the lactate dehydrogenase in a biological specimen.	Lactate Dehydrogenase Measurement	Production
C64856	C65047		Laboratory Test Code	LEUKASE	LEUKASE	Leukocyte Esterase	A measurement of the enzyme which indicates the presence of white blood cells in a biological specimen.	Leukocyte Esterase Measurement	Production
C64857	C65047		Laboratory Test Code	PHOS	PHOS	Phosphate	A measurement of the phosphate in a biological specimen.	Phosphate Measurement	Production
C64858	C65047		Laboratory Test Code	PROT	PROT	Protein	A measurement of a group of complex organic macromolecules composed of one or more alpha-L-amino acid chains in a biological specimen.	Total Protein Measurement	Production
C67154	C67154	Yes	Laboratory Test Name 	LBTEST	LBTEST	Laboratory Test Name 	Terminology used for Laboratory Tests of the CDISC Standard Data Tabulation Model.	CDISC SDTM Laboratory Test Terminology by Name	Production
C35266	C67154		Laboratory Test Name 	Anisocytosis	ANISO	Anisocytosis	A measurement of the inequality in the size of the red blood cells in a whole blood specimen.	Anisocytosis	Production
C35267	C67154		Laboratory Test Name 	Poikilocytes	POIKILO	Poikilocytes	A measurement of the odd-shaped erythrocytes in a whole blood specimen.	Poikilocytosis	Production
C38037	C67154		Laboratory Test Name 	Bilirubin	BILI	Bilirubin	A measurement of the total bilirubin in a biological specimen.	Total Bilirubin	Production
C38462	C67154		Laboratory Test Name 	Activated Partial Thromboplastin Time	APTT	Activated Partial Thromboplastin Time	A measurement of the length of time that it takes for clotting to occur when reagents are added to a plasma specimen. The test is partial due to the absence of tissue factor (Factor III) from the reaction mixture.	Partial Thromboplastin Time	Production
C41376	C67154		Laboratory Test Name 	Glucose	GLUC	Glucose	A measurement of the glucose in a biological specimen.	Plasma Glucose Measurement	Production
C45997	C67154		Laboratory Test Name 	pH	PH	pH	A measure of the acidity or alkalinity of a fluid on a scale of 0 to 14.	pH	Production
C51946	C67154		Laboratory Test Name 	Erythrocytes	RBC	Erythrocytes	A count of the total erythrocytes per unit of a biological specimen.	Erythrocyte Count	Production
C51947	C67154		Laboratory Test Name 	Reticulocytes	RETI	Reticulocytes	A count of the reticulocytes per unit of a biological specimen.	Reticulocyte Count	Production
C51948	C67154		Laboratory Test Name 	Leukocytes	WBC	Leukocytes	A count of the leukocytes per unit of a biological specimen.	Leukocyte Count	Production
C51949	C67154		Laboratory Test Name 	Lymphocytes	LYM	Lymphocytes	A count of the lymphocytes per unit of a biological specimen.	Lymphocyte Count	Production
C51951	C67154		Laboratory Test Name 	Platelet	PLAT	Platelet	A count of the platelets per unit of a biological specimen.	Platelet Count	Production
C61019	C67154		Laboratory Test Name 	Blood Urea Nitrogen	BUN	Blood Urea Nitrogen	A measurement of the urea nitrogen in a blood specimen.	Blood Urea Nitrogen Measurement	Production
C61032	C67154		Laboratory Test Name 	Cholesterol	CHOL	Cholesterol	A measurement of the cholesterol in a biological specimen.	Serum Total Cholesterol Measurement	Production
C61041	C67154		Laboratory Test Name 	HDL Cholesterol	HDL	HDL Cholesterol	A measurement of the high density lipoprotein cholesterol in a biological specimen.	Serum HDL Cholesterol Measurement	Production
C61042	C67154		Laboratory Test Name 	LDL Cholesterol	LDL	LDL Cholesterol	A measurement of the low density lipoprotein cholesterol in a biological specimen.	Serum LDL Cholesterol Measurement	Production
C62656	C67154		Laboratory Test Name 	Prothrombin Time	PT	Prothrombin Time	A blood clotting measurement that evaluates the extrinsic pathway of coagulation and is expressed in units of time or percent activity.	Prothrombin Time	Production
C63321	C67154		Laboratory Test Name 	Neutrophils	NEUT	Neutrophils	A count of the neutrophils per unit of a biological specimen.	Absolute Neutrophil Count	Production
C64431	C67154		Laboratory Test Name 	Albumin	ALB	Albumin	A measurement of the albumin protein in a biological specimen.	Albumin Measurement	Production
C64432	C67154		Laboratory Test Name 	Alkaline Phosphatase	ALP	Alkaline Phosphatase	A measurement of the alkaline phosphatase in a biological specimen.	Alkaline Phosphatase Measurement	Production
C64433	C67154		Laboratory Test Name 	Alanine Aminotransferase	ALT	Alanine Aminotransferase	A measurement of the alanine aminotransferase in a biological specimen.	Alanine Aminotransferase Measurement	Production
C64434	C67154		Laboratory Test Name 	Amylase	AMYLASE	Amylase	A measurement of the pancreatic enzyme amylase in a biological specimen.	Amylase Measurement	Production
C64467	C67154		Laboratory Test Name 	Aspartate Aminotransferase	AST	Aspartate Aminotransferase	A measurement of the aspartate aminotransferase in a biological specimen.	Aspartate Aminotransferase Measurement	Production
C64469	C67154		Laboratory Test Name 	Bacteria	BACT	Bacteria	A measurement of the bacteria in a biological specimen.	Bacterial Count	Production
C64470	C67154		Laboratory Test Name 	Basophils	BASO	Basophils	A count of the basophils per unit of a biological specimen.	Total Basophil Count	Production
C64471	C67154		Laboratory Test Name 	Basophils/Leukocytes	BASOLE	Basophils/Leukocytes	A relative measure (ratio or percentage) of the basophils to leukocytes in a biological specimen.	Basophil To Leukocyte Ratio	Production
C64481	C67154		Laboratory Test Name 	Direct Bilirubin	BILDIR	Direct Bilirubin	A measurement of the conjugated or water-soluble bilirubin in a biological specimen.	Direct Bilirubin Measurement	Production
C64483	C67154		Laboratory Test Name 	Indirect Bilirubin	BILIND	Indirect Bilirubin	A measurement of the unconjugated or non-water-soluble bilirubin in a biological specimen.	Indirect Bilirubin Measurement	Production
C64487	C67154		Laboratory Test Name 	Blasts/Leukocytes	BLASTLE	Blasts/Leukocytes	A relative measure (ratio or percentage) of the blasts to leukocytes in a biological specimen.	Blast To Leukocyte Ratio	Production
C64488	C67154		Laboratory Test Name 	Calcium	CA	Calcium	A measurement of the calcium in a biological specimen.	Calcium Measurement	Production
C64489	C67154		Laboratory Test Name 	Creatine Kinase	CK	Creatine Kinase	A measurement of the total creatine kinase in a biological specimen.	Creatine Kinase Measurement	Production
C64490	C67154		Laboratory Test Name 	Creatine Kinase BB	CKBB	Creatine Kinase BB	A measurement of the homozygous B-type creatine kinase in a biological specimen.	Creatine Kinase BB Measurement	Production
C64491	C67154		Laboratory Test Name 	Creatine Kinase MB	CKMB	Creatine Kinase MB	A measurement of the heterozygous MB-type creatine kinase in a biological specimen.	Creatine Kinase MB Measurement	Production
C64494	C67154		Laboratory Test Name 	Creatine Kinase MM	CKMM	Creatine Kinase MM	A measurement of the homozygous M-type creatine kinase in a biological specimen.	Creatine Kinase MM Measurement	Production
C64495	C67154		Laboratory Test Name 	Chloride	CL	Chloride	A measurement of the chloride in a biological specimen.	Chloride Measurement	Production
C64545	C67154		Laboratory Test Name 	Carbon Dioxide	CO2	Carbon Dioxide	A measurement of the carbon dioxide gas in a biological specimen.	Carbon Dioxide Measurement	Production
C64546	C67154		Laboratory Test Name 	Color	COLOR	Color	A measurement of the color of a biological specimen.	Color Assessment	Production
C64547	C67154		Laboratory Test Name 	Creatinine	CREAT	Creatinine	A measurement of the creatinine in a biological specimen.	Creatinine Measurement	Production
C64548	C67154		Laboratory Test Name 	C Reactive Protein	CRP	C Reactive Protein	A measurement of the C reactive protein in a biological specimen.	C-Reactive Protein Measurement	Production
C64549	C67154		Laboratory Test Name 	Elliptocytes	ELLIPCY	Elliptocytes	A count of the elliptocytes per unit of a biological specimen.	Elliptocyte Count	Production
C64550	C67154		Laboratory Test Name 	Eosinophils	EOS	Eosinophils	A count of the eosinophils per unit of a biological specimen.	Eosinophil Count	Production
C64604	C67154		Laboratory Test Name 	Eosinophils/Leukocytes	EOSLE	Eosinophils/Leukocytes	A relative measure (ratio or percentage) of the eosinophils to leukocytes in a biological specimen.	Eosinophil To Leukocyte Ratio	Production
C64605	C67154		Laboratory Test Name 	Epithelial Cells	EPIC	Epithelial Cells	A measurement of the epithelial cells in a biological specimen.	Epithelial Cell Count	Production
C64606	C67154		Laboratory Test Name 	Fibrinogen	FIBRINO	Fibrinogen	A measurement of the fibrinogen in a biological specimen.	Fibrinogen Measurement	Production
C64796	C67154		Laboratory Test Name 	Hematocrit	HCT	Hematocrit	The percentage of a whole blood specimen that is composed of red blood cells (erythrocytes).	Hematocrit	Production
C64797	C67154		Laboratory Test Name 	Ery. Mean Corpuscular Hemoglobin	MCH	Ery. Mean Corpuscular Hemoglobin	A quantitative measurement of the mean amount of hemoglobin per erythrocyte in a biological specimen.	Erythrocyte Mean Corpuscular Hemoglobin	Production
C64798	C67154		Laboratory Test Name 	Ery. Mean Corpuscular HB Concentration	MCHC	Ery. Mean Corpuscular HB Concentration	A quantitative measurement of the mean amount of hemoglobin per erythrocytes in a specified volume of a biological specimen.	Erythrocyte Mean Corpuscular Hemoglobin Concentration	Production
C64799	C67154		Laboratory Test Name 	Ery. Mean Corpuscular Volume	MCV	Ery. Mean Corpuscular Volume	A quantitative measurement of the mean volume of erythrocytes in a biological specimen.	Erythrocyte Mean Corpuscular Volume	Production
C64800	C67154		Laboratory Test Name 	Erythrocytes Distribution Width	RDW	Erythrocytes Distribution Width	A value derived from mean corpuscular volume and the standard deviation of the red blood cell volume in a whole blood specimen.	Erythrocyte Distribution Width Measurement	Production
C64801	C67154		Laboratory Test Name 	Dacryocytes	TEARDCY	Dacryocytes	A count of dacryocytes in unit of a biological specimen.	Dacryocyte Analysis	Production
C64802	C67154		Laboratory Test Name 	Hypochromia	HYPO	Hypochromia	An observation which indicates that the hemoglobin concentration in a red blood cell specimen has fallen below a specified level.	Hypochromia	Production
C64803	C67154		Laboratory Test Name 	Polychromasia	POLYCHR	Polychromasia	A measurement of the blue-staining characteristic of newly generated erythrocytes.	Polychromasia	Production
C64805	C67154		Laboratory Test Name 	Prothrombin Intl. Normalized Ratio	INR	Prothrombin Intl. Normalized Ratio	A ratio that represents the prothrombin time for a plasma specimen, divided by the result for a control plasma specimen, further standardized for the International Sensitivity Index of the tissue factor (thromboplastin) used in the test.	International Normalized Ratio of Prothrombin Time	Production
C64806	C67154		Laboratory Test Name 	VLDL Cholesterol	VLDL	VLDL Cholesterol	A measurement of the very low density lipoprotein cholesterol in a biological specimen.	Serum VLDL Cholesterol Measurement	Production
C64807	C67154		Laboratory Test Name 	Triacylglycerol Lipase	LIPASE	Triacylglycerol Lipase	A measurement of the pancreatic lipase in a biological specimen.	Triacylglycerol Lipase Measurement	Production
C64809	C67154		Laboratory Test Name 	Sodium	SODIUM	Sodium	A measurement of the sodium in a biological specimen.	Sodium Measurement	Production
C64810	C67154		Laboratory Test Name 	Nitrite	NITRITE	Nitrite	A measurement of the nitrite in a urine specimen.	Nitrite Measurement	Production
C64812	C67154		Laboratory Test Name 	Triglycerides	TRIG	Triglycerides	A measurement of the triglycerides in a biological specimen.	Triglyceride Measurement	Production
C64813	C67154		Laboratory Test Name 	Thyrotropin	TSH	Thyrotropin	A measurement of the thyrotropin in a biological specimen.	Thyrotropin Measurement	Production
C64814	C67154		Laboratory Test Name 	Urate	URATE	Urate	A measurement of the urate in a biological specimen.	Urate Measurement	Production
C64815	C67154		Laboratory Test Name 	Urea	UREA	Urea	A measurement of the urea in a biological specimen.	Urea Measurement	Production
C64816	C67154		Laboratory Test Name 	Urobilinogen	UROBIL	Urobilinogen	A measurement of the urobilinogen in a biological specimen.	Urobilinogen Measurement	Production
C64817	C67154		Laboratory Test Name 	Vitamin B12	VITB12	Vitamin B12	A measurement of the Vitamin B12 in a serum specimen.	Vitamin B12 Measurement	Production
C64818	C67154		Laboratory Test Name 	Lymphocytes Atypical	LYMAT	Lymphocytes Atypical	A count of the atypical lymphocytes per unit of a biological specimen.	Atypical Lymphocyte Count	Production
C64819	C67154		Laboratory Test Name 	Lymphocytes Atypical/Leukocytes	LYMATLE	Lymphocytes Atypical/Leukocytes	A relative measure (ratio or percentage) of the atypical lymphocytes to leukocytes in a biological specimen.	Atypical Lymphocyte To Leukocyte Ratio	Production
C64820	C67154		Laboratory Test Name 	Lymphocytes/Leukocytes	LYMLE	Lymphocytes/Leukocytes	A relative measure (ratio or percentage) of the lymphocytes to leukocytes in a biological specimen.	Lymphocyte To Leukocyte Ratio	Production
C64821	C67154		Laboratory Test Name 	Macrocytes	MACROCY	Macrocytes	A count of the macrocytes per unit of a biological specimen.	Macrocyte Count	Production
C64822	C67154		Laboratory Test Name 	Microcytes	MICROCY	Microcytes	A count of the microcytes per unit of a biological specimen.	Microcyte Count	Production
C64823	C67154		Laboratory Test Name 	Monocytes	MONO	Monocytes	A count of the monocytes per unit of a biological specimen.	Monocyte Count	Production
C64824	C67154		Laboratory Test Name 	Monocytes/Leukocytes	MONOLE	Monocytes/Leukocytes	A relative measure (ratio or percentage) of the monocytes to leukocytes in a biological specimen.	Monocyte To Leukocyte Ratio	Production
C64825	C67154		Laboratory Test Name 	Myeloblasts/Leukocytes	MYBLALE	Myeloblasts/Leukocytes	A relative measure (ratio or percentage) of the myeloblasts to leukocytes in a biological specimen.	Myeloblast To Leukocyte Ratio	Production
C64826	C67154		Laboratory Test Name 	Myelocytes/Leukocytes	MYCYLE	Myelocytes/Leukocytes	A relative measure (ratio or percentage) of the myelocytes to leukocytes in a biological specimen.	Myelocyte To Leukocyte Ratio	Production
C64827	C67154		Laboratory Test Name 	Neutrophils/Leukocytes	NEUTLE	Neutrophils/Leukocytes	The determination of the ratio of neutrophils compared to leukocytes in a blood sample. The measurement may be expressed as a ratio or percentage.	Neutrophil To Leukocyte Ratio	Production
C64828	C67154		Laboratory Test Name 	Reticulocytes/Erythrocytes	RETIRBC	Reticulocytes/Erythrocytes	A relative measure (ratio or percentage) of reticulocytes to erythrocytes in a biological specimen.	Reticulocyte To Erythrocyte Ratio	Production
C64829	C67154		Laboratory Test Name 	Prolymphocytes/Leukocytes	PRLYMLE	Prolymphocytes/Leukocytes	A relative measure (ratio or percentage) of prolymphocytes to leukocytes in a biological specimen.	Prolymphocyte To Leukocyte Ratio	Production
C64830	C67154		Laboratory Test Name 	Neutrophils Band Form	NEUTB	Neutrophils Band Form	A count of the banded neutrophils per unit of a biological specimen.	Neutrophil Band Form Count	Production
C64831	C67154		Laboratory Test Name 	Neutrophils Band Form/Leukocytes	NEUTBLE	Neutrophils Band Form/Leukocytes	A relative measure (ratio or percentage) of the banded neutrophils to leukocytes in a biological specimen.	Neutrophil Band Form To Leukocyte Ratio	Production
C64832	C67154		Laboratory Test Name 	Specific Gravity	SPGRAV	Specific Gravity	A ratio of the density of a fluid to the density of water.	Specific Gravity	Production
C64840	C67154		Laboratory Test Name 	Magnesium	MG	Magnesium	A measurement of the magnesium in a biological specimen.	Magnesium Measurement	Production
C64847	C67154		Laboratory Test Name 	Gamma Glutamyl Transferase	GGT	Gamma Glutamyl Transferase	A measurement of the gamma glutamyl transpeptidase in a biological specimen.	Gamma Glutamyl Transpeptidase Measurement	Production
C64848	C67154		Laboratory Test Name 	Hemoglobin	HGB	Hemoglobin	A measurement of the hemoglobin in a biological specimen.	Hemoglobin Measurement	Production
C64849	C67154		Laboratory Test Name 	Hemoglobin A1C	HBA1C	Hemoglobin A1C	A measurement of the glycosylated hemoglobin in a biological specimen.	Glycosylated Hemoglobin Measurement	Production
C64850	C67154		Laboratory Test Name 	Hepatitis B Virus Surface Antigen	HBSAG	Hepatitis B Virus Surface Antigen	A measurement of the surface antigen reaction of a biological specimen to the Hepatitis B virus.	Hepatitis B Virus Surface Antigen Measurement	Production
C64851	C67154		Laboratory Test Name 	Choriogonadotropin Beta	HCG	Choriogonadotropin Beta	A measurement of the Choriogonadotropin Beta in a biological specimen.	Choriogonadotropin Beta Measurement	Production
C64853	C67154		Laboratory Test Name 	Potassium	K	Potassium	A measurement of the potassium in a biological specimen.	Potassium Measurement	Production
C64854	C67154		Laboratory Test Name 	Ketones	KETONES	Ketones	A measurement of the ketones in a biological specimen.	Ketone Measurement	Production
C64855	C67154		Laboratory Test Name 	Lactate Dehydrogenase	LDH	Lactate Dehydrogenase	A measurement of the lactate dehydrogenase in a biological specimen.	Lactate Dehydrogenase Measurement	Production
C64856	C67154		Laboratory Test Name 	Leukocyte Esterase	LEUKASE	Leukocyte Esterase	A measurement of the enzyme which indicates the presence of white blood cells in a biological specimen.	Leukocyte Esterase Measurement	Production
C64857	C67154		Laboratory Test Name 	Phosphate	PHOS	Phosphate	A measurement of the phosphate in a biological specimen.	Phosphate Measurement	Production
C64858	C67154		Laboratory Test Name 	Protein	PROT	Protein	A measurement of a group of complex organic macromolecules composed of one or more alpha-L-amino acid chains in a biological specimen.	Total Protein Measurement	Production